CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 1-naphthyl isothiocyanate
Accession: CHEBI:35455
browse the term
Definition: An isothiocyanate that has formula C11H7NS.
Synonyms: exact_synonym: 1-isothiocyanatonaphthalene
related_synonym: 1-Naphthylisothiocyanate; ANIT; Formula=C11H7NS; InChI=1S/C11H7NS/c13-8-12-11-7-3-5-9-4-1-2-6-10(9)11/h1-7H; InChIKey=JBDOSUUXMYMWQH-UHFFFAOYSA-N; SMILES=S=C=Nc1cccc2ccccc12; alpha-Naphthyl isothiocyanate
xref: Beilstein:637868; CAS:551-06-4
xref_mesh: MESH:D015058
G
A2m
alpha-2-macroglobulin
affects expression increases expression
EXP
1-Naphthylisothiocyanate affects the expression of A2M mRNA 1-Naphthylisothiocyanate results in increased expression of A2M mRNA
CTD
PMID:12883083 PMID:18289764 PMID:25380136
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
A3galt2
alpha 1,3-galactosyltransferase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of A3GALT2 mRNA
CTD
PMID:30723492
NCBI chr 5:141,101,329...141,113,760
Ensembl chr 5:141,107,983...141,115,641
G
Aacs
acetoacetyl-CoA synthetase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AACS mRNA
CTD
PMID:30723492
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
G
Aadac
arylacetamide deacetylase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AADAC mRNA
CTD
PMID:25380136
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
G
Aadacl2fm3
AADACL2 family member 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AADACL2FM3 mRNA
CTD
PMID:30723492
NCBI chr 2:143,936,599...143,975,506
Ensembl chr 2:143,936,554...144,045,987
G
Aadat
aminoadipate aminotransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AADAT mRNA
CTD
PMID:25380136
NCBI chr16:29,509,392...29,544,332
Ensembl chr16:29,509,394...29,544,332
G
Abat
4-aminobutyrate aminotransferase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ABAT mRNA
CTD
PMID:25380136
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases expression increases expression
ISO EXP
18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of ABCB11 mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of ABCB11 mRNA; [liquiritin co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCB11 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of ABCB11 mRNA; [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCB11 protein; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCB11 mRNA; [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCB11 mRNA; [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCB11 protein; [ursodoxicoltaurine co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCB11 protein; acadesine inhibits the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]]; acadesine inhibits the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]; Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein] 1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA; 1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein 1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA; 1-Naphthylisothiocyanate results in increased expression of ABCB11 protein dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 protein] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ABCB11 mRNA
CTD
PMID:17522070 PMID:19181614 PMID:19407337 PMID:24120425 PMID:25418378 PMID:25655198 PMID:27317372 PMID:27344345 PMID:27702592 PMID:27765674 PMID:27853831 PMID:28549656 PMID:29660435 PMID:29968724 PMID:30352267 PMID:30517764 PMID:32198087 PMID:32579994 PMID:32976922 PMID:33749747 PMID:36008890 PMID:36787806 PMID:37348807 More...
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression affects expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of ABCB1 mRNA 1-Naphthylisothiocyanate affects the expression of ABCB1A mRNA [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCB1A mRNA
CTD
PMID:17522070 PMID:30352267 PMID:30723492
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb4
ATP binding cassette subfamily B member 4
multiple interactions decreases expression increases expression
ISO EXP
18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of ABCB4 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCB4 mRNA; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 protein]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]; O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]] 1-Naphthylisothiocyanate results in decreased expression of ABCB4 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ABCB4 mRNA 1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA; 1-Naphthylisothiocyanate results in increased expression of ABCB4 protein
CTD
PMID:14623915 PMID:15913567 PMID:19181614 PMID:19407337 PMID:25655198 PMID:27344345 PMID:27765674 PMID:28549656 PMID:29968724 PMID:30352267 More...
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc1
ATP binding cassette subfamily C member 1
increases expression multiple interactions decreases expression
ISO
1-Naphthylisothiocyanate results in increased expression of ABCC1 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC1 mRNA]
CTD
PMID:15913567 PMID:28549656
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
increases response to substance decreases expression increases expression multiple interactions
ISO EXP
ABCC2 results in increased susceptibility to 1-Naphthylisothiocyanate 1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA; 1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein 1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA; 1-Naphthylisothiocyanate results in increased expression of ABCC2 protein dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; Resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; Resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein] [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of ABCC2 mRNA; [liquiritin co-treated with 1-Naphthylisothiocyanate] results in decreased expression of ABCC2 mRNA; [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC2 protein; [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC2 protein; [ursodoxicoltaurine co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC2 protein; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; NR1H4 promotes the reaction [obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC2 protein]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein]
CTD
PMID:20551477 PMID:25380136 PMID:25418378 PMID:25655198 PMID:26365562 PMID:27317372 PMID:27702592 PMID:27765674 PMID:29660435 PMID:30517764 PMID:32198087 PMID:32579994 PMID:33749747 PMID:36008890 PMID:36787806 PMID:37348807 More...
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions decreases expression affects expression increases expression
ISO EXP
18alpha-glycyrrhetinic acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ABCC3 mRNA]; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of ABCC3 mRNA; [liquiritin co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC3 mRNA; [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC3 protein; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCC3 mRNA; Glycyrrhizic Acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ABCC3 mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 protein]; Uric Acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA] 1-Naphthylisothiocyanate results in decreased expression of ABCC3 mRNA resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA]; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 protein] 1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA; 1-Naphthylisothiocyanate results in increased expression of ABCC3 protein
CTD
PMID:14623915 PMID:17522070 PMID:19181614 PMID:19407337 PMID:25418378 PMID:25655198 PMID:26365562 PMID:27765674 PMID:28549656 PMID:30352267 PMID:30517764 PMID:30723492 PMID:32579994 PMID:33749747 PMID:36008890 PMID:36787806 More...
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
decreases expression increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of ABCC4 mRNA 1-Naphthylisothiocyanate results in increased expression of ABCC4 mRNA [liquiritin co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC4 mRNA; [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC4 protein; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCC4 mRNA; [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC4 protein; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC4 mRNA]
CTD
PMID:27765674 PMID:30352267 PMID:30517764 PMID:36008890 PMID:36787806 PMID:37348807 More...
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcc8
ATP binding cassette subfamily C member 8
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ABCC8 mRNA
CTD
PMID:30723492
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
G
Abcg1
ATP binding cassette subfamily G member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ABCG1 mRNA
CTD
PMID:25380136
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
G
Abcg5
ATP binding cassette subfamily G member 5
decreases expression multiple interactions increases expression
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA] 1-Naphthylisothiocyanate results in increased expression of ABCG5 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ABCG5 mRNA
CTD
PMID:25380136 PMID:27344345 PMID:27765674 PMID:28549656 PMID:30723492
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
decreases expression increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of ABCG8 mRNA 1-Naphthylisothiocyanate results in increased expression of ABCG8 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ABCG8 mRNA
CTD
PMID:25380136 PMID:27344345 PMID:27765674 PMID:30723492
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Abhd11-as1
ABHD11 antisense RNA 1 (tail to tail)
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ABHD11OS mRNA
CTD
PMID:30723492
NCBI chr12:21,681,118...21,682,106
G
Ablim3
actin binding LIM protein family, member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ABLIM3 mRNA
CTD
PMID:25380136
NCBI chr18:55,256,135...55,376,629
Ensembl chr18:55,257,583...55,376,380
G
Abtb2
ankyrin repeat and BTB domain containing 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ABTB2 mRNA
CTD
PMID:30723492
NCBI chr 3:89,954,726...90,108,549
Ensembl chr 3:89,954,713...90,108,548
G
Acaca
acetyl-CoA carboxylase alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACACA mRNA
CTD
PMID:30723492
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acacb
acetyl-CoA carboxylase beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACACB mRNA
CTD
PMID:30723492
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
G
Acadm
acyl-CoA dehydrogenase medium chain
decreases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of ACADM mRNA Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ACADM mRNA]
CTD
PMID:17522070 PMID:33749747
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
G
Acap1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACAP1 mRNA
CTD
PMID:30723492
NCBI chr10:54,605,323...54,619,472
Ensembl chr10:54,605,323...54,619,472
G
Acat1
acetyl-CoA acetyltransferase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACAT1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
G
Acat2
acetyl-CoA acetyltransferase 2
affects expression increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate affects the expression of ACAT2 mRNA 1-Naphthylisothiocyanate results in increased expression of ACAT2 mRNA 18alpha-glycyrrhetinic acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ACAT2 mRNA]; Glycyrrhizic Acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ACAT2 mRNA]
CTD
PMID:28549656 PMID:30723492
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Acat2l1
acetyl-CoA acetyltransferase 2-like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACAT2L1 mRNA
CTD
PMID:30723492
NCBI chr 1:47,803,822...47,829,012
Ensembl chr 1:47,803,813...47,829,151
G
Acbd4
acyl-CoA binding domain containing 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACBD4 mRNA
CTD
PMID:25380136
NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500
G
Ackr3
atypical chemokine receptor 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACKR3 mRNA
CTD
PMID:25380136
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Acly
ATP citrate lyase
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACLY mRNA 1-Naphthylisothiocyanate results in increased expression of ACLY mRNA
CTD
PMID:17522070 PMID:30723492
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
G
Acod1
aconitate decarboxylase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACOD1 mRNA
CTD
PMID:30723492
NCBI chr15:79,871,819...79,881,101
Ensembl chr15:79,871,827...79,880,529
G
Acot12
acyl-CoA thioesterase 12
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACOT12 mRNA
CTD
PMID:30723492
NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536
G
Acot3
acyl-CoA thioesterase 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACOT3 mRNA
CTD
PMID:30723492
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
G
Acox1
acyl-CoA oxidase 1
increases expression multiple interactions decreases expression
EXP ISO
1-Naphthylisothiocyanate results in increased expression of ACOX1 mRNA [1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of ACOX1 mRNA; Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ACOX1 mRNA]
CTD
PMID:12883083 PMID:33749747
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
G
Acox2
acyl-CoA oxidase 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACOX2 mRNA
CTD
PMID:25380136
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
G
Acp3
acid phosphatase 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACP3 mRNA
CTD
PMID:30723492
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
G
Acp5
acid phosphatase 5, tartrate resistant
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACP5 mRNA
CTD
PMID:25380136
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACSL1 mRNA
CTD
PMID:17522070 PMID:25380136 PMID:30723492
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Acsl3
acyl-CoA synthetase long-chain family member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACSL3 mRNA
CTD
PMID:30723492
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ACSM3 mRNA
CTD
PMID:30723492
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
G
Acss2
acyl-CoA synthetase short-chain family member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACSS2 mRNA
CTD
PMID:30723492
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
G
Acta1
actin, alpha 1, skeletal muscle
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACTA1 mRNA
CTD
PMID:30723492
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
G
Acta2
actin alpha 2, smooth muscle
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACTA2 mRNA
CTD
PMID:30723492
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Actg1
actin, gamma 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACTG1 mRNA
CTD
PMID:30723492
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Actn1
actinin, alpha 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACTN1 mRNA
CTD
PMID:25380136
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
G
Actn3
actinin alpha 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ACTN3 mRNA
CTD
PMID:30723492
NCBI chr 1:202,159,081...202,175,012
Ensembl chr 1:202,159,082...202,175,012
G
Ada
adenosine deaminase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADA mRNA
CTD
PMID:25380136
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adam8
ADAM metallopeptidase domain 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ADAM8 mRNA
CTD
PMID:30723492
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adamts7
ADAM metallopeptidase with thrombospondin type 1 motif, 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADAMTS7 mRNA
CTD
PMID:30723492
NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328
G
Adcy10
adenylate cyclase 10
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADCY10 mRNA
CTD
PMID:30723492
NCBI chr13:77,747,752...77,833,952
Ensembl chr13:77,768,468...77,833,951
G
Add2
adducin 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADD2 mRNA
CTD
PMID:30723492
NCBI chr 4:118,444,594...118,538,505
Ensembl chr 4:118,497,416...118,538,505
G
Add3
adducin 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ADD3 mRNA
CTD
PMID:25380136
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adgre1
adhesion G protein-coupled receptor E1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ADGRE1 mRNA
CTD
PMID:25380136
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
G
Adgrf5
adhesion G protein-coupled receptor F5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADGRF5 mRNA
CTD
PMID:30723492
NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968
G
Adgrv1
adhesion G protein-coupled receptor V1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADGRV1 mRNA
CTD
PMID:30723492
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ADH1 mRNA
CTD
PMID:25380136
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADH7 mRNA
CTD
PMID:30723492
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
G
Adhfe1
alcohol dehydrogenase, iron containing, 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADHFE1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
G
Adipor2
adiponectin receptor 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADIPOR2 mRNA
CTD
PMID:30723492
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Adora1
adenosine A1 receptor
increases response to substance
ISO
ADORA1 protein results in increased susceptibility to 1-Naphthylisothiocyanate
CTD
PMID:22956627
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adra1b
adrenoceptor alpha 1B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ADRA1B mRNA
CTD
PMID:25380136
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
G
Afm
afamin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AFM mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
G
Agl
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AGL mRNA
CTD
PMID:25380136
NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828
G
Agtpbp1
ATP/GTP binding carboxypeptidase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AGTPBP1 mRNA
CTD
PMID:30723492
NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869
G
Agtr1a
angiotensin II receptor, type 1a
multiple interactions decreases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of AGTR1 mRNA 1-Naphthylisothiocyanate results in decreased expression of AGTR1A mRNA
CTD
PMID:25380136 PMID:27344345
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Agxt
alanine--glyoxylate aminotransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AGXT mRNA
CTD
PMID:30723492
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
G
Ahnak
AHNAK nucleoprotein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AHNAK mRNA
CTD
PMID:25380136
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
G
Ahr
aryl hydrocarbon receptor
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of AHR mRNA AHR protein affects the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; AHR protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of CHKA mRNA]
CTD
PMID:29737914 PMID:30723492
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aida
axin interactor, dorsalization associated
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AIDA mRNA
CTD
PMID:25380136
NCBI chr13:94,940,311...94,967,920
Ensembl chr13:94,939,741...94,967,920
G
Aif1
allograft inflammatory factor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AIF1 mRNA
CTD
PMID:25380136
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Aig1
androgen-induced 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AIG1 mRNA
CTD
PMID:30723492
NCBI chr 1:8,046,430...8,269,276
Ensembl chr 1:8,046,430...8,269,084
G
Ajm1
apical junction component 1 homolog
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AJM1 mRNA
CTD
PMID:30723492
NCBI chr 3:8,394,942...8,401,323
Ensembl chr 3:8,392,889...8,401,321
G
Ak1
adenylate kinase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AK1 mRNA
CTD
PMID:30723492
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
G
Akap11
A-kinase anchoring protein 11
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AKAP11 mRNA
CTD
PMID:30723492
NCBI chr15:53,911,635...53,956,138
Ensembl chr15:53,911,657...53,941,605
G
Akap5
A-kinase anchoring protein 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AKAP5 mRNA
CTD
PMID:30723492
NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AKR1B1 mRNA
CTD
PMID:25380136
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases expression
ISO EXP
1-Naphthylisothiocyanate results in decreased expression of AKR1C6 mRNA 1-Naphthylisothiocyanate results in decreased expression of AKR1C1 mRNA
CTD
PMID:15913567 PMID:25380136
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c12l1
aldo-keto reductase family 1, member C12-like 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AKR1C12L1 mRNA
CTD
PMID:30723492
NCBI chr17:65,937,834...65,948,344
Ensembl chr17:65,937,814...65,997,595
G
Akr1c3
aldo-keto reductase family 1, member C3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AKR1C3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
AKR1C3l1
aldo-keto reductase family 1 member C3-like 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AKR1C3L1 mRNA
CTD
PMID:25380136
NCBI chr17:65,847,580...65,881,488
Ensembl chr17:65,835,634...65,881,488
G
Akt1
AKT serine/threonine kinase 1
decreases expression
ISO
1-Naphthylisothiocyanate results in decreased expression of AKT1 mRNA
CTD
PMID:37348807
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Aktip
AKT interacting protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AKTIP mRNA
CTD
PMID:25380136
NCBI chr19:15,866,811...15,877,123
Ensembl chr19:15,866,928...15,886,663
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ALDH1A1 mRNA
CTD
PMID:27344345
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ALDH1B1 mRNA 1-Naphthylisothiocyanate results in increased expression of ALDH1B1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
decreases expression
EXP
1-naphthyl isothiocyanate decreases expression of ALDH1L1 mRNA in rat liver
RGD
PMID:30223280
RGD:15045612
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ALDH1L2 mRNA
CTD
PMID:25380136
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ALDOA mRNA
CTD
PMID:17522070
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Alpl
alkaline phosphatase, biomineralization associated
multiple interactions increases expression increases secretion
ISO EXP
RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ALPL protein] 1-Naphthylisothiocyanate results in increased expression of ALPL mRNA 1-Naphthylisothiocyanate results in increased secretion of ALPL protein dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in increased secretion of ALPL protein]
CTD
PMID:27702592 PMID:28049044 PMID:30723492
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Amacr
alpha-methylacyl-CoA racemase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AMACR mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
G
Amdhd1
amidohydrolase domain containing 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AMDHD1 mRNA
CTD
PMID:30723492
NCBI chr 7:28,043,923...28,059,156
Ensembl chr 7:28,043,716...28,059,156
G
Amelx
amelogenin, X-linked
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AMELX mRNA
CTD
PMID:12832660
NCBI chr X:25,076,362...25,087,660
Ensembl chr X:25,076,362...25,087,660
G
Amigo1
adhesion molecule with Ig like domain 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AMIGO1 mRNA
CTD
PMID:30723492
NCBI chr 2:195,823,138...195,828,593
Ensembl chr 2:195,823,042...195,829,585
G
Ang
angiogenin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ANG mRNA
CTD
PMID:30723492
NCBI chr15:24,312,711...24,323,361
G
Ang2
angiogenin, ribonuclease A family, member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ANG2 mRNA
CTD
PMID:30723492
NCBI chr15:24,398,330...24,415,909
Ensembl chr15:24,398,419...24,398,922
G
Angpt4
angiopoietin 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANGPT4 mRNA
CTD
PMID:30723492
NCBI chr 3:140,420,389...140,454,213
Ensembl chr 3:140,420,389...140,453,583
G
Angptl3
angiopoietin-like 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ANGPTL3 mRNA
CTD
PMID:25380136
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
G
Angptl4
angiopoietin-like 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ANGPTL4 mRNA
CTD
PMID:30723492
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Ankef1
ankyrin repeat and EF-hand domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANKEF1 mRNA
CTD
PMID:30723492
NCBI chr 3:123,847,832...123,883,060
Ensembl chr 3:123,847,817...123,883,059
G
Ankle1
ankyrin repeat and LEM domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANKLE1 mRNA
CTD
PMID:30723492
NCBI chr16:18,076,413...18,082,356
Ensembl chr16:18,076,492...18,083,729
G
Ankrd55
ankyrin repeat domain 55
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ANKRD55 mRNA
CTD
PMID:30723492
NCBI chr 2:43,883,877...43,983,820
Ensembl chr 2:43,883,857...43,983,680
G
Anln
anillin, actin binding protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANLN mRNA
CTD
PMID:30723492
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
G
Anlnl1
anillin, actin binding protein-like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANLNL1 mRNA
CTD
PMID:30723492
NCBI chr17:57,985,340...57,995,824
Ensembl chr17:57,986,511...57,989,997
G
Ano6
anoctamin 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANO6 mRNA
CTD
PMID:25380136
NCBI chr 7:126,933,919...127,113,588
Ensembl chr 7:126,933,936...127,113,589
G
Ano7
anoctamin 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANO7 mRNA
CTD
PMID:30723492
NCBI chr 9:93,917,524...93,945,323
Ensembl chr 9:93,917,524...93,945,323
G
Anxa1
annexin A1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANXA1 mRNA
CTD
PMID:25380136
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa13
annexin A13
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANXA13 mRNA
CTD
PMID:30723492
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
G
Anxa2
annexin A2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANXA2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Anxa3
annexin A3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANXA3 mRNA
CTD
PMID:25380136
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
G
Anxa4
annexin A4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANXA4 mRNA
CTD
PMID:25380136
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
Anxa5
annexin A5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ANXA5 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
G
Aoc1
amine oxidase, copper containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AOC1 mRNA
CTD
PMID:30723492
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
G
Ap1s2
adaptor related protein complex 1 subunit sigma 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AP1S2 mRNA
CTD
PMID:25380136
NCBI chr X:30,572,746...30,598,961
Ensembl chr X:30,572,751...30,597,262
G
Apbb1ip
amyloid beta precursor protein binding family B member 1 interacting protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of APBB1IP mRNA
CTD
PMID:25380136
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of APEX1 mRNA
CTD
PMID:17522070
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Apmap
adipocyte plasma membrane associated protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of APMAP mRNA
CTD
PMID:25380136
NCBI chr 3:139,409,021...139,437,296
Ensembl chr 3:139,409,022...139,437,341
G
Apoa1
apolipoprotein A1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of APOA1 mRNA
CTD
PMID:30723492
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apoa4
apolipoprotein A4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of APOA4 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Apob
apolipoprotein B
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of APOB mRNA
CTD
PMID:27344345
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoc2
apolipoprotein C2
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of APOC2 mRNA
CTD
PMID:27344345
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Apoc4
apolipoprotein C4
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of APOC4 mRNA
CTD
PMID:27344345
NCBI chr 1:79,335,745...79,339,942
Ensembl chr 1:79,335,745...79,339,981
G
Apof
apolipoprotein F
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of APOF mRNA
CTD
PMID:27344345
NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
G
Apol9a
apolipoprotein L9a
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of APOL9A mRNA
CTD
PMID:25380136
NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
G
App
amyloid beta precursor protein
affects expression increases expression
EXP
1-Naphthylisothiocyanate affects the expression of APP mRNA 1-Naphthylisothiocyanate results in increased expression of APP mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Appl1
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of APPL1 mRNA
CTD
PMID:25380136
NCBI chr16:2,118,503...2,166,741
Ensembl chr16:2,121,255...2,166,692
G
Aqp4
aquaporin 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AQP4 mRNA
CTD
PMID:30723492
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Aqp5
aquaporin 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of AQP5 mRNA
CTD
PMID:20551477 PMID:30723492
NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:130,721,748...130,726,209
G
Aqp7
aquaporin 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AQP7 mRNA
CTD
PMID:25380136
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
G
Ar
androgen receptor
multiple interactions
ISO
1-Naphthylisothiocyanate binds to and results in decreased activity of AR protein; 1-Naphthylisothiocyanate binds to and results in increased activity of AR protein
CTD
PMID:25752796
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Areg
amphiregulin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AREG mRNA
CTD
PMID:20551477
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arhgap11a
Rho GTPase activating protein 11A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARHGAP11A mRNA
CTD
PMID:30723492
NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559
G
Arhgap19
Rho GTPase activating protein 19
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARHGAP19 mRNA
CTD
PMID:30723492
NCBI chr 1:240,571,554...240,617,361
Ensembl chr 1:240,580,871...240,617,287
G
Arhgap9
Rho GTPase activating protein 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARHGAP9 mRNA
CTD
PMID:25380136
NCBI chr 7:63,148,573...63,157,025
Ensembl chr 7:63,148,900...63,157,524
G
Arhgef16
Rho guanine nucleotide exchange factor 16
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARHGEF16 mRNA
CTD
PMID:30723492
NCBI chr 5:164,843,656...164,866,212
Ensembl chr 5:164,844,161...164,866,212
G
Arhgef37
Rho guanine nucleotide exchange factor 37
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ARHGEF37 mRNA
CTD
PMID:30723492
NCBI chr18:54,935,256...55,001,017
Ensembl chr18:54,949,110...55,000,669
G
Arl11
ADP-ribosylation factor like GTPase 11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARL11 mRNA
CTD
PMID:25380136
NCBI chr15:35,483,330...35,485,579
Ensembl chr15:35,480,018...35,496,596
G
Arl4d
ADP-ribosylation factor like GTPase 4D
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARL4D mRNA
CTD
PMID:30723492
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
G
Arl8a
ADP-ribosylation factor like GTPase 8A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARL8A mRNA
CTD
PMID:25380136
NCBI chr13:46,585,845...46,594,851
Ensembl chr13:46,585,845...46,594,851
G
Arpc1b
actin related protein 2/3 complex, subunit 1B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARPC1B mRNA
CTD
PMID:25380136
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
G
Arpin
actin-related protein 2/3 complex inhibitor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARPIN mRNA
CTD
PMID:30723492
NCBI chr 1:133,864,288...133,873,124
Ensembl chr 1:133,864,265...133,873,124
G
Arpp19
cAMP-regulated phosphoprotein 19
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ARPP19 mRNA
CTD
PMID:30723492
NCBI chr 8:75,779,640...75,802,474
Ensembl chr 8:75,779,523...75,802,452 Ensembl chr 8:75,779,523...75,802,452
G
Arrb2
arrestin, beta 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ARRB2 mRNA
CTD
PMID:25380136
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
G
Arrdc3
arrestin domain containing 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ARRDC3 mRNA
CTD
PMID:30723492
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ASAH1 mRNA
CTD
PMID:25380136
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Asb2
ankyrin repeat and SOCS box-containing 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ASB2 mRNA
CTD
PMID:30723492
NCBI chr 6:122,474,754...122,511,014
Ensembl chr 6:122,474,756...122,510,854
G
Asb5
ankyrin repeat and SOCS box-containing 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ASB5 mRNA
CTD
PMID:30723492
NCBI chr16:37,237,869...37,305,207
Ensembl chr16:37,235,405...37,278,109
G
Ascl1
achaete-scute family bHLH transcription factor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ASCL1 mRNA
CTD
PMID:30723492
NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
G
Asf1b
anti-silencing function 1B histone chaperone
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ASF1B mRNA
CTD
PMID:30723492
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
G
Asl
argininosuccinate lyase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ASL mRNA
CTD
PMID:17522070
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of ASNS mRNA
CTD
PMID:17175557 PMID:25380136
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Aspm
assembly factor for spindle microtubules
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ASPM mRNA
CTD
PMID:30723492
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
G
Aspn
asporin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ASPN mRNA
CTD
PMID:25380136
NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
G
Astn2
astrotactin 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ASTN2 mRNA
CTD
PMID:30723492
NCBI chr 5:78,758,142...79,744,021
Ensembl chr 5:78,758,142...79,748,273
G
Atf3
activating transcription factor 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ATF3 mRNA
CTD
PMID:20551477 PMID:25380136
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of ATF4 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ATF4 mRNA
CTD
PMID:20551477 PMID:27344345
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atg16l2
autophagy related 16-like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ATG16L2 mRNA
CTD
PMID:30723492
NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420
G
Atosa
atos homolog A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ATOSA mRNA
CTD
PMID:30723492
NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549
G
Atp10a
ATPase phospholipid transporting 10A (putative)
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ATP10A mRNA
CTD
PMID:30723492
NCBI chr 1:109,556,760...109,730,440
Ensembl chr 1:109,556,782...109,730,437
G
Atp1a2
ATPase Na+/K+ transporting subunit alpha 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ATP1A2 mRNA
CTD
PMID:30723492
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
G
Atp4a
ATPase H+/K+ transporting subunit alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ATP4A mRNA
CTD
PMID:30723492
NCBI chr 1:85,961,607...85,974,972
Ensembl chr 1:85,961,708...85,974,844
G
Atp6v0d2
ATPase H+ transporting V0 subunit D2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ATP6V0D2 mRNA
CTD
PMID:30723492
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
G
Atp6v1d
ATPase H+ transporting V1 subunit D
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ATP6V1D mRNA
CTD
PMID:25380136
NCBI chr 6:97,656,725...97,672,295
Ensembl chr 6:97,656,576...97,672,303
G
Atp8b1
ATPase phospholipid transporting 8B1
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of ATP8B1 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ATP8B1 mRNA]
CTD
PMID:19407337 PMID:28549656
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
G
Atp8b2
ATPase phospholipid transporting 8B2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ATP8B2 mRNA
CTD
PMID:30723492
NCBI chr 2:175,378,514...175,402,265
Ensembl chr 2:175,378,517...175,401,883
G
Atrn
attractin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ATRN mRNA
CTD
PMID:25380136
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
G
Atxn1l
ataxin 1 like
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ATXN1L mRNA
CTD
PMID:30723492
NCBI chr19:37,700,341...37,711,529
Ensembl chr19:37,700,106...37,711,538
G
Atxn7l1
ataxin 7-like 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ATXN7L1 mRNA
CTD
PMID:30723492
NCBI chr 6:49,759,876...49,982,323
Ensembl chr 6:49,759,883...49,982,320
G
Aurkb
aurora kinase B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AURKB mRNA; 1-Naphthylisothiocyanate results in increased expression of AURKB protein
CTD
PMID:23411599 PMID:30723492
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Axl
Axl receptor tyrosine kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of AXL mRNA
CTD
PMID:25380136
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
G
B3galnt1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of B3GALNT1 mRNA
CTD
PMID:30723492
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
G
B4galt5
beta-1,4-galactosyltransferase 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of B4GALT5 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
G
B9d1
B9 domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of B9D1 mRNA
CTD
PMID:25380136
NCBI chr10:46,186,222...46,196,309
Ensembl chr10:46,186,691...46,196,008
G
Baat
bile acid CoA:amino acid N-acyltransferase
increases expression decreases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of BAAT mRNA; 1-Naphthylisothiocyanate results in increased expression of BAAT protein 1-Naphthylisothiocyanate results in decreased expression of BAAT mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of BAAT mRNA alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of BAAT mRNA]
CTD
PMID:25655198 PMID:27344345 PMID:37348807
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
G
Bard1
BRCA1 associated RING domain 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BARD1 mRNA
CTD
PMID:30723492
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
G
Basp1
brain abundant, membrane attached signal protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BASP1 mRNA
CTD
PMID:30723492
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO EXP
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of BAX mRNA]
CTD
PMID:12883083 PMID:15913567 PMID:20551477
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbox1
gamma-butyrobetaine hydroxylase 1
affects expression
EXP
1-Naphthylisothiocyanate affects the expression of BBOX1 mRNA
CTD
PMID:25380136
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
G
Bcas3
BCAS3, microtubule associated cell migration factor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of BCAS3 mRNA
CTD
PMID:30723492
NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080
G
Bckdha
branched chain keto acid dehydrogenase E1 subunit alpha
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of BCKDHA mRNA
CTD
PMID:30723492
NCBI chr 1:81,138,946...81,167,765
Ensembl chr 1:81,138,947...81,167,862
G
Bcl10
BCL10, immune signaling adaptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BCL10 mRNA
CTD
PMID:30723492
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
G
Bcl2
BCL2, apoptosis regulator
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA]; [C188-9 compound co-treated with 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA]; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA]
CTD
PMID:12883083 PMID:36460194
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l11
Bcl2-like 11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BCL2L11 mRNA
CTD
PMID:30723492
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Bcl3
BCL3, transcription coactivator
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BCL3 mRNA
CTD
PMID:30723492
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of BDH1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
G
Bdkrb1
bradykinin receptor B1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BDKRB1 mRNA
CTD
PMID:30723492
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bet1l
Bet1 golgi vesicular membrane trafficking protein-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BET1L mRNA
CTD
PMID:12832660
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
G
Bex3
brain expressed X-linked 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BEX3 mRNA
CTD
PMID:30723492
NCBI chr X:99,273,270...99,274,799
Ensembl chr X:99,273,161...99,274,800
G
Bhlhe40
basic helix-loop-helix family, member e40
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BHLHE40 mRNA
CTD
PMID:30723492
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Bhlhe41
basic helix-loop-helix family, member e41
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BHLHE41 mRNA
CTD
PMID:30723492
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
G
Bicc1
BicC family RNA binding protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BICC1 mRNA
CTD
PMID:30723492
NCBI chr20:17,449,639...17,686,775
Ensembl chr20:17,449,560...17,686,776
G
Bicd2
BICD cargo adaptor 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BICD2 mRNA
CTD
PMID:25380136
NCBI chr17:15,259,773...15,304,889
Ensembl chr17:15,259,773...15,304,889
G
Bicdl1
BICD family like cargo adaptor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BICDL1 mRNA
CTD
PMID:30723492
NCBI chr12:40,878,190...41,001,152
Ensembl chr12:40,876,884...40,966,130
G
Birc3
baculoviral IAP repeat-containing 3
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of BIRC3 mRNA 1-Naphthylisothiocyanate results in increased expression of BIRC3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BIRC5 mRNA
CTD
PMID:30723492
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bloc1s2
biogenesis of lysosomal organelles complex-1, subunit 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BLOC1S2 mRNA
CTD
PMID:25380136
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
G
Bmf
Bcl2 modifying factor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of BMF mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
G
Bmp3
bone morphogenetic protein 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BMP3 mRNA
CTD
PMID:30723492
NCBI chr14:10,712,489...10,737,153
Ensembl chr14:10,712,489...10,737,153
G
Boc
BOC cell adhesion associated, oncogene regulated
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BOC mRNA
CTD
PMID:30723492
NCBI chr11:56,122,697...56,198,060
Ensembl chr11:56,122,750...56,198,059
G
Bok
BCL2 family apoptosis regulator BOK
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BOK mRNA
CTD
PMID:30723492
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
G
Borcs8
BLOC-1 related complex subunit 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BORCS8 mRNA
CTD
PMID:30723492
NCBI chr16:19,274,305...19,280,969
Ensembl chr16:19,274,023...19,280,339
G
Brca1
BRCA1, DNA repair associated
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BRCA1 mRNA
CTD
PMID:30723492
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Btc
betacellulin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BTC mRNA
CTD
PMID:30723492
NCBI chr14:16,708,447...16,746,961
Ensembl chr14:16,707,982...16,747,049
G
Btg2
BTG anti-proliferation factor 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BTG2 mRNA
CTD
PMID:17522070 PMID:30723492
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Btg3
BTG anti-proliferation factor 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BTG3 mRNA
CTD
PMID:30723492
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
G
Btla
B and T lymphocyte associated
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of BTLA mRNA
CTD
PMID:30723492
NCBI chr11:55,563,683...55,588,187
Ensembl chr11:55,564,899...55,587,181
G
Btnl2
butyrophilin-like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BTNL2 mRNA
CTD
PMID:30723492
NCBI chr20:4,490,169...4,504,002
Ensembl chr20:4,489,517...4,503,341
G
Btnl7
butyrophilin-like 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BTNL7 mRNA
CTD
PMID:30723492
NCBI chr20:4,301,078...4,313,522
Ensembl chr20:4,301,854...4,313,274
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BUB1 mRNA
CTD
PMID:30723492
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of BUB1B mRNA
CTD
PMID:30723492
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
G
C11h3orf70
similar to human chromosome 3 open reading frame 70
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of C11H3ORF70 mRNA
CTD
PMID:25380136
NCBI chr11:79,345,857...79,396,140
Ensembl chr11:79,345,304...79,396,142
G
C19h16orf74
similar to human chromosome 16 open reading frame 74
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of C19H16ORF74 mRNA
CTD
PMID:30723492
NCBI chr19:48,660,288...48,686,287
Ensembl chr19:48,660,288...48,686,349
G
C1h11orf24
similar to human chromosome 11 open reading frame 24
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of C1H11ORF24 mRNA
CTD
PMID:30723492
NCBI chr 1:200,945,188...200,953,953
Ensembl chr 1:200,945,180...200,962,585
G
C1qa
complement C1q A chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of C1QA mRNA
CTD
PMID:25380136
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
G
C1qb
complement C1q B chain
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of C1QB mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C1QB mRNA
CTD
PMID:25380136 PMID:27344345
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
G
C1qc
complement C1q C chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of C1QC mRNA
CTD
PMID:25380136
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
G
C3
complement C3
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C3 mRNA
CTD
PMID:27344345
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C4bpa
complement component 4 binding protein, alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of C4BPA mRNA
CTD
PMID:30723492
NCBI chr13:42,075,715...42,111,205
Ensembl chr13:42,075,717...42,111,205
G
C4bpb
complement component 4 binding protein, beta
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C4BPB mRNA
CTD
PMID:27344345
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
G
C5
complement C5
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C5 mRNA
CTD
PMID:27344345
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
C5ar1
complement C5a receptor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of C5AR1 mRNA
CTD
PMID:25380136
NCBI chr 1:76,948,622...76,959,826
G
C5h1orf210
similar to human chromosome 1 open reading frame 210
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of C5H1ORF210 mRNA
CTD
PMID:25380136
NCBI chr 5:132,048,755...132,051,913
Ensembl chr 5:132,048,773...132,051,925
G
C7
complement C7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of C7 mRNA
CTD
PMID:25380136
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
G
C7h12orf42
similar to human chromosome 12 open reading frame 42
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of C7H12ORF42 mRNA
CTD
PMID:30723492
NCBI chr 7:21,455,182...21,653,232
Ensembl chr 7:21,463,790...21,653,244
G
C8g
complement C8 gamma chain
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of C8G mRNA
CTD
PMID:25380136
NCBI chr 3:8,320,503...8,322,087
Ensembl chr 3:8,305,920...8,323,495
G
C8h11orf54
similar to human chromosome 11 open reading frame 54
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of C8H11ORF54 mRNA
CTD
PMID:25380136
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
G
C9
complement C9
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C9 mRNA
CTD
PMID:27344345
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
G
Cabp2
calcium binding protein 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CABP2 mRNA
CTD
PMID:30723492
NCBI chr 1:201,374,649...201,380,469
Ensembl chr 1:201,375,276...201,380,469
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CACNA1D mRNA
CTD
PMID:12832660
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Cacna2d3
calcium voltage-gated channel auxiliary subunit alpha2delta 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CACNA2D3 mRNA
CTD
PMID:30723492
NCBI chr16:4,098,439...4,912,498
Ensembl chr16:4,098,445...4,912,351
G
Cacna2d4
calcium voltage-gated channel auxiliary subunit alpha2delta 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CACNA2D4 mRNA
CTD
PMID:30723492
NCBI chr 4:152,408,588...152,521,478
Ensembl chr 4:152,408,657...152,521,268
G
Calcb
calcitonin-related polypeptide, beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CALCB mRNA
CTD
PMID:30723492
NCBI chr 1:168,965,383...168,970,259
Ensembl chr 1:168,966,465...168,970,125
G
Calm1
calmodulin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CALM1 mRNA
CTD
PMID:30723492
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
G
Calu
calumenin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CALU mRNA
CTD
PMID:17522070
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CAMK2D mRNA
CTD
PMID:25380136
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CAMK2N1 mRNA
CTD
PMID:30723492
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Camkmt
calmodulin-lysine N-methyltransferase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CAMKMT mRNA
CTD
PMID:30723492
NCBI chr 6:9,198,945...9,580,200
Ensembl chr 6:9,198,947...9,580,242
G
Capg
capping actin protein, gelsolin like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CAPG mRNA
CTD
PMID:25380136
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
G
Capn13
calpain 13
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CAPN13 mRNA
CTD
PMID:30723492
NCBI chr 6:22,071,845...22,166,864
Ensembl chr 6:22,071,845...22,166,850
G
Capn9
calpain 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CAPN9 mRNA
CTD
PMID:30723492
NCBI chr19:52,549,448...52,586,413
Ensembl chr19:52,549,448...52,586,413
G
Car3
carbonic anhydrase 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CAR3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Car5a
carbonic anhydrase 5A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CAR5A mRNA
CTD
PMID:25380136
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
G
Casp1
caspase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CASP1 mRNA
CTD
PMID:25380136
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CASP12 mRNA
CTD
PMID:25380136
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
increases cleavage multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased cleavage of CASP3 protein ursodoxicoltaurine inhibits the reaction [1-Naphthylisothiocyanate results in increased cleavage of CASP3 protein]
CTD
PMID:26011634 PMID:36787806
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CASP4 mRNA
CTD
PMID:25380136
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp7
caspase 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CASP7 mRNA
CTD
PMID:25380136
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Cat
catalase
decreases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in decreased expression of CAT mRNA [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased activity of CAT protein [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CAT mRNA
CTD
PMID:15913567 PMID:17522070 PMID:27344345 PMID:37348807
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cavin2
caveolae associated protein 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CAVIN2 mRNA
CTD
PMID:30723492
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
G
Cblc
Cbl proto-oncogene C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CBLC mRNA
CTD
PMID:30723492
NCBI chr 1:79,439,975...79,456,755
Ensembl chr 1:79,439,977...79,456,755
G
Cbln3
cerebellin 3 precursor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CBLN3 mRNA
CTD
PMID:30723492
NCBI chr15:29,362,014...29,364,523
Ensembl chr15:29,362,302...29,364,612
G
Cbx7
chromobox 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CBX7 mRNA
CTD
PMID:30723492
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Ccdc126
coiled-coil domain containing 126
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CCDC126 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:78,297,625...78,318,655
Ensembl chr 4:78,297,551...78,318,655
G
Ccdc180
coiled-coil domain containing 180
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCDC180 mRNA
CTD
PMID:30723492
NCBI chr 5:60,154,883...60,223,508
Ensembl chr 5:60,154,910...60,223,522
G
Ccdc34
coiled-coil domain containing 34
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCDC34 mRNA
CTD
PMID:30723492
NCBI chr 3:96,553,074...96,588,310
Ensembl chr 3:96,552,992...96,588,146
G
Ccdc68
coiled-coil domain containing 68
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCDC68 mRNA
CTD
PMID:30723492
NCBI chr18:63,541,828...63,584,122
Ensembl chr18:63,541,896...63,584,119
G
Ccdc92
coiled-coil domain containing 92
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCDC92 mRNA
CTD
PMID:30723492
NCBI chr12:31,796,102...31,823,333
Ensembl chr12:31,796,684...31,823,337
G
Ccl11
C-C motif chemokine ligand 11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCL11 mRNA
CTD
PMID:30723492
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases expression
ISO EXP
3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; [3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid co-treated with C188-9 compound] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CCL2 mRNA; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA] 1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA; 1-Naphthylisothiocyanate results in increased expression of CCL2 protein
CTD
PMID:21037076 PMID:21356363 PMID:22094456 PMID:25051504 PMID:26921287 PMID:36460194 More...
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCL20 mRNA
CTD
PMID:30723492
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl24
C-C motif chemokine ligand 24
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CCL24 mRNA
CTD
PMID:30723492
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Ccl3
C-C motif chemokine ligand 3
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of CCL3 mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCL3 mRNA]
CTD
PMID:15913567 PMID:26921287
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of CCL4 mRNA
CTD
PMID:26921287
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
affects expression decreases expression increases expression
EXP
1-Naphthylisothiocyanate affects the expression of CCL5 protein 1-Naphthylisothiocyanate results in decreased expression of CCL5 mRNA 1-Naphthylisothiocyanate results in increased expression of CCL5 mRNA
CTD
PMID:25051504 PMID:25380136 PMID:30723492
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn1
cellular communication network factor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCN1 mRNA
CTD
PMID:30723492
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCN2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccn3
cellular communication network factor 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCN3 mRNA
CTD
PMID:30723492
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
G
Ccn4
cellular communication network factor 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCN4 mRNA
CTD
PMID:30723492
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
G
Ccn5
cellular communication network factor 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CCN5 mRNA
CTD
PMID:30723492
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
G
Ccna2
cyclin A2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCNA2 mRNA
CTD
PMID:30723492
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of CCNB1 mRNA; 1-Naphthylisothiocyanate results in increased expression of CCNB1 protein obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 mRNA]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 protein]]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 protein]
CTD
PMID:29660435 PMID:30723492
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CCNB2 mRNA 1-Naphthylisothiocyanate results in increased expression of CCNB2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA; 1-Naphthylisothiocyanate results in increased expression of CCND1 protein O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 protein]]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 protein]
CTD
PMID:15913567 PMID:29660435 PMID:30723492
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCNE1 mRNA
CTD
PMID:30723492
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccng1
cyclin G1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CCNG1 mRNA
CTD
PMID:17522070 PMID:18289764 PMID:25380136
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Ccnj
cyclin J
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CCNJ mRNA
CTD
PMID:30723492
NCBI chr 1:239,659,588...239,677,367
G
Cd163
CD163 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD163 mRNA
CTD
PMID:25380136
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
G
Cd19
CD19 molecule
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CD19 mRNA
CTD
PMID:30723492
NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
G
Cd207
CD207 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD207 mRNA
CTD
PMID:30723492
NCBI chr 4:116,155,229...116,161,587
Ensembl chr 4:116,155,212...116,161,518
G
Cd226
CD226 molecule
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CD226 mRNA
CTD
PMID:30723492
NCBI chr18:82,449,924...82,545,107
Ensembl chr18:82,450,568...82,543,051
G
Cd24
CD24 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD24 mRNA
CTD
PMID:25380136
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd247
Cd247 molecule
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CD247 mRNA
CTD
PMID:30723492
NCBI chr13:78,043,302...78,118,437
Ensembl chr13:78,043,307...78,122,263
G
Cd274
CD274 molecule
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CD274 mRNA
CTD
PMID:30723492
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd276
Cd276 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD276 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:58,937,751...58,968,082
Ensembl chr 8:58,937,751...58,968,380
G
Cd300e
Cd300e molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD300E mRNA
CTD
PMID:30723492
NCBI chr10:100,289,729...100,309,996
Ensembl chr10:100,291,437...100,299,311
G
Cd36
CD36 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD36 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd38
CD38 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD38 mRNA
CTD
PMID:25380136
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
G
Cd44
CD44 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD44 mRNA
CTD
PMID:30723492
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd48
Cd48 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD48 mRNA
CTD
PMID:25380136
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
G
Cd53
Cd53 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD53 mRNA
CTD
PMID:25380136
NCBI chr 2:194,352,139...194,399,668
Ensembl chr 2:194,352,139...194,399,657
G
Cd55
CD55 molecule (Cromer blood group)
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CD55 mRNA
CTD
PMID:27344345
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
G
Cd5l
Cd5 molecule-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD5L mRNA
CTD
PMID:25380136
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
G
Cd63
Cd63 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD63 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
G
Cd68
Cd68 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD68 mRNA
CTD
PMID:25380136
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cd7
Cd7 molecule
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CD7 mRNA
CTD
PMID:25380136
NCBI chr10:106,304,046...106,306,963
Ensembl chr10:106,304,056...106,306,967
G
Cd72
Cd72 molecule
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CD72 mRNA
CTD
PMID:30723492
NCBI chr 5:57,697,361...57,704,980
Ensembl chr 5:57,697,367...57,704,725
G
Cd74
CD74 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD74 mRNA
CTD
PMID:25380136
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
G
Cd79b
CD79b molecule
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CD79B mRNA
CTD
PMID:30723492
NCBI chr10:91,239,354...91,242,500
Ensembl chr10:91,239,356...91,242,625
G
Cd83
CD83 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD83 mRNA
CTD
PMID:25380136
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cd8a
CD8 subunit alpha
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CD8A mRNA
CTD
PMID:30723492
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
G
Cd9
CD9 molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CD9 mRNA
CTD
PMID:30723492
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cdc20
cell division cycle 20
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDC20 mRNA
CTD
PMID:30723492
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
G
Cdc25c
cell division cycle 25C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDC25C mRNA
CTD
PMID:30723492
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
G
Cdc42ep5
CDC42 effector protein 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDC42EP5 mRNA
CTD
PMID:30723492
NCBI chr 1:70,035,921...70,038,990
G
Cdc42se1
CDC42 small effector 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDC42SE1 mRNA
CTD
PMID:25380136
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
G
Cdc45
cell division cycle 45
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDC45 mRNA
CTD
PMID:30723492
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
G
Cdc7
cell division cycle 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDC7 mRNA
CTD
PMID:30723492
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
G
Cdca2
cell division cycle associated 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDCA2 mRNA
CTD
PMID:30723492
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
G
Cdca3
cell division cycle associated 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDCA3 mRNA
CTD
PMID:30723492
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdca8
cell division cycle associated 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDCA8 mRNA
CTD
PMID:30723492
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
G
Cdh3
cadherin 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDH3 mRNA
CTD
PMID:30723492
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdhr5
cadherin-related family member 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDHR5 mRNA
CTD
PMID:30723492
NCBI chr 1:196,373,110...196,381,609
Ensembl chr 1:196,373,112...196,381,543
G
Cdk1
cyclin-dependent kinase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDK1 mRNA
CTD
PMID:30723492
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk10
cyclin-dependent kinase 10
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CDK10 mRNA
CTD
PMID:30723492
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
G
Cdkl2
cyclin dependent kinase like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDKL2 mRNA
CTD
PMID:30723492
NCBI chr14:16,027,381...16,063,257
Ensembl chr14:16,028,363...16,063,252
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDKN1A mRNA; 1-Naphthylisothiocyanate results in increased expression of CDKN1A protein
CTD
PMID:20551477 PMID:23411599 PMID:25380136 PMID:26011634
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CDKN1B mRNA
CTD
PMID:20551477
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2aipnl
CDKN2A interacting protein N-terminal like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDKN2AIPNL mRNA
CTD
PMID:25380136
NCBI chr10:36,231,134...36,240,569
Ensembl chr10:36,231,087...36,240,564
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDKN2B mRNA
CTD
PMID:30723492
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CDKN3 mRNA 1-Naphthylisothiocyanate results in increased expression of CDKN3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cdt1
chromatin licensing and DNA replication factor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CDT1 mRNA
CTD
PMID:30723492
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
G
Ceacam4
CEA cell adhesion molecule 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CEACAM4 mRNA
CTD
PMID:30723492
NCBI chr 1:80,376,667...80,382,943
Ensembl chr 1:80,376,648...80,382,915
G
Cebpb
CCAAT/enhancer binding protein beta
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CEBPB mRNA
CTD
PMID:27344345
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cebpd
CCAAT/enhancer binding protein delta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CEBPD mRNA
CTD
PMID:25380136
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
G
Celf5
CUGBP, Elav-like family member 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CELF5 mRNA
CTD
PMID:30723492
NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322
G
Celsr1
cadherin, EGF LAG seven-pass G-type receptor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CELSR1 mRNA
CTD
PMID:30723492
NCBI chr 7:116,987,616...117,125,035
Ensembl chr 7:116,987,605...117,125,164
G
Cemip
cell migration inducing hyaluronidase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CEMIP mRNA
CTD
PMID:30723492
NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415
G
Cemip2
cell migration inducing hyaluronidase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CEMIP2 mRNA
CTD
PMID:25380136
NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760
G
Cenpa
centromere protein A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CENPA mRNA
CTD
PMID:30723492
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Cenpe
centromere protein E
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CENPE mRNA
CTD
PMID:30723492
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
G
Cenpf
centromere protein F
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CENPF mRNA
CTD
PMID:30723492
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cenph
centromere protein H
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CENPH mRNA
CTD
PMID:30723492
NCBI chr 2:31,896,675...31,910,179
Ensembl chr 2:31,894,667...31,910,154
G
Cenpi
centromere protein I
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CENPI mRNA
CTD
PMID:30723492
NCBI chr X:97,515,919...97,567,671
Ensembl chr X:97,515,972...97,567,657
G
Cenpq
centromere protein Q
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CENPQ mRNA
CTD
PMID:30723492
NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789
G
Cenpt
centromere protein T
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CENPT mRNA
CTD
PMID:30723492
NCBI chr19:33,734,684...33,741,159
Ensembl chr19:33,734,685...33,741,142
G
Cenpu
centromere protein U
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CENPU mRNA
CTD
PMID:30723492
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
G
Cenpw
centromere protein W
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CENPW mRNA
CTD
PMID:30723492
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
G
Cep128
centrosomal protein 128
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CEP128 mRNA
CTD
PMID:30723492
NCBI chr 6:109,951,009...110,328,686
Ensembl chr 6:109,951,061...110,328,713
G
Cep55
centrosomal protein 55
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CEP55 mRNA
CTD
PMID:30723492
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
G
Cers3
ceramide synthase 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CERS3 mRNA
CTD
PMID:30723492
NCBI chr 1:120,316,930...120,422,926
Ensembl chr 1:120,318,212...120,422,902
G
Ces1d
carboxylesterase 1D
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CES1D mRNA
CTD
PMID:30723492
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Ces2h
carboxylesterase 2H
multiple interactions increases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CES2 mRNA 1-Naphthylisothiocyanate results in increased expression of CES2 mRNA
CTD
PMID:27344345 PMID:30723492
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Cfap20
cilia and flagella associated protein 20
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CFAP20 mRNA
CTD
PMID:30723492
NCBI chr19:9,608,867...9,622,558
Ensembl chr19:9,608,859...9,622,558
G
Cfap91
cilia and flagella associated protein 91
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CFAP91 mRNA
CTD
PMID:30723492
NCBI chr11:62,413,613...62,457,281
Ensembl chr11:62,413,602...62,457,293
G
Cfd
complement factor D
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CFD mRNA
CTD
PMID:25380136
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
G
Cfh
complement factor H
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CFH mRNA
CTD
PMID:27344345
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Cfp
complement factor properdin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CFP mRNA
CTD
PMID:25380136
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
G
Cgas
cyclic GMP-AMP synthase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CGAS mRNA
CTD
PMID:30723492
NCBI chr 8:79,292,282...79,306,998
Ensembl chr 8:79,294,511...79,305,496
G
Cggbp1
CGG triplet repeat binding protein 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CGGBP1 mRNA
CTD
PMID:30723492
NCBI chr11:2,565,629...2,572,869
Ensembl chr11:2,565,484...2,573,031
G
Chaf1a
chromatin assembly factor 1 subunit A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CHAF1A mRNA
CTD
PMID:30723492
NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654
G
Chaf1b
chromatin assembly factor 1 subunit B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CHAF1B mRNA
CTD
PMID:30723492
NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070
G
Chka
choline kinase alpha
increases expression multiple interactions decreases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of CHKA mRNA AHR protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of CHKA mRNA] 1-Naphthylisothiocyanate results in decreased expression of CHKA mRNA
CTD
PMID:27853831 PMID:29737914 PMID:30723492
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Chpt1
choline phosphotransferase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CHPT1 mRNA
CTD
PMID:30723492
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
G
Chrd
chordin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CHRD mRNA
CTD
PMID:12832660
NCBI chr11:80,171,994...80,181,166
Ensembl chr11:80,171,994...80,180,673
G
Chrdl2
chordin-like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CHRDL2 mRNA
CTD
PMID:30723492
NCBI chr 1:154,343,201...154,370,651
Ensembl chr 1:154,343,201...154,370,640
G
Chrna2
cholinergic receptor nicotinic alpha 2 subunit
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CHRNA2 mRNA
CTD
PMID:30723492
NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CHRNA5 mRNA
CTD
PMID:30723492
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
G
Chrne
cholinergic receptor nicotinic epsilon subunit
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CHRNE mRNA
CTD
PMID:30723492
NCBI chr10:55,331,211...55,339,923
Ensembl chr10:55,331,212...55,335,530
G
Chst4
carbohydrate sulfotransferase 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CHST4 mRNA
CTD
PMID:30723492
NCBI chr19:37,993,471...38,002,123
Ensembl chr19:37,991,417...38,003,608
G
Chsy1
chondroitin sulfate synthase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CHSY1 mRNA
CTD
PMID:25380136
NCBI chr 1:119,689,626...119,750,711
Ensembl chr 1:119,686,350...119,750,601
G
Chtf18
chromosome transmission fidelity factor 18
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CHTF18 mRNA
CTD
PMID:30723492
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050
G
Cidea
cell death-inducing DFFA-like effector a
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CIDEA mRNA
CTD
PMID:25380136
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
G
Cimap1b
ciliary microtubule associated protein 1B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CIMAP1B mRNA
CTD
PMID:30723492
NCBI chr 7:120,444,232...120,447,294
Ensembl chr 7:120,444,232...120,446,749
G
Cip2a
cellular inhibitor of PP2A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CIP2A mRNA
CTD
PMID:30723492
NCBI chr11:51,792,143...51,823,016
Ensembl chr11:51,795,024...51,822,938
G
Cirbp
cold inducible RNA binding protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CIRBP mRNA
CTD
PMID:12832660
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
G
Cited4
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CITED4 mRNA
CTD
PMID:30723492
NCBI chr 5:134,246,936...134,247,827
Ensembl chr 5:134,246,682...134,248,135
G
Ckap2
cytoskeleton associated protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CKAP2 mRNA
CTD
PMID:30723492
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
G
Ckap2l
cytoskeleton associated protein 2-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CKAP2L mRNA
CTD
PMID:30723492
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
G
Ckap4
cytoskeleton-associated protein 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CKAP4 mRNA
CTD
PMID:30723492
NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
G
Clca4l
chloride channel calcium activated 4-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLCA4L mRNA
CTD
PMID:30723492
NCBI chr 2:233,826,133...233,846,137
Ensembl chr 2:233,826,133...233,846,716
G
Clcn6
chloride voltage-gated channel 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLCN6 mRNA
CTD
PMID:30723492
NCBI chr 5:158,434,299...158,465,174
Ensembl chr 5:158,434,299...158,465,059
G
Cldn1
claudin 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CLDN1 mRNA
CTD
PMID:30723492
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Cldn23
claudin 23
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLDN23 mRNA
CTD
PMID:30723492
NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523
G
Cldn4
claudin 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLDN4 mRNA
CTD
PMID:20551477 PMID:30723492
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
G
Cldn6
claudin 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLDN6 mRNA
CTD
PMID:30723492
NCBI chr10:12,710,302...12,713,987
Ensembl chr10:12,709,960...12,715,973
G
Cldn7
claudin 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLDN7 mRNA
CTD
PMID:30723492
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
G
Cldn9
claudin 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLDN9 mRNA
CTD
PMID:30723492
NCBI chr10:12,714,137...12,715,568
G
Clec4a1
C-type lectin domain family 4, member A1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLEC4A1 mRNA
CTD
PMID:25380136
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
G
Clec4a3
C-type lectin domain family 4, member A3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLEC4A mRNA; 1-Naphthylisothiocyanate results in increased expression of CLEC4A3 mRNA
CTD
PMID:25380136
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
G
Clec5a
C-type lectin domain containing 5A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLEC5A mRNA
CTD
PMID:30723492
NCBI chr 4:69,407,125...69,416,872
Ensembl chr 4:69,407,835...69,416,859
G
Clic1
chloride intracellular channel 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLIC1 mRNA
CTD
PMID:25380136
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
G
Clp1
cleavage factor polyribonucleotide kinase subunit 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CLP1 mRNA
CTD
PMID:25380136
NCBI chr 3:69,806,774...69,818,633
Ensembl chr 3:69,806,778...69,810,421
G
Clpx
caseinolytic mitochondrial matrix peptidase chaperone subunit X
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CLPX mRNA
CTD
PMID:30723492
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
G
Clspn
claspin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLSPN mRNA
CTD
PMID:30723492
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
G
Clstn3
calsyntenin 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CLSTN3 mRNA
CTD
PMID:30723492
NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769
G
Cltrn
collectrin, amino acid transport regulator
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLTRN mRNA
CTD
PMID:30723492
NCBI chr X:30,361,967...30,395,264
Ensembl chr X:30,361,967...30,395,349
G
Clu
clusterin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CLU mRNA
CTD
PMID:17522070 PMID:18289764 PMID:30723492
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cmtm3
CKLF-like MARVEL transmembrane domain containing 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CMTM3 mRNA
CTD
PMID:25380136
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
G
Cndp1
carnosine dipeptidase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CNDP1 mRNA
CTD
PMID:25380136
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
G
Cngb1
cyclic nucleotide gated channel subunit beta 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CNGB1 mRNA
CTD
PMID:30723492
NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CNP mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
G
Cntfr
ciliary neurotrophic factor receptor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CNTFR mRNA
CTD
PMID:30723492
NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:56,823,965...56,841,392
G
Col11a1
collagen type XI alpha 1 chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COL11A1 mRNA
CTD
PMID:30723492
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
G
Col12a1
collagen type XII alpha 1 chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COL12A1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
G
Col18a1
collagen type XVIII alpha 1 chain
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of COL18A1 mRNA
CTD
PMID:27344345
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col1a1
collagen type I alpha 1 chain
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; TGFB1 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; Tranexamic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA] 1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA; 1-Naphthylisothiocyanate results in increased expression of COL1A1 protein
CTD
PMID:21037076 PMID:22094456 PMID:24633426 PMID:25380136 PMID:26921287 PMID:28049044 PMID:30723492 More...
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COL1A2 mRNA
CTD
PMID:25380136
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of COL3A1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of COL3A1 mRNA
CTD
PMID:25380136 PMID:27344345
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col4a1
collagen type IV alpha 1 chain
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of COL4A1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of COL4A1 mRNA
CTD
PMID:25380136 PMID:27344345
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
G
Col4a2
collagen type IV alpha 2 chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COL4A2 mRNA
CTD
PMID:25380136
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
G
Col4a3
collagen type IV alpha 3 chain
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of COL4A3 mRNA
CTD
PMID:30723492
NCBI chr 9:83,875,849...84,004,955
Ensembl chr 9:83,875,561...84,001,895
G
Col5a1
collagen type V alpha 1 chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COL5A1 mRNA
CTD
PMID:25380136
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
G
Col5a2
collagen type V alpha 2 chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COL5A2 mRNA
CTD
PMID:25380136
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Col6a1
collagen type VI alpha 1 chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COL6A1 mRNA
CTD
PMID:25380136
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
G
Col6a2
collagen type VI alpha 2 chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COL6A2 mRNA
CTD
PMID:25380136
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Col6a3
collagen type VI alpha 3 chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COL6A3 mRNA
CTD
PMID:30723492
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
G
Colec12
collectin sub-family member 12
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COLEC12 mRNA
CTD
PMID:25380136
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of COLQ mRNA
CTD
PMID:30723492
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
G
Comp
cartilage oligomeric matrix protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COMP mRNA
CTD
PMID:30723492
NCBI chr16:19,047,206...19,055,584
Ensembl chr16:19,047,207...19,055,845
G
Coq10a
coenzyme Q10A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of COQ10A mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 7:792,089...798,392
Ensembl chr 7:792,089...800,161
G
Cotl1
coactosin-like F-actin binding protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of COTL1 mRNA
CTD
PMID:25380136
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
G
Cp
ceruloplasmin
increases expression
EXP ISO
1-Naphthylisothiocyanate results in increased expression of CP mRNA
CTD
PMID:15913567 PMID:18289764
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpq
carboxypeptidase Q
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CPQ mRNA
CTD
PMID:25380136
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
G
Cpt2
carnitine palmitoyltransferase 2
decreases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in decreased expression of CPT2 mRNA Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CPT2 mRNA]
CTD
PMID:33749747
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Cpvl
carboxypeptidase, vitellogenic-like
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CPVL mRNA
CTD
PMID:30723492
NCBI chr 4:82,981,421...83,091,730
Ensembl chr 4:82,981,422...83,085,655
G
Cpxm2
carboxypeptidase X (M14 family), member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CPXM2 mRNA
CTD
PMID:30723492
NCBI chr 1:186,836,797...186,947,222
Ensembl chr 1:186,836,797...186,947,220
G
Cracr2a
calcium release activated channel regulator 2A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CRACR2A mRNA
CTD
PMID:30723492
NCBI chr 4:160,428,987...160,517,427
Ensembl chr 4:160,408,077...160,518,107
G
Creb5
cAMP responsive element binding protein 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CREB5 mRNA
CTD
PMID:30723492
NCBI chr 4:82,393,091...82,794,320
Ensembl chr 4:82,393,730...82,790,325
G
Crebzf
CREB/ATF bZIP transcription factor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CREBZF mRNA
CTD
PMID:30723492
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
G
Crip1
cysteine rich protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CRIP mRNA
CTD
PMID:25380136
NCBI chr 6:132,226,746...132,234,620
Ensembl chr 6:132,226,746...132,234,620
G
Crlf1
cytokine receptor-like factor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CRLF1 mRNA
CTD
PMID:30723492
NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,924,722...18,935,997
G
Crot
carnitine O-octanoyltransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CROT mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
G
Crtap
cartilage associated protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CRTAP mRNA
CTD
PMID:25380136
NCBI chr 8:114,047,929...114,067,636
Ensembl chr 8:114,047,933...114,067,631
G
Cryab
crystallin, alpha B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CRYAB mRNA
CTD
PMID:30723492
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Crym
crystallin, mu
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CRYM mRNA
CTD
PMID:30723492
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
G
Csf1r
colony stimulating factor 1 receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CSF1R mRNA
CTD
PMID:25380136
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Cthrc1
collagen triple helix repeat containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CTHRC1 mRNA
CTD
PMID:30723492
NCBI chr 7:70,122,474...70,132,756
Ensembl chr 7:70,122,474...70,132,756
G
Ctnna3
catenin alpha 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CTNNA3 mRNA
CTD
PMID:30723492
NCBI chr20:23,614,469...25,200,026
Ensembl chr20:23,623,560...25,199,978
G
Ctse
cathepsin E
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CTSE mRNA
CTD
PMID:25380136
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
G
Ctsl
cathepsin L
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CTSL mRNA
CTD
PMID:17522070
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Ctss
cathepsin S
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CTSS mRNA
CTD
PMID:18289764 PMID:25380136
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Ctsz
cathepsin Z
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CTSZ mRNA
CTD
PMID:25380136
NCBI chr 3:163,224,875...163,235,645
Ensembl chr 3:163,224,875...163,235,645
G
Cttnbp2nl
CTTNBP2 N-terminal like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CTTNBP2NL mRNA
CTD
PMID:25380136
NCBI chr 2:192,507,963...192,554,548
Ensembl chr 2:192,507,963...192,541,101
G
Cxadr
CXADR, Ig-like cell adhesion molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CXADR mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
G
Cxcl1
C-X-C motif chemokine ligand 1
multiple interactions increases expression
EXP
Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]
CTD
PMID:18364083 PMID:18590720 PMID:25380136 PMID:30723492
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
affects expression increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate affects the expression of CXCL10 protein 1-Naphthylisothiocyanate results in increased expression of CXCL10 mRNA 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL10 mRNA]; [3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid co-treated with C188-9 compound] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL10 mRNA]; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL10 mRNA] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CXCL10 mRNA
CTD
PMID:25051504 PMID:25380136 PMID:27344345 PMID:36460194
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
affects expression decreases expression
EXP
1-Naphthylisothiocyanate affects the expression of CXCL12 mRNA 1-Naphthylisothiocyanate results in decreased expression of CXCL12 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl13
C-X-C motif chemokine ligand 13
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CXCL13 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
G
Cxcl16
C-X-C motif chemokine ligand 16
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CXCL16 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions increases expression
EXP ISO
Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA] 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]; [3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid co-treated with C188-9 compound] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]; [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CXCL2 mRNA; [Progesterone co-treated with 1-Naphthylisothiocyanate] results in increased expression of CXCL2 mRNA; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]; pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]] 1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA; 1-Naphthylisothiocyanate results in increased expression of CXCL2 protein
CTD
PMID:15130876 PMID:18364083 PMID:18590720 PMID:20594950 PMID:21070799 PMID:21356363 PMID:22094456 PMID:22157104 PMID:25051504 PMID:27853831 PMID:36460194 More...
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions increases expression
ISO EXP
[3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid co-treated with C188-9 compound] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]; [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CXCL1 mRNA; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]; pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]]; Progesterone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA] 1-Naphthylisothiocyanate results in increased expression of CXCL3 mRNA 1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA; 1-Naphthylisothiocyanate results in increased expression of CXCL1 protein
CTD
PMID:21070799 PMID:21356363 PMID:22094456 PMID:22157104 PMID:27853831 PMID:30723492 PMID:36460194 More...
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxxc4
CXXC finger protein 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CXXC4 mRNA
CTD
PMID:30723492
NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365
G
Cyb5r3
cytochrome b5 reductase 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYB5R3 mRNA
CTD
PMID:17522070
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
G
Cyba
cytochrome b-245 alpha chain
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYBA mRNA
CTD
PMID:25380136
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cybb
cytochrome b-245 beta chain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYBB mRNA
CTD
PMID:25380136
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
EXP ISO
1-Naphthylisothiocyanate results in increased expression of CYP1A1 mRNA; 1-Naphthylisothiocyanate results in increased expression of CYP1A1 protein
CTD
PMID:12832660 PMID:15598703 PMID:20551477 PMID:29737914 PMID:30723492
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases expression decreases expression
EXP ISO
[1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in decreased expression of CYP1A2 protein; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 1-Naphthylisothiocyanate] results in decreased expression of CYP1A2 protein [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA 1-Naphthylisothiocyanate results in increased expression of CYP1A2 mRNA 1-Naphthylisothiocyanate results in decreased expression of CYP1A2 protein
CTD
PMID:15598703 PMID:20551477 PMID:27344345
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
EXP ISO
1-Naphthylisothiocyanate results in increased expression of CYP1B1 mRNA
CTD
PMID:29737914 PMID:30723492
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP26A1 mRNA
CTD
PMID:25380136
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of CYP27A1 mRNA
CTD
PMID:24120425 PMID:25655198 PMID:30517764
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP2A1 mRNA
CTD
PMID:30723492
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
G
Cyp2a2
cytochrome P450, family 2, subfamily a, polypeptide 2
increases expression decreases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYP2A2 mRNA 1-Naphthylisothiocyanate results in decreased expression of CYP2A2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:82,263,833...82,289,487
Ensembl chr 1:82,263,833...82,289,487
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYP2B1 mRNA
CTD
PMID:30723492
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYP2B2 mRNA
CTD
PMID:26365562 PMID:30723492
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases expression multiple interactions
EXP
1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA; 1-Naphthylisothiocyanate results in increased expression of CYP2B10 protein; 1-Naphthylisothiocyanate results in increased expression of CYP2B6 mRNA ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 protein]
CTD
PMID:20551477 PMID:32198087
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP2C11 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c12
cytochrome P450, family 2, subfamily c, polypeptide 12
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYP2C12 mRNA
CTD
PMID:30723492
NCBI chr 1:238,699,859...238,757,011
Ensembl chr 1:238,699,854...238,757,019
G
Cyp2c13
cytochrome P450, family 2, subfamily c, polypeptide 13
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP2C13 mRNA
CTD
PMID:30723492
NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
G
Cyp2c22
cytochrome P450, family 2, subfamily c, polypeptide 22
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYP2C22 mRNA
CTD
PMID:30723492
NCBI chr 1:238,991,698...239,031,323
Ensembl chr 1:238,991,610...239,021,738
G
Cyp2c24
cytochrome P450, family 2, subfamily c, polypeptide 24
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYP2C24 mRNA
CTD
PMID:30723492
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
G
Cyp2d3
cytochrome P450, family 2, subfamily d, polypeptide 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP2D3 mRNA
CTD
PMID:17522070
NCBI chr 7:113,917,711...113,922,068
Ensembl chr 7:113,908,947...113,922,084
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP2D4 mRNA
CTD
PMID:25380136
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
ISO EXP
1-Naphthylisothiocyanate results in decreased expression of CYP2E1 mRNA
CTD
PMID:15913567 PMID:30723492
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp2f4
cytochrome P450, family 2, subfamily f, polypeptide 4
decreases expression
ISO
1-Naphthylisothiocyanate results in decreased expression of CYP2F2 mRNA
CTD
PMID:15913567
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
G
Cyp2j3
cytochrome P450, family 2, subfamily j, polypeptide 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP2J3 mRNA
CTD
PMID:30723492
NCBI chr 5:111,219,921...111,244,987
Ensembl chr 5:111,178,703...111,244,794
G
Cyp2t1
cytochrome P450, family 2, subfamily t, polypeptide 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP2T1 mRNA
CTD
PMID:25380136
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
G
Cyp3a18
cytochrome P450, family 3, subfamily a, polypeptide 18
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP3A18 mRNA
CTD
PMID:30723492
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases expression increases expression multiple interactions
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP3A2 mRNA 1-Naphthylisothiocyanate results in increased expression of CYP3A4 mRNA; 1-Naphthylisothiocyanate results in increased expression of CYP3A4 protein ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 protein]
CTD
PMID:26365562 PMID:30723492 PMID:32198087
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:12883083
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP3A9 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP4A1 mRNA
CTD
PMID:30723492
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
G
Cyp4a2
cytochrome P450, family 4, subfamily a, polypeptide 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP4A2 mRNA
CTD
PMID:30723492
NCBI chr 5:128,922,355...128,934,188
Ensembl chr 5:128,923,615...128,934,165
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP4A3 mRNA
CTD
PMID:30723492
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP4B1 mRNA
CTD
PMID:30723492
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP4F39 mRNA
CTD
PMID:30723492
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
G
Cyp4v3
cytochrome P450, family 4, subfamily v, polypeptide 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYP4V3 mRNA
CTD
PMID:30723492
NCBI chr16:46,917,929...46,958,735
Ensembl chr16:46,918,401...46,943,395
G
Cyp51
cytochrome P450, family 51
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYP51 mRNA
CTD
PMID:30723492
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein 1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein 4-methyl-7,8-dihydroxycoumarin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein] 1-naphthyl isothiocyanate decreases expression of Cyp7a1 protein in rat liver resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein] 1-Naphthylisothiocyanate results in increased expression of CYP7A1 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; [1-Naphthylisothiocyanate co-treated with Allopurinol] results in decreased expression of CYP7A1 mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of CYP7A1 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP7A1 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of CYP7A1 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of CYP7A1 protein; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein]; Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein]; ursodoxicoltaurine inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]
CTD RGD
PMID:14623915 PMID:20551477 PMID:24120425 PMID:25418378 PMID:25655198 PMID:26365562 PMID:27853831 PMID:28549656 PMID:29660435 PMID:29968724 PMID:30352267 PMID:30517764 PMID:30723492 PMID:32579994 PMID:33749747 PMID:36581201 PMID:36787806 PMID:29655695 More...
RGD:15090803
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
decreases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in decreased expression of CYP7B1 mRNA [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP7B1 mRNA
CTD
PMID:28549656 PMID:29968724 PMID:30517764
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP8B1 mRNA 1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein [1-Naphthylisothiocyanate co-treated with Allopurinol] results in decreased expression of CYP8B1 mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of CYP8B1 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP8B1 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of CYP8B1 protein; acadesine promotes the reaction [picroside II promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]]; acadesine promotes the reaction [picroside II promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]; Chenodeoxycholic Acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]; Chenodeoxycholic Acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]; picroside II promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]; picroside II promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 protein]; yangonin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]
CTD
PMID:14623915 PMID:24120425 PMID:25655198 PMID:27344345 PMID:29660435 PMID:29968724 PMID:30352267 PMID:30517764 PMID:30723492 PMID:32579994 PMID:32976922 PMID:33749747 More...
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Cyrib
CYFIP related Rac1 interactor B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYRIB mRNA
CTD
PMID:25380136
NCBI chr 7:95,633,876...95,760,588
Ensembl chr 7:95,633,876...95,697,686
G
Cystm1
cysteine-rich transmembrane module containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of CYSTM1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr18:27,945,862...28,013,509
Ensembl chr18:27,951,653...28,013,510
G
Cytl1
cytokine like 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of CYTL1 mRNA
CTD
PMID:30723492
NCBI chr14:73,053,876...73,058,886
Ensembl chr14:73,053,877...73,058,886
G
Dab1
DAB adaptor protein 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DAB1 mRNA
CTD
PMID:30723492
NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:119,140,533...119,510,552
G
Dao
D-amino-acid oxidase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DAO mRNA
CTD
PMID:25380136
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
G
Dap
death-associated protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DAP mRNA
CTD
PMID:30723492
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
G
Daxx
death-domain associated protein
multiple interactions increases expression
ISO
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of DAXX mRNA]
CTD
PMID:15913567
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Dbf4
DBF4-CDC7 kinase regulatory subunit
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DBF4 mRNA
CTD
PMID:30723492
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066
G
Dbndd2
dysbindin domain containing 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DBNDD2 mRNA
CTD
PMID:25380136
NCBI chr 3:153,216,300...153,220,651
Ensembl chr 3:153,191,090...153,220,651
G
Dcdc2c
doublecortin domain containing 2C
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DCDC2C mRNA
CTD
PMID:30723492
NCBI chr 6:45,103,838...45,179,040
Ensembl chr 6:45,061,553...45,178,046
G
Dclk1
doublecortin-like kinase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DCLK1 mRNA
CTD
PMID:30723492
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
G
Dcxr
dicarbonyl and L-xylulose reductase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DCXR mRNA
CTD
PMID:25380136
NCBI chr10:106,006,404...106,008,293
G
Ddc
dopa decarboxylase
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DDC mRNA 1-Naphthylisothiocyanate results in increased expression of DDC mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddias
DNA damage-induced apoptosis suppressor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DDIAS mRNA
CTD
PMID:30723492
NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of DDIT3 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DDIT3 mRNA
CTD
PMID:17522070 PMID:27344345
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Decr2
2,4-dienoyl-CoA reductase 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DECR2 mRNA
CTD
PMID:30723492
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
G
Defb1
defensin beta 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DEFB1 mRNA
CTD
PMID:30723492
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
G
Depdc1
DEP domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DEPDC1 mRNA
CTD
PMID:30723492
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
G
Depdc1b
DEP domain containing 1B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DEPDC1B mRNA
CTD
PMID:30723492
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
G
Depdc7
DEP domain containing 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DEPDC7 mRNA
CTD
PMID:25380136
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
G
Depp1
DEPP autophagy regulator 1
increases expression decreases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of DEPP1 mRNA 1-Naphthylisothiocyanate results in decreased expression of DEPP1 mRNA
CTD
PMID:17175557 PMID:30723492
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Dhcr24
24-dehydrocholesterol reductase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DHCR24 mRNA
CTD
PMID:30723492
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dhcr7
7-dehydrocholesterol reductase
multiple interactions increases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DHCR7 mRNA 1-Naphthylisothiocyanate results in increased expression of DHCR7 mRNA
CTD
PMID:27344345 PMID:30723492
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dhrs3
dehydrogenase/reductase 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DHRS3 mRNA
CTD
PMID:25380136
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
G
Dhrs7
dehydrogenase/reductase 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DHRS7 mRNA
CTD
PMID:25380136
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
G
Dhrs7l1
dehydrogenase/reductase (SDR family) member 7-like 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DHRS7L1 mRNA
CTD
PMID:30723492
NCBI chr 6:91,289,200...91,312,010
Ensembl chr 6:91,289,200...91,312,010
G
Dhrs9
dehydrogenase/reductase 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DHRS9 mRNA
CTD
PMID:30723492
NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
G
Dhtkd1
dehydrogenase E1 and transketolase domain containing 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DHTKD1 mRNA
CTD
PMID:25380136
NCBI chr17:72,355,201...72,406,725
Ensembl chr17:72,355,201...72,406,723
G
Diaph3
diaphanous-related formin 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DIAPH3 mRNA
CTD
PMID:30723492
NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975
G
Dio1
iodothyronine deiodinase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DIO1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Dipk2a
divergent protein kinase domain 2A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DIPK2A mRNA
CTD
PMID:25380136
NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815
G
Disp1
dispatched RND transporter family member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DISP1 mRNA
CTD
PMID:30723492
NCBI chr13:94,720,928...94,866,695
Ensembl chr13:94,720,928...94,866,702
G
Disp2
dispatched RND transporter family member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DISP2 mRNA
CTD
PMID:30723492
NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800
G
Dkk2
dickkopf WNT signaling pathway inhibitor 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DKK2 mRNA
CTD
PMID:30723492
NCBI chr 2:220,568,338...220,660,225
Ensembl chr 2:220,568,338...220,660,225
G
Dlgap1
DLG associated protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DLGAP1 mRNA
CTD
PMID:30723492
NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817
G
Dlgap5
DLG associated protein 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DLGAP5 mRNA
CTD
PMID:30723492
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dlx4
distal-less homeobox 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DLX4 mRNA
CTD
PMID:30723492
NCBI chr10:80,085,037...80,090,434
Ensembl chr10:80,085,465...80,090,456
G
Dnaaf3
dynein, axonemal, assembly factor 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DNAAF3 mRNA
CTD
PMID:30723492
NCBI chr 1:69,291,300...69,299,365
Ensembl chr 1:69,291,454...69,299,344
G
Dnah8
dynein, axonemal, heavy chain 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DNAH8 mRNA
CTD
PMID:12832660
NCBI chr20:8,692,939...8,946,780
Ensembl chr20:8,692,963...8,946,772
G
Dnaja1
DnaJ heat shock protein family (Hsp40) member A1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DNAJA1 mRNA
CTD
PMID:20551477
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
G
Dnaja4
DnaJ heat shock protein family (Hsp40) member A4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DNAJA4 mRNA
CTD
PMID:20551477
NCBI chr 8:55,085,246...55,102,715
Ensembl chr 8:55,085,464...55,101,207
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of DNAJB1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DNAJB1 mRNA
CTD
PMID:20551477 PMID:27344345
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajb12
DnaJ heat shock protein family (Hsp40) member B12
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DNAJB12 mRNA
CTD
PMID:20551477
NCBI chr20:27,828,216...27,846,428
Ensembl chr20:27,828,235...27,846,427
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DNAJB4 mRNA
CTD
PMID:20551477
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DNAJB9 mRNA
CTD
PMID:27344345
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
G
Dnase1l2
deoxyribonuclease 1 like 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DNASE1L2 mRNA
CTD
PMID:30723492
NCBI chr10:13,471,850...13,473,447
Ensembl chr10:13,471,479...13,473,763
G
Dnmt3a
DNA methyltransferase 3 alpha
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of DNMT3A mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of DNMT3A mRNA]
CTD
PMID:15913567
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Doc2a
double C2 domain alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DOC2A mRNA
CTD
PMID:30723492
NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:181,458,390...181,462,030
G
Dpp7
dipeptidylpeptidase 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DPP7 mRNA
CTD
PMID:25380136
NCBI chr 3:8,165,091...8,169,343
Ensembl chr 3:8,165,091...8,169,355
G
Dpys
dihydropyrimidinase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DPYS mRNA
CTD
PMID:25380136
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
G
Dpysl2
dihydropyrimidinase-like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DPYSL2 mRNA
CTD
PMID:30723492
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
G
Dram1
DNA-damage regulated autophagy modulator 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DRAM1 mRNA
CTD
PMID:25380136
NCBI chr 7:22,742,794...22,776,888
Ensembl chr 7:22,742,849...22,776,765
G
Dsg1
desmoglein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DSG1 mRNA
CTD
PMID:30723492
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
G
Dsn1
DSN1 component of MIS12 kinetochore complex
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DSN1 mRNA
CTD
PMID:30723492
NCBI chr 3:145,652,741...145,668,025
Ensembl chr 3:145,652,737...145,665,856
G
Dstyk
dual serine/threonine and tyrosine protein kinase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DSTYK mRNA
CTD
PMID:30723492
NCBI chr13:43,857,266...43,905,280
Ensembl chr13:43,857,266...43,905,269
G
Dtl
denticleless E3 ubiquitin protein ligase homolog
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DTL mRNA
CTD
PMID:30723492
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
G
Duoxa2
dual oxidase maturation factor 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DUOXA2 mRNA
CTD
PMID:30723492
NCBI chr 3:109,245,337...109,249,055
Ensembl chr 3:109,245,476...109,248,968
G
Dusp10
dual specificity phosphatase 10
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DUSP10 mRNA
CTD
PMID:30723492
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Dusp16
dual specificity phosphatase 16
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DUSP16 mRNA
CTD
PMID:25380136
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp6
dual specificity phosphatase 6
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of DUSP6 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dusp8
dual specificity phosphatase 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DUSP8 mRNA
CTD
PMID:30723492
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
G
Dysf
dysferlin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of DYSF mRNA
CTD
PMID:25380136
NCBI chr 4:116,490,877...116,690,709
Ensembl chr 4:116,490,616...116,690,709
G
E2f1
E2F transcription factor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of E2F1 mRNA
CTD
PMID:30723492
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
E2f7
E2F transcription factor 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of E2F7 mRNA
CTD
PMID:30723492
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
G
E2f8
E2F transcription factor 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of E2F8 mRNA
CTD
PMID:30723492
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Ebp
EBP, cholestenol delta-isomerase
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of EBP mRNA
CTD
PMID:27344345
NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826
G
Ech1
enoyl-CoA hydratase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ECH1 mRNA
CTD
PMID:30723492
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
G
Ecm2
extracellular matrix protein 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ECM2 mRNA
CTD
PMID:30723492
NCBI chr17:15,120,194...15,152,536
Ensembl chr17:15,120,196...15,152,516
G
Ect2
epithelial cell transforming 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ECT2 mRNA
CTD
PMID:30723492
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
G
Ect2l
epithelial cell transforming 2 like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ECT2L mRNA
CTD
PMID:30723492
NCBI chr 1:12,775,705...12,857,538
Ensembl chr 1:12,778,922...12,855,449
G
Edar
ectodysplasin-A receptor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of EDAR mRNA
CTD
PMID:30723492
NCBI chr20:26,587,836...26,666,543
Ensembl chr20:26,587,839...26,666,494
G
Eeig2
EEIG family member 2
affects expression
EXP
1-Naphthylisothiocyanate affects the expression of EEIG2 mRNA
CTD
PMID:25380136
NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371
G
Efcab11
EF-hand calcium binding domain 11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EFCAB11 mRNA
CTD
PMID:30723492
NCBI chr 6:119,008,908...119,162,994
Ensembl chr 6:119,008,919...119,162,046
G
Efna5
ephrin A5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of EFNA5 mRNA
CTD
PMID:30723492
NCBI chr 9:102,316,753...102,595,480
Ensembl chr 9:102,320,295...102,597,413
G
Efs
embryonal Fyn-associated substrate
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EFS mRNA
CTD
PMID:30723492
NCBI chr15:28,392,417...28,403,016
Ensembl chr15:28,392,187...28,401,902
G
Egf
epidermal growth factor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of EGF mRNA
CTD
PMID:25380136
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfl6
EGF-like-domain, multiple 6
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of EGFL6 mRNA
CTD
PMID:30723492
NCBI chr X:27,884,087...27,942,044
Ensembl chr X:27,884,125...27,942,044
G
Egln3
egl-9 family hypoxia-inducible factor 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EGLN3 mRNA
CTD
PMID:30723492
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
G
Egr1
early growth response 1
multiple interactions increases expression
ISO EXP
[FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of EGR1 mRNA; EGR1 protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 protein]; O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]; pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]] 1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA; 1-Naphthylisothiocyanate results in increased expression of EGR1 protein Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]
CTD
PMID:15913567 PMID:18364083 PMID:18590720 PMID:20551477 PMID:21356363 PMID:22094456 PMID:27853831 More...
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr4
early growth response 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of EGR4 mRNA
CTD
PMID:12832660
NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328
G
Ehf
ets homologous factor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EHF mRNA
CTD
PMID:30723492
NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:89,641,833...89,679,997
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of EHHADH mRNA
CTD
PMID:30723492
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Eif4e3
eukaryotic translation initiation factor 4E family member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EIF4E3 mRNA
CTD
PMID:25380136
NCBI chr 4:132,258,502...132,301,808
Ensembl chr 4:132,258,502...132,301,808
G
Elapor1
endosome-lysosome associated apoptosis and autophagy regulator 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ELAPOR1 mRNA
CTD
PMID:30723492
NCBI chr 2:196,089,199...196,169,055
Ensembl chr 2:196,091,646...196,168,716
G
Elf3
E74 like ETS transcription factor 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ELF3 mRNA
CTD
PMID:30723492
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Elovl5
ELOVL fatty acid elongase 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ELOVL5 mRNA
CTD
PMID:25380136
NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284
G
Elovl6
ELOVL fatty acid elongase 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ELOVL6 mRNA
CTD
PMID:30723492
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
G
Elovl7
ELOVL fatty acid elongase 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ELOVL7 mRNA
CTD
PMID:30723492
NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845
G
Emb
embigin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EMB mRNA
CTD
PMID:25380136
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
G
Eme1
essential meiotic structure-specific endonuclease 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EME1 mRNA
CTD
PMID:30723492
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
G
Emp1
epithelial membrane protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EMP1 mRNA
CTD
PMID:25380136
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
G
Enc1
ectodermal-neural cortex 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ENC1 mRNA
CTD
PMID:25380136
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Enpep
glutamyl aminopeptidase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ENPEP mRNA
CTD
PMID:25380136
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
G
Epb41l2
erythrocyte membrane protein band 4.1-like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EPB41L2 mRNA
CTD
PMID:25380136
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
G
Epcam
epithelial cell adhesion molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EPCAM mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Epcip
exosomal polycystin 1 interacting protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EPCIP mRNA
CTD
PMID:30723492
NCBI chr11:30,307,842...30,325,829
Ensembl chr11:30,310,350...30,325,439
G
Epdr1
ependymin related 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EPDR1 mRNA
CTD
PMID:30723492
NCBI chr17:45,333,932...45,358,597
Ensembl chr17:45,333,956...45,358,594
G
Epha2
Eph receptor A2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EPHA2 mRNA
CTD
PMID:20551477
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Ephb3
Eph receptor B3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EPHB3 mRNA
CTD
PMID:30723492
NCBI chr11:79,840,668...79,859,345
Ensembl chr11:79,840,668...79,859,370
G
Ephx1
epoxide hydrolase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EPHX1 mRNA
CTD
PMID:30723492
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Ephx2
epoxide hydrolase 2
decreases activity
ISO
1-Naphthylisothiocyanate results in decreased activity of EPHX2 protein
CTD
PMID:3621371
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Epn2
epsin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EPN2 mRNA
CTD
PMID:30723492
NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642
G
Eppk1
epiplakin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EPPK1 mRNA
CTD
PMID:30723492
NCBI chr 7:107,816,919...107,842,946
Ensembl chr 7:107,817,693...107,831,159
G
Ercc6l
ERCC excision repair 6 like, spindle assembly checkpoint helicase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ERCC6L mRNA
CTD
PMID:30723492
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
G
Erg28
ergosterol biosynthesis 28 homolog
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ERG28 mRNA
CTD
PMID:30723492
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
G
Eri2
ERI1 exoribonuclease family member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ERI2 mRNA
CTD
PMID:30723492
NCBI chr 1:174,140,831...174,168,757
Ensembl chr 1:174,141,993...174,168,665
G
Erich5
glutamate-rich 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ERICH5 mRNA
CTD
PMID:30723492
NCBI chr 7:65,655,829...65,682,221
Ensembl chr 7:65,657,204...65,680,207
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ERN1 mRNA
CTD
PMID:27344345
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ESCO2 mRNA
CTD
PMID:30723492
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
G
Espl1
extra spindle pole bodies like 1, separase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ESPL1 mRNA
CTD
PMID:30723492
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
G
Ets1
ETS proto-oncogene 1, transcription factor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ETS1 mRNA
CTD
PMID:12832660
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
Exo1
exonuclease 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EXO1 mRNA
CTD
PMID:30723492
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
Exph5
exophilin 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of EXPH5 mRNA
CTD
PMID:30723492
NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:53,698,852...53,773,169
G
Extl1
exostosin-like glycosyltransferase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of EXTL1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 5:146,573,911...146,589,115
Ensembl chr 5:146,573,912...146,589,115
G
Ezr
ezrin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of EZR mRNA
CTD
PMID:25380136
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F11r
F11 receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of F11R mRNA
CTD
PMID:30723492
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
F13a1
coagulation factor XIII A1 chain
affects response to substance
ISO
F13A1 protein affects the susceptibility to 1-Naphthylisothiocyanate
CTD
PMID:26921287
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
G
F2
coagulation factor II, thrombin
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of F2 protein 1-Naphthylisothiocyanate results in increased expression of and results in increased activity of F2 protein; F3 mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of F2 protein]; F3 protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of F2 protein]
CTD
PMID:21070799 PMID:24633426
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
F2r
coagulation factor II (thrombin) receptor
multiple interactions increases expression
ISO EXP
F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] 1-Naphthylisothiocyanate results in increased expression of F2R mRNA F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of TIMP1 mRNA]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein]
CTD
PMID:21037076 PMID:25380136
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
G
F2rl1
F2R like trypsin receptor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of F2RL1 mRNA
CTD
PMID:30723492
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
F2rl3
F2R like thrombin or trypsin receptor 3
increases response to substance
ISO
F2RL3 gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate
CTD
PMID:27475285
NCBI chr16:17,117,441...17,119,434
Ensembl chr16:17,117,441...17,119,472
G
F3
coagulation factor III, tissue factor
increases activity increases expression multiple interactions increases response to substance
ISO
1-Naphthylisothiocyanate results in increased activity of F3 protein 1-Naphthylisothiocyanate results in increased expression of F3 mRNA F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] F3 mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein]; F3 mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of F2 protein]; F3 protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of F2 protein]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of TIMP1 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein] F3 protein results in increased susceptibility to 1-Naphthylisothiocyanate
CTD
PMID:21037076 PMID:21070799
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
F5
coagulation factor V
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of F5 mRNA
CTD
PMID:27344345
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
G
Faap20
FA core complex associated protein 20
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FAAP20 mRNA
CTD
PMID:30723492
NCBI chr 5:165,808,370...165,815,291
Ensembl chr 5:165,808,657...165,815,333
G
Fabp1
fatty acid binding protein 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FABP1 mRNA
CTD
PMID:17522070 PMID:30723492
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fabp12
fatty acid binding protein 12
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FABP12 mRNA
CTD
PMID:30723492
NCBI chr 2:91,539,568...91,554,999
Ensembl chr 2:91,500,539...91,554,996
G
Fabp2
fatty acid binding protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FABP2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
G
Fabp4
fatty acid binding protein 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FABP4 mRNA
CTD
PMID:30723492
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fabp5
fatty acid binding protein 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FABP5 mRNA
CTD
PMID:30723492
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
G
Fabp7
fatty acid binding protein 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FABP7 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
G
Fads1
fatty acid desaturase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FADS1 mRNA
CTD
PMID:30723492
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
G
Fads2
fatty acid desaturase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FADS2 mRNA
CTD
PMID:30723492
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
G
Fads3
fatty acid desaturase 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FADS3 mRNA
CTD
PMID:30723492
NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769
G
Fahd1
fumarylacetoacetate hydrolase domain containing 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FAHD1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr10:13,873,539...13,874,978
Ensembl chr10:13,873,527...13,875,012
G
Fam131b
family with sequence similarity 131, member B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FAM131B mRNA
CTD
PMID:30723492
NCBI chr 4:71,201,037...71,210,292
Ensembl chr 4:71,201,038...71,210,228
G
Fam25a
family with sequence similarity 25, member A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FAM25A mRNA
CTD
PMID:30723492
NCBI chr16:9,680,668...9,684,474
Ensembl chr16:9,680,668...9,684,474
G
Fam43a
family with sequence similarity 43, member A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FAM43A mRNA
CTD
PMID:25380136
NCBI chr11:70,128,253...70,131,401
Ensembl chr11:70,128,253...70,131,401
G
Fam83d
family with sequence similarity 83, member D
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FAM83D mRNA
CTD
PMID:30723492
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
G
Fam89a
family with sequence similarity 89, member A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FAM89A mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr19:52,710,002...52,722,630
Ensembl chr19:52,710,019...52,722,631
G
Fancd2
FA complementation group D2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FANCD2 mRNA
CTD
PMID:30723492
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
G
Fanci
FA complementation group I
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FANCI mRNA
CTD
PMID:30723492
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
G
Fas
Fas cell surface death receptor
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of FAS mRNA 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of FAS mRNA]; [3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid co-treated with C188-9 compound] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of FAS mRNA]; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of FAS mRNA]
CTD
PMID:14623915 PMID:36460194
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
multiple interactions increases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FASN mRNA 1-Naphthylisothiocyanate results in increased expression of FASN mRNA
CTD
PMID:27344345 PMID:30723492
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fat1
FAT atypical cadherin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FAT1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
G
Fblim1
filamin binding LIM protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FBLIM1 mRNA
CTD
PMID:30723492
NCBI chr 5:153,883,945...153,915,524
Ensembl chr 5:153,883,960...153,913,757
G
Fbln1
fibulin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FBLN1 mRNA
CTD
PMID:30723492
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fbn1
fibrillin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FBN1 mRNA
CTD
PMID:25380136
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
G
Fbn2
fibrillin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FBN2 mRNA
CTD
PMID:30723492
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
G
Fbp1
fructose-bisphosphatase 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FBP1 mRNA
CTD
PMID:27344345
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
G
Fbxl7
F-box and leucine-rich repeat protein 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FBXL7 mRNA
CTD
PMID:30723492
NCBI chr 2:77,139,775...77,509,223
Ensembl chr 2:77,140,826...77,509,223
G
Fbxo9
f-box protein 9
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FBXO9 mRNA
CTD
PMID:25380136
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
G
Fcer1g
Fc epsilon receptor Ig
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FCER1G mRNA
CTD
PMID:25380136
NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
G
Fcer2
Fc epsilon receptor II
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FCER2 mRNA
CTD
PMID:30723492
NCBI chr12:1,742,809...1,754,476
Ensembl chr12:1,742,815...1,754,476
G
Fcgr1a
Fc gamma receptor 1A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FCGR1A mRNA
CTD
PMID:25380136
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fcmr
Fc mu receptor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FCMR mRNA
CTD
PMID:30723492
NCBI chr13:42,337,363...42,351,706
Ensembl chr13:42,337,414...42,351,653
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FDFT1 mRNA
CTD
PMID:30723492
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fdps
farnesyl diphosphate synthase
multiple interactions increases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FDPS mRNA 1-Naphthylisothiocyanate results in increased expression of FDPS mRNA
CTD
PMID:27344345 PMID:30723492
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fdx1
ferredoxin 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FDX1 mRNA
CTD
PMID:12832660
NCBI chr 8:52,268,536...52,287,344
Ensembl chr 8:52,268,536...52,287,414
G
Fermt1
FERM domain containing kindlin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FERMT1 mRNA
CTD
PMID:30723492
NCBI chr 3:120,171,301...120,213,555
Ensembl chr 3:120,171,561...120,213,555
G
Fetub
fetuin B
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FETUB mRNA
CTD
PMID:27344345
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:78,082,156...78,095,135
G
Fga
fibrinogen alpha chain
increases expression multiple interactions increases response to substance affects response to substance
ISO EXP
1-Naphthylisothiocyanate results in increased expression of FGA mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FGA mRNA [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CCL2 mRNA; [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CXCL1 mRNA; [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CXCL2 mRNA; [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of EGR1 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of FGA mRNA FGA protein affects the susceptibility to 1-Naphthylisothiocyanate
CTD
PMID:17522070 PMID:20974703 PMID:21356363 PMID:27344345 PMID:30352267
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
increases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of FGB mRNA
CTD
PMID:17522070 PMID:20974703 PMID:26921287
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fgf1
fibroblast growth factor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FGF1 mRNA
CTD
PMID:30723492
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fgf11
fibroblast growth factor 11
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FGF11 mRNA
CTD
PMID:30723492
NCBI chr10:54,516,508...54,522,067
Ensembl chr10:54,517,077...54,522,062
G
Fgf19
fibroblast growth factor 19
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of FGF15 mRNA alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FGF15 mRNA]
CTD
PMID:25655198
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
G
Fgf2
fibroblast growth factor 2
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FGF2 mRNA
CTD
PMID:27344345
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fgf23
fibroblast growth factor 23
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FGF23 mRNA
CTD
PMID:30723492
NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:159,914,272...159,923,821
G
Fgf7
fibroblast growth factor 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FGF7 mRNA
CTD
PMID:30723492
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Fgg
fibrinogen gamma chain
increases expression affects expression affects response to substance multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of FGG mRNA 1-Naphthylisothiocyanate affects the expression of FGG mRNA FGG protein affects the susceptibility to 1-Naphthylisothiocyanate [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of FGG mRNA; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA]; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB1 mRNA]]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]]
CTD
PMID:20974703 PMID:26921287 PMID:30352267
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Fgl2
fibrinogen-like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FGL2 mRNA
CTD
PMID:25380136
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FGR mRNA
CTD
PMID:25380136
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
G
Fhl1
four and a half LIM domains 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FHL1 mRNA
CTD
PMID:25380136
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
G
Fhl2
four and a half LIM domains 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FHL2 mRNA
CTD
PMID:25380136
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
G
Fignl1
fidgetin-like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FIGNL1 mRNA
CTD
PMID:30723492
NCBI chr14:86,368,670...86,381,728
Ensembl chr14:86,368,675...86,377,455
G
Fkbp1a
FKBP prolyl isomerase 1A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FKBP1A mRNA
CTD
PMID:25380136
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
G
Flna
filamin A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FLNA mRNA
CTD
PMID:25380136
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
G
Flnc
filamin C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FLNC mRNA
CTD
PMID:30723492
NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844
G
Flywch2
FLYWCH family member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FLYWCH2 mRNA
CTD
PMID:30723492
NCBI chr10:12,798,757...12,807,082
Ensembl chr10:12,798,762...12,806,439
G
Fmnl2
formin-like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FMNL2 mRNA
CTD
PMID:25380136
NCBI chr 3:37,348,791...37,624,746
Ensembl chr 3:37,348,574...37,624,754
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
ISO EXP
1-Naphthylisothiocyanate results in decreased expression of FMO1 mRNA
CTD
PMID:15913567 PMID:17522070 PMID:25380136 PMID:30723492
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of FMO3 mRNA; 1-Naphthylisothiocyanate results in increased expression of FMO3 protein
CTD
PMID:25193093
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Fndc4
fibronectin type III domain containing 4
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of FNDC4 mRNA
CTD
PMID:17175557
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
G
Folr2
folate receptor beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FOLR2 mRNA
CTD
PMID:25380136
NCBI chr 1:156,200,044...156,218,380
Ensembl chr 1:156,200,060...156,205,724
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions affects expression increases expression
ISO EXP
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOS mRNA] 1-Naphthylisothiocyanate affects the expression of FOS mRNA
CTD
PMID:15913567 PMID:25380136 PMID:30352267
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxa2
forkhead box A2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FOXA2 mRNA
CTD
PMID:25380136
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
G
Foxm1
forkhead box M1
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of FOXM1 mRNA; 1-Naphthylisothiocyanate results in increased expression of FOXM1 protein NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 mRNA]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]
CTD
PMID:29660435 PMID:30723492
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Foxn3
forkhead box N3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FOXN3 mRNA
CTD
PMID:30723492
NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401
G
Foxp3
forkhead box P3
affects expression decreases expression
ISO EXP
1-Naphthylisothiocyanate affects the expression of FOXP3 mRNA 1-Naphthylisothiocyanate results in decreased expression of FOXP3 mRNA
CTD
PMID:20594950 PMID:30723492
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Frem2
FRAS1 related extracellular matrix 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FREM2 mRNA
CTD
PMID:30723492
NCBI chr 2:137,602,784...137,740,785
Ensembl chr 2:137,602,784...137,740,785
G
Fsip1
fibrous sheath interacting protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FSIP1 mRNA
CTD
PMID:30723492
NCBI chr 3:105,074,584...105,217,180
Ensembl chr 3:105,068,543...105,217,167
G
Fst
follistatin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FST mRNA
CTD
PMID:30723492
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
G
Fstl1
follistatin-like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FSTL1 mRNA
CTD
PMID:25380136
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
G
Fstl3
follistatin like 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FSTL3 mRNA
CTD
PMID:30723492
NCBI chr 7:9,923,574...9,929,223
Ensembl chr 7:9,923,576...9,939,639
G
Ftcd
formimidoyltransferase cyclodeaminase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FTCD mRNA
CTD
PMID:25380136
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
G
Fth1
ferritin heavy chain 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FTH1 mRNA
CTD
PMID:27344345
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Fut2
fucosyltransferase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FUT2 mRNA
CTD
PMID:30723492
NCBI chr 1:96,119,549...96,139,567
Ensembl chr 1:96,119,371...96,140,360
G
Fxyd2
FXYD domain-containing ion transport regulator 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FXYD2 mRNA
CTD
PMID:25380136
NCBI chr 8:45,712,901...45,720,032
Ensembl chr 8:45,712,903...45,720,203
G
Fxyd5
FXYD domain-containing ion transport regulator 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FXYD5 mRNA
CTD
PMID:25380136
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
G
Fxyd6
FXYD domain-containing ion transport regulator 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of FXYD6 mRNA
CTD
PMID:25380136
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
G
Fzd1
frizzled class receptor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FZD1 mRNA
CTD
PMID:30723492
NCBI chr 4:29,310,303...29,314,701
Ensembl chr 4:29,310,091...29,312,643 Ensembl chr 4:29,310,091...29,312,643
G
Fzd7
frizzled class receptor 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FZD7 mRNA
CTD
PMID:30723492
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
Fzd8
frizzled class receptor 8
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of FZD8 mRNA
CTD
PMID:25380136
NCBI chr17:57,312,924...57,320,551
Ensembl chr17:57,314,450...57,320,650
G
G0s2
G0/G1switch 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of G0S2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
increases expression decreases expression
EXP
1-Naphthylisothiocyanate results in increased expression of G6PC1 mRNA 1-Naphthylisothiocyanate results in decreased expression of G6PC1 mRNA
CTD
PMID:18289764 PMID:25380136 PMID:30723492
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of GADD45A mRNA Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GADD45A mRNA] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GADD45A mRNA
CTD
PMID:17522070 PMID:27344345 PMID:30517764 PMID:30723492
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gal3st1
galactose-3-O-sulfotransferase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GAL3ST1 mRNA
CTD
PMID:30723492
NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388
G
Galc
galactosylceramidase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GALC mRNA
CTD
PMID:25380136
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
G
Gale
UDP-galactose-4-epimerase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GALE mRNA
CTD
PMID:30723492
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
G
Gars1
glycyl-tRNA synthetase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GARS1 mRNA
CTD
PMID:20551477
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gas2l3
growth arrest-specific 2 like 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GAS2L3 mRNA
CTD
PMID:30723492
NCBI chr 7:23,803,578...23,836,816
Ensembl chr 7:23,806,310...23,836,411
G
Gask1a
golgi associated kinase 1A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GASK1A mRNA
CTD
PMID:30723492
NCBI chr 8:121,610,779...121,643,742
Ensembl chr 8:121,610,787...121,642,942
G
Gask1b
golgi associated kinase 1B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GASK1B mRNA
CTD
PMID:25380136
NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
G
Gata3
GATA binding protein 3
affects expression decreases expression
ISO EXP
1-Naphthylisothiocyanate affects the expression of GATA3 mRNA 1-Naphthylisothiocyanate results in decreased expression of GATA3 mRNA
CTD
PMID:20594950 PMID:30723492
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
G
Gatb
glutamyl-tRNA amidotransferase subunit B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GATB mRNA
CTD
PMID:30723492
NCBI chr 2:170,930,547...171,017,133
Ensembl chr 2:170,930,542...171,016,695
G
Gbp2
guanylate binding protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GBP2 mRNA
CTD
PMID:25380136
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gbp4
guanylate binding protein 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GBP4 mRNA
CTD
PMID:25380136
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
G
Gc
GC, vitamin D binding protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GC mRNA
CTD
PMID:25380136
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gca
grancalcin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GCA mRNA
CTD
PMID:30723492
NCBI chr 3:47,297,320...47,329,913
Ensembl chr 3:47,297,383...47,328,581
G
Gcat
glycine C-acetyltransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GCAT mRNA
CTD
PMID:25380136
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
G
Gcgr
glucagon receptor
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GCGR mRNA
CTD
PMID:27344345
NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640
G
Gchfr
GTP cyclohydrolase I feedback regulator
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GCHFR mRNA
CTD
PMID:25380136
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
G
Gck
glucokinase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GCK mRNA
CTD
PMID:17522070
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
G
Gckr
glucokinase regulator
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GCKR mRNA
CTD
PMID:30723492
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression decreases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of GCLC mRNA 1-Naphthylisothiocyanate results in decreased expression of GCLC mRNA [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of GCLC protein; tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of GCLC mRNA]
CTD
PMID:20551477 PMID:37348807
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression decreases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of GCLM mRNA 1-Naphthylisothiocyanate results in decreased expression of GCLM mRNA [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of GCLM protein; tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of GCLM mRNA] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GCLM mRNA
CTD
PMID:20551477 PMID:27344345 PMID:37348807
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gcnt1
glucosaminyl (N-acetyl) transferase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GCNT1 mRNA
CTD
PMID:25380136
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GCNT3 mRNA
CTD
PMID:30723492
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of GDPD3 mRNA
CTD
PMID:17175557
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
G
Gem
GTP binding protein overexpressed in skeletal muscle
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GEM mRNA
CTD
PMID:30723492
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
G
Get1
guided entry of tail-anchored proteins factor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GET1 mRNA
CTD
PMID:25380136
NCBI chr11:35,438,555...35,460,156
Ensembl chr11:35,445,815...35,459,973
G
Gfi1
growth factor independent 1 transcriptional repressor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GFI1 mRNA
CTD
PMID:30723492
NCBI chr14:2,040,576...2,056,874
Ensembl chr14:2,042,434...2,051,814
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GFPT2 mRNA
CTD
PMID:30723492
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
G
Gfra1
GDNF family receptor alpha 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GFRA1 mRNA
CTD
PMID:30723492
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
G
Ghr
growth hormone receptor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GHR mRNA
CTD
PMID:25380136
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Gins1
GINS complex subunit 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GINS1 mRNA
CTD
PMID:30723492
NCBI chr 3:139,724,513...139,745,930
Ensembl chr 3:139,724,490...139,745,936
G
Gja1
gap junction protein, alpha 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GJA1 mRNA
CTD
PMID:20551477 PMID:25380136
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gja4
gap junction protein, alpha 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GJA4 mRNA
CTD
PMID:25380136
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
G
Gjb1
gap junction protein, beta 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GJB1 mRNA
CTD
PMID:17522070
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
G
Gjc3
gap junction protein, gamma 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GJC3 mRNA
CTD
PMID:30723492
NCBI chr12:16,899,846...16,912,309
Ensembl chr12:16,896,813...16,964,246
G
Gk
glycerol kinase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GK mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
G
Gkap1
G kinase anchoring protein 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GKAP1 mRNA
CTD
PMID:30723492
NCBI chr17:6,383,963...6,423,684
Ensembl chr17:6,383,963...6,423,679
G
Glipr1
GLI pathogenesis-related 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GLIPR1 mRNA
CTD
PMID:25380136
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
G
Glis3
GLIS family zinc finger 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GLIS3 mRNA
CTD
PMID:30723492
NCBI chr 1:225,976,029...226,395,849
Ensembl chr 1:225,976,326...226,395,899
G
Gls
glutaminase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GLS mRNA
CTD
PMID:25380136
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
G
Gls2
glutaminase 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GLS2 mRNA
CTD
PMID:25380136
NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426
G
Glt8d1
glycosyltransferase 8 domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GLT8D1 mRNA
CTD
PMID:25380136
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
G
Gmfg
glia maturation factor, gamma
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GMFG mRNA
CTD
PMID:25380136
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
G
Gmnn
geminin, DNA replication inhibitor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GMNN mRNA
CTD
PMID:30723492
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
G
Gna14
G protein subunit alpha 14
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GNA14 mRNA
CTD
PMID:25380136
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
G
Gnai1
G protein subunit alpha i1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GNAI1 mRNA
CTD
PMID:30723492
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnai2
G protein subunit alpha i2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GNAI2 mRNA
CTD
PMID:25380136
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnat1
G protein subunit alpha transducin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GNAT1 mRNA
CTD
PMID:30723492
NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671
G
Gnat2
G protein subunit alpha transducin 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GNAT2 mRNA
CTD
PMID:30723492
NCBI chr 2:195,726,371...195,735,866
Ensembl chr 2:195,726,762...195,735,866
G
Gng11
G protein subunit gamma 11
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GNG11 mRNA
CTD
PMID:30723492
NCBI chr 4:32,023,003...32,028,443
Ensembl chr 4:32,023,003...32,028,442
G
Gng13
G protein subunit gamma 13
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GNG13 mRNA
CTD
PMID:30723492
NCBI chr10:14,741,179...14,743,083
Ensembl chr10:14,741,239...14,743,083
G
Gngt2
G protein subunit gamma transducin 2
affects expression
EXP
1-Naphthylisothiocyanate affects the expression of GNGT2 mRNA
CTD
PMID:25380136
NCBI chr10:80,776,003...80,784,235
G
Gnmt
glycine N-methyltransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GNMT mRNA
CTD
PMID:30723492
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
G
Gnpda1
glucosamine-6-phosphate deaminase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GNPDA1 mRNA
CTD
PMID:25380136
NCBI chr18:30,165,435...30,177,462
Ensembl chr18:30,165,427...30,177,486
G
Gp1bb
glycoprotein Ib platelet subunit beta
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GP1BB mRNA
CTD
PMID:30723492
NCBI chr11:82,378,216...82,379,393
Ensembl chr11:82,378,199...82,379,392
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GPAM mRNA
CTD
PMID:25380136
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Gpat2
glycerol-3-phosphate acyltransferase 2, mitochondrial
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GPAT2 mRNA
CTD
PMID:30723492
NCBI chr 3:114,646,446...114,657,051
Ensembl chr 3:114,648,498...114,657,051
G
Gpnmb
glycoprotein nmb
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GPNMB mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr176
G protein-coupled receptor 176
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GPR176 mRNA
CTD
PMID:30723492
NCBI chr 3:105,236,794...105,337,664
Ensembl chr 3:105,236,795...105,337,226
G
Gpt
glutamic--pyruvic transaminase
increases activity increases expression multiple interactions decreases expression
EXP ISO
1-Naphthylisothiocyanate results in increased activity of GPT protein 1-Naphthylisothiocyanate results in increased expression of GPT protein 4-methyl-7,8-dihydroxycoumarin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPT protein] 1-Naphthylisothiocyanate results in decreased expression of GPT mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; [3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid co-treated with C188-9 compound] inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; [Mifepristone co-treated with 1-Naphthylisothiocyanate] results in decreased expression of GPT protein; AHR protein affects the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPT protein]; Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; liquiritin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPT protein]; NR1H4 protein affects the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPT protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPT protein]; pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPT protein]; ursodoxicoltaurine affects the reaction [NR1H4 protein affects the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]]; ursodoxicoltaurine promotes the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; VWF protein affects the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein] dioscin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPT protein]
CTD
PMID:24418708 PMID:24633426 PMID:26921287 PMID:27317372 PMID:27374722 PMID:27853831 PMID:28549656 PMID:29737914 PMID:30352267 PMID:30723492 PMID:32579994 PMID:32976922 PMID:33400020 PMID:34619301 PMID:36008890 PMID:36460194 PMID:36581201 PMID:36787806 PMID:37348807 More...
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GPX1 mRNA
CTD
PMID:17522070
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of GPX2 mRNA [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GPX2 mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of GPX2 mRNA; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPX2 mRNA]
CTD
PMID:30517764 PMID:30723492 PMID:33749747
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gpx8
glutathione peroxidase 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GPX8 mRNA
CTD
PMID:25380136
NCBI chr 2:44,676,448...44,680,042
Ensembl chr 2:44,676,454...44,680,195
G
Gramd2b
GRAM domain containing 2B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GRAMD2B mRNA
CTD
PMID:30723492
NCBI chr18:49,884,014...49,981,955
Ensembl chr18:49,884,014...49,981,953
G
Grap2
GRB2-related adaptor protein 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GRAP2 mRNA
CTD
PMID:30723492
NCBI chr 7:112,117,142...112,190,880
Ensembl chr 7:112,117,142...112,190,877
G
Grik5
glutamate ionotropic receptor kainate type subunit 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GRIK5 mRNA
CTD
PMID:30723492
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GRIN1 mRNA
CTD
PMID:12832660
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grip2
glutamate receptor interacting protein 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GRIP2 mRNA
CTD
PMID:30723492
NCBI chr 4:124,271,456...124,356,538
Ensembl chr 4:124,271,456...124,321,268
G
Grn
granulin precursor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GRN mRNA
CTD
PMID:25380136
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gsr
glutathione-disulfide reductase
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of GSR mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GSR mRNA]
CTD
PMID:15913567
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gss
glutathione synthetase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GSS mRNA
CTD
PMID:20551477
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
G
Gsta1
glutathione S-transferase alpha 1
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of GSTA1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GSTA1 mRNA
CTD
PMID:20551477 PMID:27344345
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta2
glutathione S-transferase alpha 2
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of GSTA2 mRNA [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of GSTA2 mRNA; O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GSTA2 mRNA]
CTD
PMID:12883083 PMID:15913567 PMID:33749747
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta3
glutathione S-transferase alpha 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GSTA3 mRNA
CTD
PMID:20551477 PMID:25380136 PMID:30723492
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gsta5
glutathione S-transferase alpha 5
multiple interactions increases expression
ISO
[1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GSTA1 mRNA 1-Naphthylisothiocyanate results in increased expression of GSTA1 mRNA
CTD
PMID:33749747
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Gstk1
glutathione S-transferase kappa 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GSTK1 mRNA
CTD
PMID:27344345
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
G
Gstm1
glutathione S-transferase mu 1
increases expression
EXP ISO
1-Naphthylisothiocyanate results in increased expression of GSTM1 mRNA 1-Naphthylisothiocyanate results in increased expression of GSTM5 mRNA
CTD
PMID:15913567 PMID:30723492
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GSTM2 mRNA
CTD
PMID:18289764
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstm5
glutathione S-transferase, mu 5
decreases expression multiple interactions increases expression
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of GSTM3 mRNA [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GSTM3 mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of GSTM3 mRNA 1-Naphthylisothiocyanate results in increased expression of GSTM3 mRNA
CTD
PMID:17522070 PMID:30517764 PMID:30723492 PMID:33749747
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Gstm5l
glutathione S-transferase, mu 5-like
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GSTM5L mRNA
CTD
PMID:30723492
NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP ISO
1-Naphthylisothiocyanate results in increased expression of GSTP1 mRNA
CTD
PMID:15913567 PMID:20551477
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstp3
glutathione S-transferase pi 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GSTP3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:201,355,682...201,358,216
Ensembl chr 1:201,355,682...201,358,330
G
Gstt1
glutathione S-transferase theta 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GSTT1 mRNA
CTD
PMID:12883083
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Gtse1
G-2 and S-phase expressed 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GTSE1 mRNA
CTD
PMID:30723492
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
G
Gucy1b2
guanylate cyclase 1 soluble subunit beta 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GUCY1B2 mRNA
CTD
PMID:30723492
NCBI chr15:36,589,501...36,669,441
Ensembl chr15:36,598,883...36,669,441
G
Gucy2c
guanylate cyclase 2C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GUCY2C mRNA
CTD
PMID:30723492
NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092
G
Gucy2f
guanylate cyclase 2F
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GUCY2F mRNA
CTD
PMID:12832660
NCBI chr X:105,710,356...105,808,183
Ensembl chr X:105,710,356...105,808,183
G
Gulp1
GULP PTB domain containing engulfment adaptor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GULP1 mRNA
CTD
PMID:25380136
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
G
Gzma
granzyme A
increases expression decreases expression
EXP
1-Naphthylisothiocyanate results in increased expression of GZMA mRNA 1-Naphthylisothiocyanate results in decreased expression of GZMA mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
G
Gzmk
granzyme K
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GZMK mRNA
CTD
PMID:30723492
NCBI chr 2:44,840,811...44,848,829
Ensembl chr 2:44,840,811...44,848,894
G
Gzmm
granzyme M
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of GZMM mRNA
CTD
PMID:30723492
NCBI chr 7:10,011,065...10,016,841
Ensembl chr 7:10,011,066...10,016,665
G
H2ax
H2A.X variant histone
affects expression
EXP
1-Naphthylisothiocyanate affects the expression of H2AX protein
CTD
PMID:26011634
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hacd4
3-hydroxyacyl-CoA dehydratase 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HACD4 mRNA
CTD
PMID:30723492
NCBI chr 5:102,887,597...102,915,376
Ensembl chr 5:102,887,588...102,915,338
G
Hacl1
2-hydroxyacyl-CoA lyase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HACL1 mRNA
CTD
PMID:30723492
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
G
Hadh
hydroxyacyl-CoA dehydrogenase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HADH mRNA
CTD
PMID:30723492
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
multiple interactions decreases expression
ISO
[1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of HADHA mRNA; Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of HADHA mRNA]
CTD
PMID:33749747
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hagh
hydroxyacyl glutathione hydrolase
increases expression decreases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HAGH mRNA 1-Naphthylisothiocyanate results in decreased expression of HAGH mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504
G
Hal
histidine ammonia lyase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HAL mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
G
Hao1
hydroxyacid oxidase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HAO1 mRNA
CTD
PMID:25380136
NCBI chr 3:121,757,400...121,828,721
Ensembl chr 3:121,771,836...121,828,721
G
Hao2
hydroxyacid oxidase 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HAO2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Haspin
histone H3 associated protein kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HASPIN mRNA
CTD
PMID:30723492
NCBI chr10:57,747,731...57,750,518
Ensembl chr10:57,747,573...57,750,512
G
Haus4
HAUS augmin-like complex, subunit 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HAUS4 mRNA
CTD
PMID:30723492
NCBI chr15:27,994,530...28,006,147
Ensembl chr15:27,994,532...28,005,938
G
Havcr1
hepatitis A virus cellular receptor 1
affects expression
EXP
1-Naphthylisothiocyanate affects the expression of HAVCR1 mRNA
CTD
PMID:18289764
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hba-a1
hemoglobin alpha, adult chain 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HBA-A1 mRNA
CTD
PMID:30723492
NCBI chr10:15,337,265...15,338,121
Ensembl chr10:15,307,815...15,338,392
G
Hbq1b
hemoglobin subunit theta 1B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HBQ1B mRNA
CTD
PMID:30723492
NCBI chr10:15,334,293...15,336,061
Ensembl chr10:15,320,762...15,321,397 Ensembl chr10:15,320,762...15,321,397
G
Hcar1
hydroxycarboxylic acid receptor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HCAR1 mRNA
CTD
PMID:30723492
NCBI chr12:32,710,680...32,713,934
Ensembl chr12:32,711,027...32,712,082
G
Hck
HCK proto-oncogene, Src family tyrosine kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HCK mRNA
CTD
PMID:25380136
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
G
Hebp2
heme binding protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HEBP2 mRNA
CTD
PMID:30723492
NCBI chr 1:13,194,982...13,201,777
Ensembl chr 1:13,194,982...13,201,777
G
Hells
helicase, lymphoid specific
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HELLS mRNA
CTD
PMID:25380136
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of HERPUD1 mRNA
CTD
PMID:27344345
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hexim1
HEXIM P-TEFb complex subunit 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HEXIM1 mRNA
CTD
PMID:25380136
NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,062,803...88,066,189
G
Hey1
hes-related family bHLH transcription factor with YRPW motif 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HEY1 mRNA
CTD
PMID:30723492
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
G
Hibadh
3-hydroxyisobutyrate dehydrogenase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HIBADH mRNA
CTD
PMID:17522070
NCBI chr 4:81,649,180...81,747,244
Ensembl chr 4:81,649,175...81,780,617
G
Hif1a
hypoxia inducible factor 1 subunit alpha
decreases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in decreased expression of HIF1A mRNA NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of HIF1A mRNA]
CTD
PMID:19181614
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hjv
hemojuvelin BMP co-receptor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HJV mRNA
CTD
PMID:25380136
NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850
G
Hlf
HLF transcription factor, PAR bZIP family member
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HLF mRNA
CTD
PMID:30723492
NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
G
Hmgb2l1
high mobility group box 2-like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HMGB2L1 mRNA
CTD
PMID:30723492
NCBI chr11:47,252,583...47,253,646
Ensembl chr11:47,252,569...47,253,669
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HMGCR mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HMGCS1 mRNA
CTD
PMID:30723492
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hmgn5b
high mobility group nucleosome binding domain 5B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HMGN5B mRNA
CTD
PMID:25380136
NCBI chr 1:117,222,188...117,224,158
Ensembl chr 1:117,222,298...117,223,587
G
Hmmr
hyaluronan-mediated motility receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HMMR mRNA
CTD
PMID:30723492
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
G
Hmox1
heme oxygenase 1
increases expression decreases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of HMOX1 mRNA; 1-Naphthylisothiocyanate results in increased expression of HMOX1 protein 1-Naphthylisothiocyanate results in decreased expression of HMOX1 mRNA [liquiritin co-treated with 1-Naphthylisothiocyanate] results in increased expression of HMOX1 mRNA; [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of HMOX1 protein; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of HMOX1 mRNA]; liquiritin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of HMOX1 protein]; tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of HMOX1 mRNA]
CTD
PMID:15913567 PMID:18289764 PMID:20551477 PMID:25380136 PMID:30517764 PMID:30723492 PMID:36008890 PMID:37348807 More...
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hmx2
H6 family homeobox 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HMX2 mRNA
CTD
PMID:30723492
NCBI chr 1:186,319,110...186,326,771
Ensembl chr 1:186,319,110...186,326,771
G
Hnf4g
hepatocyte nuclear factor 4, gamma
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HNF4G mRNA
CTD
PMID:30723492
NCBI chr 2:97,885,773...98,036,650
Ensembl chr 2:97,887,432...98,036,592
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:12832660
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hopx
HOP homeobox
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HOPX mRNA
CTD
PMID:25380136
NCBI chr14:31,055,912...31,082,909
Ensembl chr14:31,075,148...31,082,909
G
Hoxb5
homeo box B5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HOXB5 mRNA
CTD
PMID:30723492
NCBI chr10:81,269,372...81,271,580
Ensembl chr10:81,269,372...81,271,580
G
Hras
HRas proto-oncogene, GTPase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HRAS mRNA
CTD
PMID:20551477
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Hs3st2
heparan sulfate-glucosamine 3-sulfotransferase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HS3ST2 mRNA
CTD
PMID:30723492
NCBI chr 1:175,956,161...176,077,400
Ensembl chr 1:175,956,157...176,077,399
G
Hsd17b14
hydroxysteroid (17-beta) dehydrogenase 14
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HSD17B14 mRNA
CTD
PMID:30723492
NCBI chr 1:96,029,224...96,039,577
Ensembl chr 1:96,029,284...96,039,883
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of HSD17B2 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of HSD17B2 mRNA
CTD
PMID:25380136 PMID:27344345 PMID:30723492
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HSD17B7 mRNA
CTD
PMID:30723492
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
G
Hsf1
heat shock transcription factor 1
increases activity
ISO
1-Naphthylisothiocyanate results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HSP90AA1 mRNA
CTD
PMID:20551477
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HSP90AB1 mRNA
CTD
PMID:20551477
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression affects expression
EXP
1-Naphthylisothiocyanate results in increased expression of HSPA1A mRNA 1-Naphthylisothiocyanate affects the expression of HSPA1A mRNA
CTD
PMID:17522070 PMID:20551477
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
affects expression
EXP
1-Naphthylisothiocyanate affects the expression of HSPA1B mRNA
CTD
PMID:20551477
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa4
heat shock protein family A (Hsp70) member 4
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of HSPA4 mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of HSPA4 mRNA]
CTD
PMID:15913567
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Hspa8
heat shock protein family A (Hsp70) member 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HSPA8 mRNA
CTD
PMID:20551477
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspa9
heat shock protein family A (Hsp70) member 9
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of HSPA9 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of HSPA9 mRNA
CTD
PMID:20551477 PMID:27344345
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
G
Hspb1
heat shock protein family B (small) member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HSPB1 mRNA
CTD
PMID:20551477
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Hspb2
heat shock protein family B (small) member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HSPB2 mRNA
CTD
PMID:20551477
NCBI chr 8:51,093,267...51,094,528
Ensembl chr 8:51,081,342...51,094,533
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HSPD1 mRNA
CTD
PMID:20551477
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of HSPH1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of HSPH1 mRNA
CTD
PMID:20551477 PMID:27344345
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Htr1b
5-hydroxytryptamine receptor 1B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of HTR1B mRNA
CTD
PMID:30723492
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Hykk
hydroxylysine kinase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of HYKK mRNA
CTD
PMID:25380136
NCBI chr 8:55,315,919...55,339,720
Ensembl chr 8:55,315,969...55,337,339
G
Iars1
isoleucyl-tRNA synthetase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IARS1 mRNA
CTD
PMID:20551477
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
G
Ica1
islet cell autoantigen 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ICA1 mRNA
CTD
PMID:30723492
NCBI chr 4:36,656,475...36,804,705
Ensembl chr 4:36,656,475...36,804,298
G
Icam1
intercellular adhesion molecule 1
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of ICAM1 mRNA; 1-Naphthylisothiocyanate results in increased expression of ICAM1 protein Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ICAM1 protein]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ICAM1 protein]
CTD
PMID:17522070 PMID:18590720 PMID:21070799 PMID:22094456 PMID:26921287
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icam5
intercellular adhesion molecule 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ICAM5 mRNA
CTD
PMID:30723492
NCBI chr 8:19,567,390...19,575,588
Ensembl chr 8:19,568,600...19,575,588
G
Id1
inhibitor of DNA binding 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ID1 mRNA
CTD
PMID:20551477
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id4
inhibitor of DNA binding 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ID4 mRNA
CTD
PMID:25380136
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
G
Idi1
isopentenyl-diphosphate delta isomerase 1
multiple interactions increases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IDI1 mRNA 1-Naphthylisothiocyanate results in increased expression of IDI1 mRNA
CTD
PMID:27344345 PMID:30723492
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ido2
indoleamine 2,3-dioxygenase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IDO2 mRNA
CTD
PMID:30723492
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:67,459,190...67,496,324
G
Ifitm1
interferon induced transmembrane protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IFITM1 mRNA
CTD
PMID:25380136
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IFITM3 mRNA
CTD
PMID:30723492
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ifng
interferon gamma
increases expression multiple interactions decreases expression
EXP ISO
1-Naphthylisothiocyanate results in increased expression of IFNG protein ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IFNG protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IFNG protein] 1-Naphthylisothiocyanate results in increased expression of IFNG mRNA IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of KRT19 protein]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA] 1-Naphthylisothiocyanate results in decreased expression of IFNG mRNA
CTD
PMID:12912871 PMID:20594950 PMID:26921287 PMID:32198087
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifngr1
interferon gamma receptor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IFNGR1 mRNA
CTD
PMID:25380136
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Ifrd1
interferon-related developmental regulator 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IFRD1 mRNA
CTD
PMID:25380136
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Igf2
insulin-like growth factor 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IGF2 mRNA
CTD
PMID:30723492
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Igf2bp3
insulin-like growth factor 2 mRNA binding protein 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IGF2BP3 mRNA
CTD
PMID:25380136
NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865
G
Igf2r
insulin-like growth factor 2 receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IGF2R mRNA
CTD
PMID:25380136
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IGFALS mRNA
CTD
PMID:25380136
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IGFBP1 mRNA
CTD
PMID:15913567 PMID:17522070 PMID:18289764 PMID:25380136 PMID:27344345
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Igfbp2
insulin-like growth factor binding protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IGFBP2 mRNA
CTD
PMID:25380136
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of IGFBP3 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IGFBP3 mRNA
CTD
PMID:25380136 PMID:27344345 PMID:30723492
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Igfbp5
insulin-like growth factor binding protein 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IGFBP5 mRNA
CTD
PMID:30723492
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Igfbp7
insulin-like growth factor binding protein 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IGFBP7 mRNA
CTD
PMID:25380136
NCBI chr14:30,737,414...30,797,317
Ensembl chr14:30,737,164...30,797,314
G
Igh-6
immunoglobulin heavy chain 6
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IGH-6 mRNA
CTD
PMID:30723492
G
Igkc
immunoglobulin kappa constant
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IGKC mRNA
CTD
PMID:18289764
G
Igsf6
immunoglobulin superfamily, member 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IGSF6 mRNA
CTD
PMID:25380136
NCBI chr 1:175,610,167...175,620,662
Ensembl chr 1:175,610,167...175,620,722
G
Ikbke
inhibitor of nuclear factor kappa B kinase subunit epsilon
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IKBKE mRNA
CTD
PMID:30723492
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
G
Ikzf3
IKAROS family zinc finger 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IKZF3 mRNA
CTD
PMID:30723492
NCBI chr10:83,460,564...83,553,591
Ensembl chr10:83,465,745...83,553,591
G
Ikzf4
IKAROS family zinc finger 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IKZF4 mRNA
CTD
PMID:30723492
NCBI chr 7:1,063,283...1,102,940
Ensembl chr 7:1,056,890...1,084,341
G
Il10
interleukin 10
affects expression increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate affects the expression of IL10 protein 1-Naphthylisothiocyanate results in increased expression of IL10 mRNA [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of IL10 mRNA; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL10 mRNA]
CTD
PMID:25051504 PMID:30352267 PMID:30517764
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il11
interleukin 11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IL11 mRNA
CTD
PMID:30723492
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
G
Il12b
interleukin 12B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IL12B mRNA
CTD
PMID:30723492
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il17a
interleukin 17A
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of IL17A protein
CTD
PMID:20594950
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1b
interleukin 1 beta
affects expression multiple interactions increases expression
EXP ISO
1-Naphthylisothiocyanate affects the expression of IL1B mRNA ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B protein] [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of IL1B mRNA; [Hypoxanthine co-treated with potassium oxonate] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; liquiritin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B protein]; NR1H4 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; NR1H4 promotes the reaction [yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]]; pregna-4,17-diene-3,16-dione promotes the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B protein]; Uric Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA] 1-Naphthylisothiocyanate results in increased expression of IL1B mRNA; 1-Naphthylisothiocyanate results in increased expression of IL1B protein
CTD
PMID:15135310 PMID:25051504 PMID:26921287 PMID:29660435 PMID:30352267 PMID:30517764 PMID:32198087 PMID:33400020 PMID:33749747 PMID:36008890 More...
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
increases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of IL1R1 mRNA
CTD
PMID:12832660 PMID:15913567
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il1rl1
interleukin 1 receptor-like 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IL1RL1 mRNA
CTD
PMID:27344345
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il2rg
interleukin 2 receptor subunit gamma
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IL2RG mRNA
CTD
PMID:25380136
NCBI chr X:66,395,330...66,399,026
Ensembl chr X:66,392,542...66,399,823
G
Il33
interleukin 33
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IL33 mRNA
CTD
PMID:25380136
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il6
interleukin 6
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of IL6 mRNA; 1-Naphthylisothiocyanate results in increased expression of IL6 protein [Hypoxanthine co-treated with potassium oxonate] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 mRNA]; Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 mRNA]; Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 protein]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 mRNA]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 protein]; Uric Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 mRNA]; Uric Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 protein]; yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 mRNA] Dexamethasone inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 protein]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 protein]
CTD
PMID:15135310 PMID:18364083 PMID:18590720 PMID:25051504 PMID:25418378 PMID:26921287 PMID:27853831 PMID:29660435 PMID:30352267 PMID:30517764 PMID:33400020 PMID:33749747 More...
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il7r
interleukin 7 receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IL7R mRNA
CTD
PMID:25380136
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Incenp
inner centromere protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of INCENP mRNA; 1-Naphthylisothiocyanate results in increased expression of INCENP protein
CTD
PMID:23411599 PMID:30723492
NCBI chr 1:206,520,655...206,550,575
Ensembl chr 1:206,523,380...206,553,265
G
Inf2
inverted formin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of INF2 mRNA
CTD
PMID:30723492
NCBI chr 6:131,649,162...131,675,944
Ensembl chr 6:131,649,211...131,675,941
G
Inhba
inhibin subunit beta A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of INHBA mRNA
CTD
PMID:30723492
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Inhbc
inhibin subunit beta C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of INHBC mRNA
CTD
PMID:25380136
NCBI chr 7:63,184,141...63,197,630
Ensembl chr 7:63,184,142...63,197,630
G
Inhbe
inhibin subunit beta E
increases expression decreases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of INHBE mRNA 1-Naphthylisothiocyanate results in decreased expression of INHBE mRNA
CTD
PMID:17175557 PMID:25380136
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Inmt
indolethylamine N-methyltransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of INMT mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
G
Inpp5d
inositol polyphosphate-5-phosphatase D
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of INPP5D mRNA
CTD
PMID:25380136
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
G
Insig1
insulin induced gene 1
multiple interactions increases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of INSIG1 mRNA 1-Naphthylisothiocyanate results in increased expression of INSIG1 mRNA
CTD
PMID:27344345 PMID:30723492
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Insig2
insulin induced gene 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of INSIG2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Insyn1
inhibitory synaptic factor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of INSYN1 mRNA
CTD
PMID:30723492
NCBI chr 8:58,904,153...58,914,850
Ensembl chr 8:58,904,153...58,914,843
G
Iqgap1
IQ motif containing GTPase activating protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IQGAP1 mRNA
CTD
PMID:25380136
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
G
Iqgap3
IQ motif containing GTPase activating protein 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IQGAP3 mRNA
CTD
PMID:30723492
NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956
G
Irak2
interleukin-1 receptor-associated kinase 2
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IRAK2 mRNA
CTD
PMID:27344345
NCBI chr 4:146,786,004...146,842,615
Ensembl chr 4:146,786,100...146,842,602
G
Isg20
interferon stimulated exonuclease gene 20
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ISG20 mRNA
CTD
PMID:25380136
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Islr
immunoglobulin superfamily containing leucine-rich repeat
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ISLR mRNA
CTD
PMID:30723492
NCBI chr 8:58,571,155...58,574,128
Ensembl chr 8:58,570,777...58,574,130
G
Isyna1
inositol-3-phosphate synthase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ISYNA1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
G
Itga2
integrin subunit alpha 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ITGA2 mRNA
CTD
PMID:30723492
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itga2b
integrin subunit alpha 2b
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ITGA2B mRNA
CTD
PMID:25380136
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
G
Itga3
integrin subunit alpha 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ITGA3 mRNA
CTD
PMID:30723492
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
G
Itga5
integrin subunit alpha 5
multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]; [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] which results in increased activity of TGFB1 protein; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] [ITGA5 protein co-treated with ITGB6 protein] promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein]
CTD
PMID:21037076
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
G
Itga8
integrin subunit alpha 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ITGA8 mRNA
CTD
PMID:30723492
NCBI chr17:75,304,004...75,501,510
Ensembl chr17:75,304,008...75,501,510
G
Itgal
integrin subunit alpha L
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ITGAL mRNA
CTD
PMID:25380136
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
G
Itgam
integrin subunit alpha M
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ITGAM mRNA
CTD
PMID:12832660
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgav
integrin subunit alpha V
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ITGAV mRNA
CTD
PMID:30723492
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
G
Itgb1
integrin subunit beta 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ITGB1 mRNA
CTD
PMID:25380136
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Itgb2
integrin subunit beta 2
increases response to substance multiple interactions increases expression
ISO EXP
ITGB2 protein results in increased susceptibility to 1-Naphthylisothiocyanate [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ITGB2 mRNA 1-Naphthylisothiocyanate results in increased expression of ITGB2 mRNA
CTD
PMID:16614373 PMID:21070799 PMID:25380136 PMID:27344345
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Itgb3
integrin subunit beta 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ITGB3 mRNA
CTD
PMID:25380136
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Itgb6
integrin subunit beta 6
multiple interactions increases expression
ISO
[ITGA5 protein co-treated with ITGB6 protein] promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein]; EGR1 protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 protein]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; TGFB1 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA] 1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]; [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] which results in increased activity of TGFB1 protein; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] 1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA; 1-Naphthylisothiocyanate results in increased expression of ITGB6 protein
CTD
PMID:21037076 PMID:22094456 PMID:24633426 PMID:26921287 PMID:28049044
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
G
Itih4
inter-alpha-trypsin inhibitor heavy chain 4
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ITIH4 mRNA
CTD
PMID:27344345
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
G
Itk
IL2-inducible T-cell kinase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ITK mRNA
CTD
PMID:30723492
NCBI chr10:30,753,344...30,814,685
Ensembl chr10:30,753,344...30,814,685
G
Ivd
isovaleryl-CoA dehydrogenase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IVD mRNA
CTD
PMID:25380136
NCBI chr 3:105,851,710...105,872,144
Ensembl chr 3:105,851,683...105,872,575
G
Iyd
iodotyrosine deiodinase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of IYD mRNA
CTD
PMID:25380136
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Izumo4
IZUMO family member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IZUMO4 mRNA
CTD
PMID:30723492
NCBI chr 7:9,007,276...9,010,428
Ensembl chr 7:9,007,280...9,010,032
G
Jak2
Janus kinase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of JAK2 mRNA
CTD
PMID:25380136
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jam3
junctional adhesion molecule 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of JAM3 mRNA
CTD
PMID:30723492
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
G
Jdp2
Jun dimerization protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of JDP2 mRNA
CTD
PMID:25380136
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Jph3
junctophilin 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of JPH3 mRNA
CTD
PMID:30723492
NCBI chr19:49,793,967...49,855,338
Ensembl chr19:49,793,092...49,855,338
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of JUN mRNA 1-Naphthylisothiocyanate results in increased expression of and results in increased phosphorylation of JUN protein; 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of and results in increased phosphorylation of JUN protein]; [C188-9 compound co-treated with 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of and results in increased phosphorylation of JUN protein]; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of and results in increased phosphorylation of JUN protein]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of JUN mRNA]
CTD
PMID:15913567 PMID:20551477 PMID:30352267 PMID:30723492 PMID:36460194
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of JUNB mRNA
CTD
PMID:30723492
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kank1
KN motif and ankyrin repeat domains 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KANK1 mRNA
CTD
PMID:25380136
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
G
Kank4
KN motif and ankyrin repeat domains 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KANK4 mRNA
CTD
PMID:30723492
NCBI chr 5:113,401,491...113,465,526
Ensembl chr 5:113,402,468...113,465,555
G
Kat14
lysine acetyltransferase 14
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KAT14 mRNA
CTD
PMID:30723492
NCBI chr 3:131,736,430...131,781,732
Ensembl chr 3:131,736,549...131,781,706
G
Kcna5
potassium voltage-gated channel subfamily A member 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KCNA5 mRNA
CTD
PMID:30723492
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
G
Kcnc2
potassium voltage-gated channel subfamily C member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KCNC2 mRNA
CTD
PMID:12832660
NCBI chr 7:47,700,035...47,883,979
Ensembl chr 7:47,700,288...47,883,968
G
Kcnd3
potassium voltage-gated channel subfamily D member 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KCND3 mRNA
CTD
PMID:30723492
NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KCNJ8 mRNA
CTD
PMID:25380136
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
G
Kcnk2
potassium two pore domain channel subfamily K member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KCNK2 mRNA
CTD
PMID:30723492
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kcnk5
potassium two pore domain channel subfamily K member 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KCNK5 mRNA
CTD
PMID:30723492
NCBI chr15:4,122,442...4,164,718
Ensembl chr15:4,122,442...4,164,718
G
Kcnq5
potassium voltage-gated channel subfamily Q member 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KCNQ5 mRNA
CTD
PMID:30723492
NCBI chr 9:23,830,185...24,395,984
Ensembl chr 9:23,833,087...24,394,704
G
Kctd14
potassium channel tetramerization domain containing 14
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KCTD14 mRNA
CTD
PMID:30723492
NCBI chr 1:151,761,688...151,766,693
Ensembl chr 1:151,761,663...151,766,691
G
Kctd19
potassium channel tetramerization domain containing 19
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KCTD19 mRNA
CTD
PMID:30723492
NCBI chr19:33,259,869...33,292,011
Ensembl chr19:33,259,970...33,292,006
G
Kdelr3
KDEL endoplasmic reticulum protein retention receptor 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KDELR3 mRNA
CTD
PMID:30723492
NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:111,079,218...111,101,600
G
Kdm5c
lysine demethylase 5C
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KDM5C mRNA
CTD
PMID:30723492
NCBI chr X:21,345,459...21,387,045
Ensembl chr X:21,345,481...21,381,870
G
Keap1
Kelch-like ECH-associated protein 1
decreases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in decreased expression of KEAP1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of KEAP1 protein liquiritin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of KEAP1 protein]
CTD
PMID:36008890 PMID:37348807
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Kif11
kinesin family member 11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF11 mRNA
CTD
PMID:30723492
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
G
Kif12
kinesin family member 12
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF12 mRNA
CTD
PMID:30723492
NCBI chr 5:76,596,204...76,603,261
Ensembl chr 5:76,596,208...76,602,843
G
Kif14
kinesin family member 14
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF14 mRNA
CTD
PMID:30723492
NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
G
Kif15
kinesin family member 15
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF15 mRNA
CTD
PMID:30723492
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Kif18a
kinesin family member 18A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF18A mRNA
CTD
PMID:30723492
NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
G
Kif18b
kinesin family member 18B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF18B mRNA
CTD
PMID:30723492
NCBI chr10:87,870,424...87,889,895
Ensembl chr10:87,870,428...87,889,850
G
Kif20a
kinesin family member 20A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF20A mRNA
CTD
PMID:30723492
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
G
Kif20b
kinesin family member 20B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF20B mRNA
CTD
PMID:30723492
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
G
Kif22
kinesin family member 22
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF22 mRNA
CTD
PMID:30723492
NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401
G
Kif23
kinesin family member 23
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF23 mRNA
CTD
PMID:30723492
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
G
Kif24
kinesin family member 24
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF24 mRNA
CTD
PMID:30723492
NCBI chr 5:56,561,019...56,628,040
Ensembl chr 5:56,561,154...56,628,025
G
Kif2c
kinesin family member 2C
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KIF2C mRNA 1-Naphthylisothiocyanate results in increased expression of KIF2C mRNA
CTD
PMID:12832660 PMID:30723492
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Kif9
kinesin family member 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIF9 mRNA
CTD
PMID:30723492
NCBI chr 8:110,459,467...110,504,492
Ensembl chr 8:110,459,383...110,505,252
G
Kifc1
kinesin family member C1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KIFC1 mRNA
CTD
PMID:30723492
NCBI chr20:4,998,832...5,017,107
Ensembl chr20:4,999,047...5,017,105
G
Klf4
KLF transcription factor 4
multiple interactions increases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of KLF4 mRNA 1-Naphthylisothiocyanate results in increased expression of KLF4 mRNA
CTD
PMID:27344345 PMID:30723492
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Klf6
KLF transcription factor 6
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of KLF6 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of KLF6 mRNA
CTD
PMID:25380136 PMID:27344345 PMID:30723492
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klhdc7a
kelch domain containing 7A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KLHDC7A mRNA
CTD
PMID:30723492
NCBI chr 5:152,218,604...152,224,707
Ensembl chr 5:152,221,033...152,224,551
G
Klhdc8a
kelch domain containing 8A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KLHDC8A mRNA
CTD
PMID:30723492
NCBI chr13:43,735,702...43,744,277
Ensembl chr13:43,736,192...43,744,277
G
Klkb1
kallikrein B1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of KLKB1 mRNA
CTD
PMID:27344345
NCBI chr16:46,958,634...46,982,054
Ensembl chr16:46,958,707...46,982,053
G
Kmo
kynurenine 3-monooxygenase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KMO mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Kng1
kininogen 1
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of KNG1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of KNG1 mRNA
CTD
PMID:27344345 PMID:30723492
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Kng2
kininogen 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KNG2 mRNA
CTD
PMID:30723492
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
G
Knl1
kinetochore scaffold 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KNL1 mRNA
CTD
PMID:30723492
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
G
Knstrn
kinetochore-localized astrin/SPAG5 binding protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KNSTRN mRNA
CTD
PMID:30723492
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
G
Kntc1
kinetochore associated 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KNTC1 mRNA
CTD
PMID:30723492
NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561
G
Krt18
keratin 18
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of KRT18 mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of KRT18 mRNA]
CTD
PMID:15913567 PMID:17522070 PMID:25380136 PMID:30723492
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Krt19
keratin 19
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of KRT19 mRNA IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of KRT19 protein]; leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of KRT19 protein]; Tranexamic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of KRT19 protein]
CTD
PMID:21037076 PMID:24633426 PMID:25380136 PMID:26921287
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Krt7
keratin 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KRT7 mRNA
CTD
PMID:30723492
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Krt8
keratin 8
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of KRT8 mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of KRT8 mRNA]
CTD
PMID:15913567 PMID:17522070 PMID:25380136 PMID:30723492
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Krt80
keratin 80
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KRT80 mRNA
CTD
PMID:30723492
NCBI chr 7:132,463,216...132,485,134
Ensembl chr 7:132,463,218...132,485,508
G
Ksr2
kinase suppressor of ras 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KSR2 mRNA
CTD
PMID:30723492
NCBI chr12:38,802,796...39,187,809
Ensembl chr12:38,802,004...39,188,375
G
Ktn1
kinectin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of KTN1 mRNA
CTD
PMID:25380136
NCBI chr15:20,913,665...21,002,588
Ensembl chr15:20,914,642...21,002,578
G
Kyat3
kynurenine aminotransferase 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KAT3 mRNA; 1-Naphthylisothiocyanate results in decreased expression of KYAT3 mRNA
CTD
PMID:30723492
NCBI chr 2:231,701,881...231,747,462
Ensembl chr 2:231,701,963...231,747,227
G
Kynu
kynureninase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of KYNU mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
L3hypdh
trans-L-3-hydroxyproline dehydratase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of L3HYPDH mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 6:90,636,310...90,647,106
Ensembl chr 6:90,636,310...90,647,106
G
Lama1
laminin subunit alpha 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LAMA1 mRNA
CTD
PMID:30723492
NCBI chr 9:107,692,770...107,816,847
Ensembl chr 9:107,692,770...107,817,478
G
Lama5
laminin subunit alpha 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LAMA5 mRNA
CTD
PMID:30723492
NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451
G
Lamc2
laminin subunit gamma 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LAMC2 mRNA
CTD
PMID:30723492
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Lamp2
lysosomal-associated membrane protein 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LAMP2 mRNA
CTD
PMID:30723492
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
G
Laptm5
lysosomal protein transmembrane 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LAPTM5 mRNA
CTD
PMID:25380136
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
G
Lbh
LBH regulator of WNT signaling pathway
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LBH mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 6:22,569,238...22,593,056
Ensembl chr 6:22,568,834...22,593,079
G
Lbp
lipopolysaccharide binding protein
increases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of LBP mRNA
CTD
PMID:15913567 PMID:17522070 PMID:25380136 PMID:30723492
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lca5
lebercilin LCA5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LCA5 mRNA
CTD
PMID:30723492
NCBI chr 8:84,307,696...84,375,025
Ensembl chr 8:84,317,659...84,374,956
G
Lcn12
lipocalin 12
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LCN12 mRNA
CTD
PMID:30723492
NCBI chr 3:8,312,412...8,315,392
Ensembl chr 3:8,305,920...8,323,495
G
Lcn2
lipocalin 2
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA]]
CTD
PMID:18289764 PMID:25380136 PMID:27853831 PMID:30723492
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lcp1
lymphocyte cytosolic protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LCP1 mRNA
CTD
PMID:25380136
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
G
Lcp2
lymphocyte cytosolic protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LCP2 mRNA
CTD
PMID:25380136
NCBI chr10:18,642,600...18,689,562
Ensembl chr10:18,642,658...18,689,559
G
Ldlr
low density lipoprotein receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LDLR mRNA
CTD
PMID:30723492
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lep
leptin
affects expression
EXP
1-Naphthylisothiocyanate affects the expression of LEP protein
CTD
PMID:25051504
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals1
galectin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LGALS1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Lgals2
galectin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LGALS2 mRNA
CTD
PMID:25380136
NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:110,403,173...110,404,802
G
Lgals3
galectin 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LGALS3 mRNA
CTD
PMID:17522070 PMID:25380136 PMID:30723492
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lgalsl
galectin-like
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LGALSL mRNA
CTD
PMID:25380136
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
G
Lgi1
leucine-rich, glioma inactivated 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LGI1 mRNA
CTD
PMID:30723492
NCBI chr 1:236,043,269...236,084,617
Ensembl chr 1:236,042,954...236,084,616
G
Lgi2
leucine-rich repeat LGI family, member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LGI2 mRNA
CTD
PMID:30723492
NCBI chr14:58,415,965...58,443,450
Ensembl chr14:58,415,965...58,443,407
G
Lgmn
legumain
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LGMN mRNA
CTD
PMID:25380136
NCBI chr 6:121,544,048...121,582,495
Ensembl chr 6:121,544,053...121,582,480
G
Lhx8
LIM homeobox 8
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LHX8 mRNA
CTD
PMID:30723492
NCBI chr 2:243,244,958...243,269,624
Ensembl chr 2:243,244,961...243,269,416
G
Lif
LIF, interleukin 6 family cytokine
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LIF mRNA
CTD
PMID:30723492
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Limk2
LIM domain kinase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LIMK2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr14:78,208,182...78,286,106
Ensembl chr14:78,218,063...78,286,007
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LIN7A mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
G
Lin9
lin-9 DREAM MuvB core complex component
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LIN9 mRNA
CTD
PMID:30723492
NCBI chr13:92,374,612...92,419,664
Ensembl chr13:92,374,593...92,419,654
G
Lipc
lipase C, hepatic type
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LIPC mRNA
CTD
PMID:17522070
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
G
Lipo1
lipase, member O1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LIPO1 mRNA
CTD
PMID:30723492
NCBI chr 1:231,311,828...231,328,805
Ensembl chr 1:231,311,315...231,325,187
G
Lman1l
lectin, mannose-binding, 1 like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LMAN1L mRNA
CTD
PMID:30723492
NCBI chr 8:58,010,839...58,029,599
Ensembl chr 8:58,010,839...58,023,681
G
Lmcd1
LIM and cysteine-rich domains 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LMCD1 mRNA
CTD
PMID:23558518
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
G
Lmntd1
lamin tail domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LMNTD1 mRNA
CTD
PMID:30723492
NCBI chr 4:178,354,302...178,588,483
Ensembl chr 4:178,354,137...178,588,477
G
Lmx1a
LIM homeobox transcription factor 1 alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LMX1A mRNA
CTD
PMID:30723492
NCBI chr13:79,834,614...79,978,253
Ensembl chr13:79,835,019...79,978,253
G
Lnx2
ligand of numb-protein X 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LNX2 mRNA
CTD
PMID:30723492
NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494
G
Lox
lysyl oxidase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LOX mRNA
CTD
PMID:25380136
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Loxl1
lysyl oxidase-like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LOXL1 mRNA
CTD
PMID:30723492
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Lpar1
lysophosphatidic acid receptor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LPAR1 mRNA
CTD
PMID:30723492
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
G
Lpin2
lipin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LPIN2 mRNA
CTD
PMID:30723492
NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
G
Lpl
lipoprotein lipase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LPL mRNA
CTD
PMID:17522070 PMID:25380136
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrat
lecithin retinol acyltransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LRAT mRNA
CTD
PMID:25380136
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
G
Lrr1
leucine rich repeat protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LRR1 mRNA
CTD
PMID:30723492
NCBI chr 6:87,643,195...87,651,894
Ensembl chr 6:87,643,217...87,651,894
G
Lrrc2
leucine rich repeat containing 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LRRC2 mRNA
CTD
PMID:30723492
NCBI chr 8:110,936,119...110,969,189
Ensembl chr 8:110,938,165...110,969,185
G
Lrrc28
leucine rich repeat containing 28
affects expression
EXP
1-Naphthylisothiocyanate affects the expression of LRRC28 mRNA
CTD
PMID:25380136
NCBI chr 1:121,116,833...121,245,805
Ensembl chr 1:121,127,733...121,245,784
G
Lrrc75b
leucine rich repeat containing 75B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LRRC75B mRNA
CTD
PMID:30723492
NCBI chr20:13,100,302...13,106,503
Ensembl chr20:13,100,302...13,106,503
G
Lrrfip1
LRR binding FLII interacting protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LRRFIP1 mRNA
CTD
PMID:25380136
NCBI chr 9:91,592,032...91,720,250
Ensembl chr 9:91,643,197...91,720,250
G
Lrriq3
leucine-rich repeats and IQ motif containing 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LRRIQ3 mRNA
CTD
PMID:30723492
NCBI chr 2:244,119,975...244,214,590
Ensembl chr 2:244,126,200...244,212,339
G
Lrrn1
leucine rich repeat neuronal 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LRRN1 mRNA
CTD
PMID:30723492
NCBI chr 4:140,476,752...140,520,210
Ensembl chr 4:140,476,324...140,518,620
G
Lss
lanosterol synthase
multiple interactions increases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of LSS mRNA 1-Naphthylisothiocyanate results in increased expression of LSS mRNA
CTD
PMID:27344345 PMID:30723492
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Lta4h
leukotriene A4 hydrolase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LTA4H mRNA
CTD
PMID:25380136
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
G
Ltb
lymphotoxin beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LTB mRNA
CTD
PMID:25380136
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Ltbp1
latent transforming growth factor beta binding protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LTBP1 mRNA
CTD
PMID:25380136
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
G
Lum
lumican
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LUM mRNA
CTD
PMID:25380136
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
G
Lurap1l
leucine rich adaptor protein 1-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LURAP1L mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 5:95,362,005...95,409,439
Ensembl chr 5:95,362,005...95,409,438
G
Ly6g6c
lymphocyte antigen 6 family member G6C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LY6G6C mRNA
CTD
PMID:30723492
NCBI chr20:3,753,632...3,757,205
Ensembl chr20:3,753,632...3,758,867
G
Ly9
lymphocyte antigen 9
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LY9 mRNA
CTD
PMID:30723492
NCBI chr13:84,079,345...84,100,783
Ensembl chr13:84,079,458...84,100,823
G
Ly96
lymphocyte antigen 96
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of LY96 mRNA
CTD
PMID:25380136
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Lyst
lysosomal trafficking regulator
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LYST mRNA
CTD
PMID:30723492
NCBI chr17:86,241,384...86,443,501
Ensembl chr17:86,241,384...86,443,480
G
Lzts1
leucine zipper tumor suppressor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of LZTS1 mRNA
CTD
PMID:30723492
NCBI chr16:20,542,756...20,598,204
Ensembl chr16:20,542,809...20,598,203
G
M6pr
mannose-6-phosphate receptor, cation dependent
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of M6PR mRNA
CTD
PMID:30723492
NCBI chr 4:155,501,080...155,510,219
Ensembl chr 4:155,500,921...155,510,216
G
Mad2l1
mitotic arrest deficient 2 like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAD2L1 mRNA
CTD
PMID:30723492
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
G
Maff
MAF bZIP transcription factor F
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of MAFF mRNA
CTD
PMID:27344345
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Magee1
MAGE family member E1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAGEE1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr X:70,189,242...70,192,789
Ensembl chr X:70,189,187...70,192,810
G
Magix
MAGI family member, X-linked
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MAGIX mRNA
CTD
PMID:30723492
NCBI chr X:14,824,114...14,832,466
Ensembl chr X:14,824,188...14,831,045
G
Mamdc2
MAM domain containing 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MAMDC2 mRNA
CTD
PMID:30723492
NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354
G
Manba
mannosidase beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MANBA mRNA
CTD
PMID:30723492
NCBI chr 2:223,910,432...224,002,988
Ensembl chr 2:223,910,432...224,002,983
G
Maob
monoamine oxidase B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MAOB mRNA
CTD
PMID:17522070
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Map1b
microtubule-associated protein 1B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAP1B mRNA
CTD
PMID:30723492
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAP1LC3A mRNA
CTD
PMID:25380136
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map2
microtubule-associated protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAP2 mRNA
CTD
PMID:30723492
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAP2K3 mRNA
CTD
PMID:20551477
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map3k20
mitogen-activated protein kinase kinase kinase 20
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MAP3K20 mRNA
CTD
PMID:30723492
NCBI chr 3:57,130,539...57,289,943
Ensembl chr 3:57,130,551...57,289,626
G
Map3k6
mitogen-activated protein kinase kinase kinase 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAP3K6 mRNA
CTD
PMID:30723492
NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAP3K8 mRNA
CTD
PMID:25380136
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Map9
microtubule-associated protein 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAP9 mRNA
CTD
PMID:30723492
NCBI chr 2:167,708,661...167,743,927
Ensembl chr 2:167,708,765...167,740,736
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased phosphorylation of MAPK1 protein Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK1 protein]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK1 protein]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK1 protein]; U 0126 promotes the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK1 protein]]
CTD
PMID:27702592 PMID:32976922 PMID:33400020
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
EXP ISO
U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK3 protein] Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK3 protein]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK3 protein]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK3 protein]; U 0126 promotes the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK3 protein]]
CTD
PMID:27702592 PMID:32976922 PMID:33400020
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk4
mitogen-activated protein kinase 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MAPK4 mRNA
CTD
PMID:30723492
NCBI chr18:67,512,805...67,661,271
Ensembl chr18:67,512,807...67,661,842
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation multiple interactions
ISO
1-Naphthylisothiocyanate results in increased phosphorylation of MAPK8 protein 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK8 protein]; [3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid co-treated with C188-9 compound] inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK8 protein]; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of MAPK8 protein]
CTD
PMID:36460194
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mars1
methionyl-tRNA synthetase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MARS1 mRNA
CTD
PMID:20551477
NCBI chr 7:63,121,142...63,138,550
Ensembl chr 7:63,121,142...63,138,495
G
Mastl
microtubule associated serine/threonine kinase-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MASTL mRNA
CTD
PMID:30723492
NCBI chr17:85,250,512...85,287,479
Ensembl chr17:85,251,997...85,287,353
G
Matn4
matrilin 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MATN4 mRNA
CTD
PMID:30723492
NCBI chr 3:153,120,605...153,135,628
Ensembl chr 3:153,120,632...153,135,865
G
Mbl2
mannose binding lectin 2
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of MBL2 mRNA
CTD
PMID:27344345
NCBI chr 1:228,016,439...228,024,736
G
Mcm2
minichromosome maintenance complex component 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MCM2 mRNA
CTD
PMID:30723492
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Mcm3
minichromosome maintenance complex component 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MCM3 mRNA
CTD
PMID:30723492
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcm4
minichromosome maintenance complex component 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MCM4 mRNA
CTD
PMID:30723492
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mcm5
minichromosome maintenance complex component 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MCM5 mRNA
CTD
PMID:30723492
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm6
minichromosome maintenance complex component 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MCM6 mRNA
CTD
PMID:30723492
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
G
Mcpt8l2
mast cell protease 8-like 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MCPT8L2 mRNA
CTD
PMID:30723492
G
Mcpt8l3
mast cell protease 8-like 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MCPT8L3 mRNA
CTD
PMID:30723492
G
Mcub
mitochondrial calcium uniporter dominant negative subunit beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MCUB mRNA
CTD
PMID:30723492
NCBI chr 2:218,479,301...218,549,594
Ensembl chr 2:218,479,301...218,549,593
G
Mdh1
malate dehydrogenase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MDH1 mRNA
CTD
PMID:25380136
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Mef2c
myocyte enhancer factor 2C
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MEF2C mRNA
CTD
PMID:30723492
NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880
G
Meiob
meiosis specific with OB-fold
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MEIOB mRNA
CTD
PMID:30723492
NCBI chr10:13,833,170...13,865,684
Ensembl chr10:13,833,750...13,865,046
G
Melk
maternal embryonic leucine zipper kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MELK mRNA
CTD
PMID:30723492
NCBI chr 5:58,540,393...58,600,562
Ensembl chr 5:58,540,449...58,600,937
G
Meox2
mesenchyme homeobox 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MEOX2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 6:53,856,760...53,917,467
Ensembl chr 6:53,856,758...53,917,467
G
Mfap4
microfibril associated protein 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MFAP4 mRNA
CTD
PMID:25380136
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
G
Mfrp
membrane frizzled-related protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MFRP mRNA
CTD
PMID:30723492
NCBI chr 8:44,445,636...44,450,859
Ensembl chr 8:44,445,697...44,450,859
G
Mfsd8
major facilitator superfamily domain containing 8
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MFSD8 mRNA
CTD
PMID:30723492
NCBI chr 2:123,822,042...123,847,808
Ensembl chr 2:123,816,614...123,857,971
G
Mgp
matrix Gla protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MGP mRNA
CTD
PMID:18289764 PMID:25380136
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mgst2
microsomal glutathione S-transferase 2
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of MGST2 mRNA
CTD
PMID:27344345
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
G
Mid1ip1
MID1 interacting protein 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MID1IP1 mRNA
CTD
PMID:25380136
NCBI chr X:12,060,993...12,063,318
Ensembl chr X:12,060,883...12,065,774
G
Miga1
mitoguardin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MIGA1 mRNA
CTD
PMID:30723492
NCBI chr 2:241,224,118...241,279,174
Ensembl chr 2:241,226,015...241,279,106
G
Mindy3
MINDY lysine 48 deubiquitinase 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MINDY3 mRNA
CTD
PMID:25380136
NCBI chr17:75,545,286...75,623,884
Ensembl chr17:75,545,286...75,623,854
G
Mir122
microRNA 122
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MIR122 mRNA
CTD
PMID:23143187
NCBI chr18:58,758,703...58,758,787
G
Mir16
microRNA 16
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MIR16 mRNA
CTD
PMID:17522070
NCBI chr 2:153,245,349...153,245,443
Ensembl chr 2:153,245,349...153,245,443
G
Mir190
microRNA 190
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MIR190A mRNA
CTD
PMID:22363424
NCBI chr 8:67,850,987...67,851,071
Ensembl chr 8:67,850,987...67,851,071
G
Mir337
microRNA 337
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MIR337 mRNA alternative form
CTD
PMID:22363424
NCBI chr 6:128,538,903...128,538,999
Ensembl chr 6:128,538,902...128,538,998
G
Mir3557
microRNA 3557
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MIR378B mRNA
CTD
PMID:30723492
NCBI chr18:54,858,537...54,858,649
Ensembl chr18:54,858,537...54,858,649
G
Mir411
microRNA 411
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MIR411 mRNA
CTD
PMID:22363424
NCBI chr 6:128,723,189...128,723,264
Ensembl chr 6:128,723,184...128,723,279
G
Mir875
microRNA 875
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MIR875 mRNA
CTD
PMID:22363424
NCBI chr 7:66,861,955...66,862,027
Ensembl chr 7:66,861,955...66,862,027
G
Mis18bp1
MIS18 binding protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MIS18BP1 mRNA
CTD
PMID:30723492
NCBI chr 6:83,182,497...83,231,978
Ensembl chr 6:83,182,499...83,231,383
G
Mki67
marker of proliferation Ki-67
increases expression affects expression
EXP
1-Naphthylisothiocyanate results in increased expression of MKI67 mRNA; 1-Naphthylisothiocyanate results in increased expression of MKI67 protein 1-Naphthylisothiocyanate affects the expression of MKI67 protein
CTD
PMID:23411599 PMID:26011634 PMID:30723492
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mknk2
MAPK interacting serine/threonine kinase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MKNK2 mRNA
CTD
PMID:30723492
NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827
G
Mlec
malectin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MLEC mRNA
CTD
PMID:30723492
NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708
G
Mmd2
monocyte to macrophage differentiation-associated 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MMD2 mRNA
CTD
PMID:30723492
NCBI chr12:11,962,733...12,009,776
Ensembl chr12:11,962,757...12,009,773
G
Mme
membrane metallo-endopeptidase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MME mRNA
CTD
PMID:30723492
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
G
Mmp14
matrix metallopeptidase 14
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of MMP14 mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MMP14 mRNA]
CTD
PMID:15913567
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Mmp15
matrix metallopeptidase 15
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MMP15 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
G
Mmp20
matrix metallopeptidase 20
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MMP20 mRNA
CTD
PMID:30723492
NCBI chr 8:4,789,415...4,830,035
Ensembl chr 8:4,789,415...4,830,035
G
Mmp3
matrix metallopeptidase 3
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of MMP3 mRNA
CTD
PMID:15913567
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MMP7 mRNA
CTD
PMID:30723492
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of MMP9 mRNA
CTD
PMID:27344345
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mms22l
MMS22-like, DNA repair protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MMS22L mRNA
CTD
PMID:30723492
NCBI chr 5:38,197,707...38,313,745
Ensembl chr 5:38,197,779...38,313,745
G
Mnd1
meiotic nuclear divisions 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MND1 mRNA
CTD
PMID:30723492
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
G
Mnda
myeloid cell nuclear differentiation antigen
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of IFI204 mRNA
CTD
PMID:25380136
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
G
Mob3a
MOB kinase activator 3A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MOB3A mRNA
CTD
PMID:25380136
NCBI chr 7:9,010,490...9,027,888
Ensembl chr 7:9,010,587...9,027,879
G
Mpl
MPL proto-oncogene, thrombopoietin receptor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MPL mRNA
CTD
PMID:30723492
NCBI chr 5:131,973,895...131,987,472
Ensembl chr 5:131,973,895...131,986,797
G
Mpo
myeloperoxidase
multiple interactions increases expression increases activity
ISO EXP
3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MPO protein]; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MPO protein]; Clopidogrel inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein]; F3 mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein]; Uric Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein] Dexamethasone affects the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein]; resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MPO protein]
CTD
PMID:18364083 PMID:18590720 PMID:20133375 PMID:21070799 PMID:25418378 PMID:33400020 PMID:33749747 PMID:36460194 More...
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mreg
melanoregulin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MREG mRNA
CTD
PMID:30723492
NCBI chr 9:73,786,727...73,842,081
Ensembl chr 9:73,787,267...73,842,087
G
Mro
maestro
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MRO mRNA
CTD
PMID:25380136
NCBI chr18:67,450,186...67,467,593
Ensembl chr18:67,450,595...67,467,044
G
Ms4a1
membrane spanning 4-domains A1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MS4A1 mRNA
CTD
PMID:30723492
NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
G
Ms4a18
membrane spanning 4-domains A18
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MS4A18 mRNA
CTD
PMID:30723492
NCBI chr 1:207,644,858...207,662,471
Ensembl chr 1:207,645,780...207,665,793
G
Ms4a2
membrane spanning 4-domains A2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MS4A2 mRNA
CTD
PMID:12832660
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
G
Ms4a4a
membrane spanning 4-domains A4A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MS4A4A mRNA
CTD
PMID:30723492
NCBI chr 1:208,060,507...208,085,121
Ensembl chr 1:208,046,971...208,085,119
G
Msln
mesothelin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MSLN mRNA
CTD
PMID:30723492
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Msmo1
methylsterol monooxygenase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MSMO1 mRNA
CTD
PMID:30723492
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Msn
moesin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MSN mRNA
CTD
PMID:25380136
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Mst1r
macrophage stimulating 1 receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MST1R mRNA
CTD
PMID:30723492
NCBI chr 8:108,596,100...108,611,441
Ensembl chr 8:108,597,299...108,612,455
G
Mt1
metallothionein 1
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of MT1A mRNA 1-Naphthylisothiocyanate results in increased expression of MT1 mRNA pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MT1 mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MT1 mRNA]]
CTD
PMID:18289764 PMID:25380136 PMID:27853831
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
increases expression decreases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of MT2A mRNA 1-Naphthylisothiocyanate results in decreased expression of MT2A mRNA 1-Naphthylisothiocyanate results in increased expression of MT2 mRNA pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MT2 mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MT2 mRNA]]
CTD
PMID:25380136 PMID:27853831 PMID:30723492
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MTHFD1L mRNA
CTD
PMID:30723492
NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905
G
Mtmr7
myotubularin related protein 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MTMR7 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr16:51,641,267...51,732,212
Ensembl chr16:51,641,190...51,732,182
G
Mttp
microsomal triglyceride transfer protein
multiple interactions increases expression
ISO
18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MTTP mRNA]; Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MTTP mRNA]
CTD
PMID:28549656
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Muc4
mucin 4, cell surface associated
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MUC4 mRNA
CTD
PMID:30723492
NCBI chr11:68,008,245...68,053,242
G
Mug1
murinoglobulin 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MUG1 mRNA
CTD
PMID:17522070
NCBI chr 4:155,076,270...155,130,051
Ensembl chr 4:155,076,312...155,130,051
G
Mup4
major urinary protein 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MUP4 mRNA
CTD
PMID:30723492
NCBI chr 5:74,961,143...74,964,686
Ensembl chr 5:74,842,319...75,061,474
G
Mup4l1
major urinary protein 4 like 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of MUP4L1 mRNA
CTD
PMID:30723492
NCBI chr 5:75,221,340...75,224,797
Ensembl chr 5:75,142,157...75,564,845
G
Musk
muscle associated receptor tyrosine kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MUSK mRNA
CTD
PMID:12832660
NCBI chr 5:73,058,427...73,169,696
Ensembl chr 5:73,058,121...73,171,932
G
Mvd
mevalonate diphosphate decarboxylase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MVD mRNA
CTD
PMID:30723492
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
G
Mvk
mevalonate kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MVK mRNA
CTD
PMID:30723492
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
G
Mvp
major vault protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MVP mRNA
CTD
PMID:25380136
NCBI chr 1:181,594,734...181,622,336
Ensembl chr 1:181,594,734...181,622,380
G
Myadm
myeloid-associated differentiation marker
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYADM mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
G
Mybl1
MYB proto-oncogene like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYBL1 mRNA
CTD
PMID:30723492
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
G
Mybl2
MYB proto-oncogene like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYBL2 mRNA
CTD
PMID:30723492
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYC mRNA
CTD
PMID:12883083 PMID:17522070 PMID:25380136 PMID:30723492
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Myh10
myosin heavy chain 10
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYH10 mRNA
CTD
PMID:30723492
NCBI chr10:53,393,901...53,525,174
Ensembl chr10:53,394,389...53,525,165
G
Myh9
myosin, heavy chain 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYH9 mRNA
CTD
PMID:30723492
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
G
Myl6
myosin light chain 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYL6 mRNA
CTD
PMID:30723492
NCBI chr 7:910,764...914,062
Ensembl chr 7:910,774...933,791
G
Myo16
myosin XVI
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYO16 mRNA
CTD
PMID:30723492
NCBI chr16:78,884,405...79,364,445
Ensembl chr16:78,884,406...79,248,388
G
Myo1f
myosin IF
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYO1F mRNA
CTD
PMID:25380136
NCBI chr 7:14,363,340...14,413,911
Ensembl chr 7:14,363,350...14,413,911
G
Myo5a
myosin VA
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYO5A mRNA
CTD
PMID:25380136
NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918
G
Myo7b
myosin VIIb
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYO7B mRNA
CTD
PMID:30723492
NCBI chr18:23,588,307...23,669,841
Ensembl chr18:23,588,307...23,669,809
G
Mypn
myopalladin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of MYPN mRNA
CTD
PMID:30723492
NCBI chr20:25,429,898...25,522,443
Ensembl chr20:25,436,843...25,522,443
G
Nab2
Ngfi-A binding protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NAB2 mRNA
CTD
PMID:20551477
NCBI chr 7:63,497,589...63,504,105
Ensembl chr 7:63,497,589...63,503,989
G
Nagk
N-acetylglucosamine kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NAGK mRNA
CTD
PMID:25380136
NCBI chr 4:116,281,179...116,293,870
Ensembl chr 4:116,281,328...116,313,137
G
Nap1l5
nucleosome assembly protein 1-like 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NAP1L5 mRNA
CTD
PMID:25380136
NCBI chr 4:88,022,670...88,024,988
Ensembl chr 4:88,022,569...88,024,654
G
Nat8
N-acetyltransferase 8
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NAT8 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
G
Nat8f2
N-acetyltransferase 8 (GCN5-related) family member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NAT8F2 mRNA
CTD
PMID:30723492
NCBI chr 4:118,319,984...118,323,159
Ensembl chr 4:118,319,988...118,324,395
G
Ncapg
non-SMC condensin I complex, subunit G
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NCAPG mRNA
CTD
PMID:30723492
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
G
Ncaph
non-SMC condensin I complex, subunit H
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NCAPH mRNA
CTD
PMID:30723492
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
G
Ncmap
noncompact myelin associated protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NCMAP mRNA
CTD
PMID:30723492
NCBI chr 5:147,608,042...147,623,266
Ensembl chr 5:147,610,677...147,618,775
G
Ncor2
nuclear receptor co-repressor 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NCOR2 mRNA
CTD
PMID:25380136
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
G
Ncr1
natural cytotoxicity triggering receptor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NCR1 mRNA
CTD
PMID:30723492
NCBI chr 1:69,614,744...69,622,594
Ensembl chr 1:69,616,601...69,660,558
G
Ncs1
neuronal calcium sensor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NCS1 mRNA
CTD
PMID:30723492
NCBI chr 3:14,523,220...14,568,829
Ensembl chr 3:14,523,220...14,568,829
G
Ndc80
NDC80 kinetochore complex component
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NDC80 mRNA
CTD
PMID:30723492
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Ndrg1
N-myc downstream regulated 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NDRG1 mRNA
CTD
PMID:25380136
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndrg2
NDRG family member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NDRG2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
G
Nectin2
nectin cell adhesion molecule 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NECTIN2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360
G
Neil3
nei-like DNA glycosylase 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NEIL3 mRNA
CTD
PMID:30723492
NCBI chr16:38,359,305...38,418,528
Ensembl chr16:38,359,371...38,418,527
G
Nek2l1
NIMA (never in mitosis gene a)-related kinase 2-like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NEK2L1 mRNA
CTD
PMID:30723492
NCBI chr 8:13,946,577...13,949,575
Ensembl chr 8:13,946,699...13,948,030
G
Nek6
NIMA-related kinase 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NEK6 mRNA
CTD
PMID:25380136
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
G
Neurl2
neuralized E3 ubiquitin protein ligase 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NEURL2 mRNA
CTD
PMID:30723492
NCBI chr 3:153,566,659...153,569,380
Ensembl chr 3:153,566,660...153,569,380
G
Neurl3
neuralized E3 ubiquitin protein ligase 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NEURL3 mRNA
CTD
PMID:30723492
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions increases expression decreases expression
ISO
[tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of NFE2L2 protein; liquiritin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NFE2L2 protein]; NFE2L2 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; NFE2L2 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of HIF1A mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased abundance of Bile Acids and Salts]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA]; tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NFE2L2 mRNA] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NFE2L2 mRNA
CTD
PMID:19181614 PMID:27344345 PMID:36008890 PMID:37348807
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfil3
nuclear factor, interleukin 3 regulated
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NFIL3 mRNA
CTD
PMID:20551477
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Nfkb1
nuclear factor kappa B subunit 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NFKB1 mRNA
CTD
PMID:20551477
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NFKB2 mRNA
CTD
PMID:30723492
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nfkbib
NFKB inhibitor beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NFKBIB mRNA
CTD
PMID:17522070
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
G
Nfkbie
NFKB inhibitor epsilon
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NFKBIE mRNA
CTD
PMID:25380136
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Nfkbiz
NFKB inhibitor zeta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NFKBIZ mRNA
CTD
PMID:25380136
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nfs1
NFS1 cysteine desulfurase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NFS1 mRNA
CTD
PMID:30723492
NCBI chr 3:144,637,309...144,659,660
Ensembl chr 3:144,637,309...144,659,666
G
Nherf4
NHERF family PDZ scaffold protein 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NHERF4 mRNA
CTD
PMID:30723492
NCBI chr 8:44,584,390...44,588,838
Ensembl chr 8:44,584,390...44,588,860
G
Nhsl3
NHS like 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NHSL3 mRNA
CTD
PMID:25380136
NCBI chr 5:141,564,399...141,593,154
Ensembl chr 5:141,564,399...141,593,176
G
Nid1
nidogen 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NID1 mRNA
CTD
PMID:25380136
NCBI chr17:86,085,133...86,158,272
Ensembl chr17:86,085,077...86,158,267
G
Nim1k
NIM1 serine/threonine protein kinase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NIM1K mRNA
CTD
PMID:30723492
NCBI chr 2:51,670,764...51,714,782
Ensembl chr 2:51,670,772...51,714,762
G
Nipal2
NIPA-like domain containing 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NIPAL2 mRNA
CTD
PMID:25380136
NCBI chr 7:65,774,477...65,884,807
Ensembl chr 7:65,774,477...65,884,807
G
Nkpd1
NTPase, KAP family P-loop domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NKPD1 mRNA
CTD
PMID:30723492
NCBI chr 1:79,165,642...79,175,126
Ensembl chr 1:79,167,130...79,174,234
G
Nlrc4
NLR family, CARD domain containing 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NLRC4 mRNA
CTD
PMID:30723492
NCBI chr 6:20,991,785...21,018,254
Ensembl chr 6:20,995,266...21,018,248
G
Nlrp12
NLR family, pyrin domain containing 12
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NLRP12 mRNA
CTD
PMID:30723492
NCBI chr 1:65,932,610...65,969,873
Ensembl chr 1:65,932,595...65,960,934
G
Nme4
NME/NM23 nucleoside diphosphate kinase 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NME4 mRNA
CTD
PMID:30723492
NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479
G
Noct
nocturnin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NOCT mRNA
CTD
PMID:25380136
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
G
Nol3
nucleolar protein 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NOL3 mRNA
CTD
PMID:30723492
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
G
Nos2
nitric oxide synthase 2
multiple interactions increases expression decreases expression
EXP ISO
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NOS2 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NOS2 protein] [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of NOS2 mRNA; [Hypoxanthine co-treated with potassium oxonate] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA]; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA]; leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA]; Uric Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA]
CTD
PMID:15135310 PMID:18364083 PMID:18590720 PMID:26921287 PMID:30517764 PMID:33749747 More...
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notum
NOTUM, palmitoleoyl-protein carboxylesterase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NOTUM mRNA
CTD
PMID:30723492
NCBI chr10:105,933,245...105,940,327
Ensembl chr10:105,933,249...105,940,315
G
Nox4
NADPH oxidase 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NOX4 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Npas2
neuronal PAS domain protein 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NPAS2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA]; Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA]
CTD
PMID:28549656
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Npdc1
neural proliferation, differentiation and control, 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NPDC1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 3:8,220,446...8,226,446
Ensembl chr 3:8,213,663...8,226,866
G
Npw
neuropeptide W
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NPW mRNA
CTD
PMID:30723492
NCBI chr10:13,680,275...13,681,618
Ensembl chr10:13,680,321...13,681,586
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of NQO1 mRNA [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of NQO1 mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of NQO1 mRNA; [liquiritin co-treated with 1-Naphthylisothiocyanate] results in increased expression of NQO1 mRNA; [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of NQO1 protein
CTD
PMID:15913567 PMID:20551477 PMID:30517764 PMID:30723492 PMID:33749747 PMID:36008890 PMID:37348807 More...
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
multiple interactions decreases expression increases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of NR0B2 mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of NR0B2 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of NR0B2 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of NR0B2 mRNA; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA]; NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR0B2 protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR0B2 protein]; ursodoxicoltaurine inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR0B2 protein] 1-Naphthylisothiocyanate results in decreased expression of NR0B2 mRNA dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NR0B2 mRNA
CTD
PMID:17175557 PMID:19181614 PMID:25655198 PMID:27317372 PMID:27344345 PMID:29968724 PMID:30352267 PMID:30723492 PMID:32579994 PMID:33749747 PMID:36787806 More...
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NR1H3 mRNA
CTD
PMID:27344345
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
increases response to substance decreases expression decreases response to substance increases expression multiple interactions
ISO EXP
NR1H4 gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate; NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate 1-naphthyl isothiocyanate decreases expression of Nr1h4 mRNA in rat liver 1-naphthyl isothiocyanate decreases expression of nr1h4 mRNA and protein in rat liver NR1H4 protein modified form results in decreased susceptibility to 1-Naphthylisothiocyanate 1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA; 1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein 1-Naphthylisothiocyanate results in increased expression of NR1H4 protein 4-methyl-7,8-dihydroxycoumarin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP7A1 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP7B1 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of CYP8B1 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of SLC10A1 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of SLCO1A2 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of ABCB11 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of ABCB4 mRNA; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of NR0B2 mRNA; [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of NR1H4 protein; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of NR1H4 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of NR1H4 protein; [ursodoxicoltaurine co-treated with 1-Naphthylisothiocyanate] results in increased expression of NR1H4 protein; acadesine inhibits the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]]; acadesine inhibits the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]]; Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; liquiritin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; liquiritin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; NR1H4 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; NR1H4 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA protein]; NR1H4 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]; NR1H4 promotes the reaction [obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]]; NR1H4 promotes the reaction [yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]]; NR1H4 promotes the reaction [yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA protein]]; NR1H4 promotes the reaction [yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein]]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]]; NR1H4 protein affects the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; ursodoxicoltaurine affects the reaction [NR1H4 protein affects the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]]; yangonin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NR1H4 protein] dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; Resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; Resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 protein] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NR1H4 mRNA
CTD RGD
PMID:19407337 PMID:25418378 PMID:27344345 PMID:27702592 PMID:29660435 PMID:29968724 PMID:30352267 PMID:32198087 PMID:32579994 PMID:32976922 PMID:36008890 PMID:36581201 PMID:36787806 PMID:37348807 PMID:30223280 PMID:29235094 More...
RGD:15045612 , RGD:15042872
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression decreases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of NR1I2 mRNA 1-Naphthylisothiocyanate results in decreased expression of NR1I2 mRNA
CTD
PMID:15913567 PMID:27765674 PMID:37348807
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions decreases expression
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NR1I3 mRNA tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1I3 mRNA]
CTD
PMID:27344345 PMID:37348807
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NR3C1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of NR3C1 protein
CTD
PMID:12912871
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nrep
neuronal regeneration related protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NREP mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Nrg1
neuregulin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NRG1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Nrgn
neurogranin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NRGN mRNA
CTD
PMID:30723492
NCBI chr 8:37,255,462...37,263,659
Ensembl chr 8:37,256,930...37,257,516
G
Nrtn
neurturin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NRTN mRNA
CTD
PMID:30723492
NCBI chr 9:1,581,860...1,587,835
Ensembl chr 9:1,581,975...1,583,102
G
Nt5c2
5'-nucleotidase, cytosolic II
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NT5C2 mRNA
CTD
PMID:30723492
NCBI chr 1:245,770,993...245,896,925
Ensembl chr 1:245,772,277...245,897,913
G
Ntm
neurotrimin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NTM mRNA
CTD
PMID:30723492
NCBI chr 8:27,376,582...28,366,604
Ensembl chr 8:27,377,773...28,366,595
G
Nuf2
NUF2 component of NDC80 kinetochore complex
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NUF2 mRNA
CTD
PMID:30723492
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
G
Numbl
NUMB-like, endocytic adaptor protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NUMBL mRNA
CTD
PMID:30723492
NCBI chr 1:82,549,814...82,573,788
Ensembl chr 1:82,550,054...82,573,776
G
Nup58
nucleoporin 58
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NUP58 mRNA
CTD
PMID:12832660
NCBI chr15:34,358,170...34,407,160
Ensembl chr15:34,358,277...34,407,060
G
Nup98
nucleoporin 98 and 96 precursor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NUP98 mRNA
CTD
PMID:30723492
NCBI chr 1:156,494,423...156,591,415
Ensembl chr 1:156,494,423...156,591,415
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of NUPR1 mRNA
CTD
PMID:17175557 PMID:25380136
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Nusap1
nucleolar and spindle associated protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NUSAP1 mRNA
CTD
PMID:30723492
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
G
Nwd2
NACHT and WD repeat domain containing 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NWD2 mRNA
CTD
PMID:30723492
NCBI chr14:44,480,049...44,671,417
Ensembl chr14:44,482,287...44,670,299
G
Nyap1
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of NYAP1 mRNA
CTD
PMID:30723492
NCBI chr12:18,956,192...18,967,624
Ensembl chr12:18,956,268...18,967,543
G
Oat
ornithine aminotransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of OAT mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Obp3
alpha-2u globulin PGCL4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of OBP3 mRNA
CTD
PMID:30723492
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
G
Oca2
OCA2 melanosomal transmembrane protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of OCA2 mRNA
CTD
PMID:30723492
NCBI chr 1:107,116,278...107,446,093
Ensembl chr 1:107,116,278...107,446,074
G
Ocln
occludin
decreases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in decreased expression of OCLN mRNA; 1-Naphthylisothiocyanate results in decreased expression of OCLN protein acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein]
CTD
PMID:32579994 PMID:33400020
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Ocm
oncomodulin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OCM mRNA
CTD
PMID:12832660
NCBI chr12:10,535,619...10,596,705
Ensembl chr12:10,586,897...10,596,707
G
Odad2
outer dynein arm docking complex subunit 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ODAD2 mRNA
CTD
PMID:30723492
NCBI chr17:55,216,877...55,409,872
Ensembl chr17:55,218,991...55,409,399
G
Odc1
ornithine decarboxylase 1
increases expression
EXP ISO
1-Naphthylisothiocyanate results in increased expression of ODC1 mRNA
CTD
PMID:12883083 PMID:15913567 PMID:17522070
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Oip5
Opa interacting protein 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OIP5 mRNA
CTD
PMID:30723492
NCBI chr 3:106,593,746...106,603,281
Ensembl chr 3:106,593,760...106,603,250
G
Oip5-as1
OIP5 antisense RNA 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OIP5-AS1 mRNA
CTD
PMID:30723492
NCBI chr 3:106,578,309...106,591,845
G
Olfm1
olfactomedin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OLFM1 mRNA
CTD
PMID:12832660
NCBI chr 3:11,520,522...11,558,240
Ensembl chr 3:11,520,729...11,558,239
G
Olfml3
olfactomedin-like 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OLFML3 mRNA
CTD
PMID:25380136
NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
G
Olr1
oxidized low density lipoprotein receptor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OLR1 mRNA
CTD
PMID:30723492
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
G
Olr36
olfactory receptor 36
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of OLR36 mRNA
CTD
PMID:30723492
NCBI chr 1:154,052,762...154,053,742
Ensembl chr 1:154,050,030...154,053,972
G
Olr59
olfactory receptor 59
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of OLR59 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
G
Omd
osteomodulin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of OMD mRNA
CTD
PMID:30723492
NCBI chr17:15,060,217...15,068,441
Ensembl chr17:15,060,217...15,068,441
G
Orm1
orosomucoid 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ORM1 mRNA
CTD
PMID:30723492
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Osbpl1a
oxysterol binding protein-like 1A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OSBPL1A mRNA
CTD
PMID:30723492
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
G
Osgin1
oxidative stress induced growth inhibitor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OSGIN1 mRNA
CTD
PMID:25380136
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
G
Osmr
oncostatin M receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OSMR mRNA
CTD
PMID:30723492
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
G
Otc
ornithine transcarbamylase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of OTC mRNA
CTD
PMID:17522070
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
G
Otub2
OTU deubiquitinase, ubiquitin aldehyde binding 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of OTUB2 mRNA
CTD
PMID:25380136
NCBI chr 6:122,545,067...122,563,657
Ensembl chr 6:122,545,061...122,563,644
G
Otulinl
OTU deubiquitinase with linear linkage specificity like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of OTULINL mRNA
CTD
PMID:25380136
NCBI chr 2:78,405,994...78,433,860
Ensembl chr 2:78,408,593...78,433,838
G
Pacsin1
protein kinase C and casein kinase substrate in neurons 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PACSIN1 mRNA
CTD
PMID:30723492
NCBI chr20:5,718,134...5,768,064
Ensembl chr20:5,719,857...5,765,313
G
Padi3
peptidyl arginine deiminase 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PADI3 mRNA
CTD
PMID:30723492
NCBI chr 5:153,089,717...153,117,146
Ensembl chr 5:153,089,717...153,117,146
G
Pam
peptidylglycine alpha-amidating monooxygenase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PAM mRNA
CTD
PMID:12832660
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
G
Pamr1
peptidase domain containing associated with muscle regeneration 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PAMR1 mRNA
CTD
PMID:25380136
NCBI chr 3:88,889,061...88,988,615
Ensembl chr 3:88,889,046...88,988,606
G
Papln
papilin, proteoglycan-like sulfated glycoprotein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PAPLN mRNA
CTD
PMID:30723492
NCBI chr 6:103,398,166...103,432,199
Ensembl chr 6:103,398,838...103,432,206
G
Paqr7
progestin and adipoQ receptor family member 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PAQR7 mRNA
CTD
PMID:30723492
NCBI chr 5:146,709,159...146,720,577
Ensembl chr 5:146,708,900...146,720,673
G
Paqr8
progestin and adipoQ receptor family member 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PAQR8 mRNA
CTD
PMID:30723492
NCBI chr 9:23,312,521...23,362,175
Ensembl chr 9:23,312,585...23,362,340
G
Paqr9
progestin and adipoQ receptor family member 9
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PAQR9 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:96,114,249...96,116,546
G
Pard6a
par-6 family cell polarity regulator alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PARD6A mRNA
CTD
PMID:30723492
NCBI chr19:33,589,531...33,591,900
Ensembl chr19:33,589,542...33,591,900
G
Parp4
poly (ADP-ribose) polymerase family, member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PARP4 mRNA
CTD
PMID:30723492
NCBI chr15:30,690,503...30,792,868
Ensembl chr15:30,686,613...30,828,810
G
Parvb
parvin, beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PARVB mRNA
CTD
PMID:30723492
NCBI chr 7:115,360,254...115,445,767
Ensembl chr 7:115,360,261...115,445,766
G
Pask
PAS domain containing serine/threonine kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PASK mRNA
CTD
PMID:30723492
NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111
G
Pbk
PDZ binding kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PBK mRNA
CTD
PMID:30723492
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
G
Pc
pyruvate carboxylase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PC mRNA
CTD
PMID:30723492
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pcdh17
protocadherin 17
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PCDH17 mRNA
CTD
PMID:30723492
NCBI chr15:60,222,088...60,316,172
Ensembl chr15:60,222,004...60,313,999
G
Pcdh19
protocadherin 19
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PCDH19 mRNA
CTD
PMID:30723492
NCBI chr X:96,767,686...96,873,477
Ensembl chr X:96,771,947...96,873,524
G
Pclaf
PCNA clamp associated factor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PCLAF mRNA
CTD
PMID:30723492
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
G
Pcna
proliferating cell nuclear antigen
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PCNA mRNA
CTD
PMID:12883083
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pcnx1
pecanex 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PCNX1 mRNA
CTD
PMID:30723492
NCBI chr 6:101,565,461...101,702,339
Ensembl chr 6:101,565,580...101,702,271
G
Pcolce
procollagen C-endopeptidase enhancer
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PCOLCE mRNA
CTD
PMID:30723492
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PCSK9 mRNA
CTD
PMID:30723492
NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
G
Pcyox1l
prenylcysteine oxidase 1 like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PCYOX1L mRNA
CTD
PMID:30723492
NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327
G
Pde4b
phosphodiesterase 4B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PDE4B mRNA
CTD
PMID:30723492
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
G
Pde5a
phosphodiesterase 5A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PDE5A mRNA
CTD
PMID:30723492
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
G
Pdgfa
platelet derived growth factor subunit A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PDGFA mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdgfra
platelet derived growth factor receptor alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PDGFRA mRNA
CTD
PMID:25380136
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of PDGFRB mRNA
CTD
PMID:27344345
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pdlim1
PDZ and LIM domain 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PDLIM1 mRNA
CTD
PMID:30723492
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
G
Pdxp
pyridoxal phosphatase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PDXP mRNA
CTD
PMID:30723492
NCBI chr 7:110,472,515...110,477,963
Ensembl chr 7:110,472,515...110,477,963
G
Pdzrn3
PDZ domain containing RING finger 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PDZRN3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:133,770,736...133,996,959
Ensembl chr 4:133,770,736...133,996,959
G
Pea15
proliferation and apoptosis adaptor protein 15
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PEA15A mRNA
CTD
PMID:25380136
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Penk
proenkephalin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PENK mRNA
CTD
PMID:30723492
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Per2
period circadian regulator 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PER2 mRNA
CTD
PMID:30723492
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
G
Per3
period circadian regulator 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PER3 mRNA
CTD
PMID:30723492
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
G
Pex11a
peroxisomal biogenesis factor 11 alpha
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PEX11A mRNA
CTD
PMID:30723492
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PFKFB4 mRNA
CTD
PMID:30723492
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
G
Pfkp
phosphofructokinase, platelet
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PFKP mRNA
CTD
PMID:25380136
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pfn3
profilin 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PFN3 mRNA
CTD
PMID:30723492
NCBI chr17:9,217,595...9,218,122
G
Pgd
phosphogluconate dehydrogenase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PGD mRNA
CTD
PMID:30723492
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Phgdh
phosphoglycerate dehydrogenase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PHGDH mRNA
CTD
PMID:30723492
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Phkb
phosphorylase kinase regulatory subunit beta
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PHKB mRNA
CTD
PMID:30723492
NCBI chr19:21,013,719...21,210,671
Ensembl chr19:21,025,733...21,210,633
G
Pigy
phosphatidylinositol glycan anchor biosynthesis, class Y
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PIGY mRNA
CTD
PMID:30723492
NCBI chr 8:20,689,621...20,691,863
Ensembl chr 8:20,689,502...20,692,585
G
Pink1
PTEN induced kinase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PINK1 mRNA
CTD
PMID:30723492
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Pkd2
polycystin 2, transient receptor potential cation channel
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PKD2 mRNA
CTD
PMID:25380136
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
G
Pklr
pyruvate kinase L/R
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PKLR mRNA
CTD
PMID:17522070 PMID:25380136
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PKMYT1 mRNA
CTD
PMID:30723492
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
G
Pkp1
plakophilin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PKP1 mRNA
CTD
PMID:30723492
NCBI chr13:47,309,607...47,357,432
Ensembl chr13:47,309,614...47,357,465
G
Pla1a
phospholipase A1 member A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLA1A mRNA
CTD
PMID:30723492
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
G
Pla2g12a
phospholipase A2, group XIIA
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLA2G12A mRNA
CTD
PMID:25380136
NCBI chr 2:218,436,497...218,452,742
Ensembl chr 2:218,436,513...218,452,740
G
Pla2g4a
phospholipase A2 group 4A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLA2G4A mRNA
CTD
PMID:25380136
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Pla2g4c
phospholipase A2 group IVC
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PLA2G4C mRNA
CTD
PMID:30723492
NCBI chr 1:74,237,714...74,275,757
Ensembl chr 1:74,236,211...74,274,656
G
Pla2g7
phospholipase A2 group VII
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLA2G7 mRNA
CTD
PMID:30723492
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Plaat5
phospholipase A and acyltransferase 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLAAT5 mRNA
CTD
PMID:30723492
NCBI chr 1:204,847,600...204,878,456
Ensembl chr 1:204,847,600...204,878,184
G
Plac8
placenta associated 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLAC8 mRNA
CTD
PMID:25380136
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
G
Plat
plasminogen activator, tissue type
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLAT mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLAU mRNA
CTD
PMID:25380136
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLAUR mRNA
CTD
PMID:20551477 PMID:30723492
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plek
pleckstrin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLEK mRNA
CTD
PMID:25380136
NCBI chr14:91,397,015...91,429,693
Ensembl chr14:91,397,019...91,454,131
G
Plekhb1
pleckstrin homology domain containing B1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PLEKHB1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:154,998,798...155,013,094
Ensembl chr 1:154,998,800...155,016,142
G
Plekhd1
pleckstrin homology and coiled-coil domain containing D1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLEKHD1 mRNA
CTD
PMID:30723492
NCBI chr 6:100,340,655...100,371,942
Ensembl chr 6:100,340,655...100,371,941
G
Plekhh1
pleckstrin homology, MyTH4 and FERM domain containing H1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLEKHH1 mRNA
CTD
PMID:25380136
NCBI chr 6:97,839,288...97,888,712
Ensembl chr 6:97,839,288...97,888,709
G
Plin2
perilipin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLIN2 mRNA
CTD
PMID:25380136
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plin3
perilipin 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLIN3 mRNA
CTD
PMID:30723492
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
G
Plin4
perilipin 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PLIN4 mRNA
CTD
PMID:30723492
NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056
G
Plin5
perilipin 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PLIN5 mRNA
CTD
PMID:30723492
NCBI chr 9:939,745...946,188
Ensembl chr 9:939,747...946,120
G
Plk1
polo-like kinase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLK1 mRNA
CTD
PMID:30723492
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Plk4
polo-like kinase 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLK4 mRNA
CTD
PMID:30723492
NCBI chr 2:123,802,527...123,820,942
Ensembl chr 2:123,802,512...123,820,942
G
Plod2
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLOD2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
G
Plp2
proteolipid protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLP2 mRNA
CTD
PMID:30723492
NCBI chr X:14,834,249...14,837,648
Ensembl chr X:14,834,231...14,838,514
G
Plpp2
phospholipid phosphatase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLPP2 mRNA
CTD
PMID:25380136
NCBI chr 7:10,175,918...10,184,032
Ensembl chr 7:10,175,948...10,184,071
G
Plscr1
phospholipid scramblase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLSCR1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:92,784,279...92,804,698
Ensembl chr 8:92,784,356...92,804,692
G
Pltp
phospholipid transfer protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLTP mRNA
CTD
PMID:25380136
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
G
Plxna3
plexin A3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLXNA3 mRNA
CTD
PMID:30723492
NCBI chr X:152,115,699...152,131,608
Ensembl chr X:152,115,819...152,131,603
G
Plxnb1
plexin B1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PLXNB1 mRNA
CTD
PMID:30723492
NCBI chr 8:109,743,470...109,769,153
Ensembl chr 8:109,744,697...109,769,027
G
Pm20d2
peptidase M20 domain containing 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PM20D2 mRNA
CTD
PMID:30723492
NCBI chr 5:47,566,059...47,586,334
Ensembl chr 5:47,566,072...47,586,212
G
Pmepa1
prostate transmembrane protein, androgen induced 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PMEPA1 mRNA
CTD
PMID:25380136
NCBI chr 3:162,011,884...162,060,343
Ensembl chr 3:162,012,751...162,060,454
G
Pmf1
polyamine-modulated factor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PMF1 mRNA
CTD
PMID:30723492
NCBI chr 2:173,848,074...173,868,272
Ensembl chr 2:173,848,074...173,868,270
G
Pmvk
phosphomevalonate kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PMVK mRNA
CTD
PMID:30723492
NCBI chr 2:174,876,586...174,886,365
Ensembl chr 2:174,876,657...174,886,364
G
Pnpla3
patatin-like phospholipase domain containing 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PNPLA3 mRNA
CTD
PMID:30723492
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
G
Pnpla5
patatin-like phospholipase domain containing 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PNPLA5 mRNA
CTD
PMID:30723492
NCBI chr 7:115,246,050...115,257,039
Ensembl chr 7:115,246,050...115,257,039
G
Pnpla7
patatin-like phospholipase domain containing 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PNPLA7 mRNA
CTD
PMID:30723492
NCBI chr 3:7,782,572...7,861,504
Ensembl chr 3:7,782,572...7,861,497
G
Pole2
DNA polymerase epsilon 2, accessory subunit
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of POLE2 mRNA
CTD
PMID:30723492
NCBI chr 6:87,674,702...87,712,723
Ensembl chr 6:87,674,702...87,699,305
G
Polq
DNA polymerase theta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of POLQ mRNA
CTD
PMID:30723492
NCBI chr11:63,673,796...63,775,905
Ensembl chr11:63,673,816...63,775,878
G
Pon1
paraoxonase 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of PON1 mRNA
CTD
PMID:27344345
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Postn
periostin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of POSTN mRNA
CTD
PMID:30723492
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
G
Pou2af1
POU class 2 homeobox associating factor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of POU2AF1 mRNA
CTD
PMID:30723492
NCBI chr 8:51,521,813...51,548,819
Ensembl chr 8:51,474,015...51,548,819
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions decreases expression affects response to substance
ISO
[1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of PPARA protein; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCB11 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCB1A mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCB4 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCC3 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of ABCC4 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of CYP7A1 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of CYP7A1 protein; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of CYP8B1 protein; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of FGA mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of FGG mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of IL10 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of NR0B2 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of NR1H4 mRNA; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of NR1H4 protein; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of SOCS3 mRNA; Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of PPARA protein]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of JUN mRNA]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA]]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MT1 mRNA]]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MT2 mRNA]]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SAA1 mRNA]]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SAA2 mRNA]]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STAT3 protein]]
CTD
PMID:27853831 PMID:30352267 PMID:33749747
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PPARG mRNA
CTD
PMID:30723492
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppef1
protein phosphatase with EF-hand domain 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PPEF1 mRNA
CTD
PMID:30723492
NCBI chr X:33,994,503...34,151,704
Ensembl chr X:34,021,350...34,151,701
G
Ppl
periplakin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PPL mRNA
CTD
PMID:30723492
NCBI chr10:10,450,919...10,496,575
Ensembl chr10:10,450,919...10,496,575
G
Ppp1r1c
protein phosphatase 1, regulatory (inhibitor) subunit 1C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PPP1R1C mRNA
CTD
PMID:12832660
NCBI chr 3:64,616,700...64,719,696
Ensembl chr 3:64,616,700...64,724,104
G
Ppp1r3b
protein phosphatase 1, regulatory subunit 3B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PPP1R3B mRNA
CTD
PMID:25380136
NCBI chr16:56,830,011...56,842,395
Ensembl chr16:56,829,660...56,842,406
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PPP1R3C mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PPP1R9A mRNA
CTD
PMID:30723492
NCBI chr 4:32,970,501...33,292,360
Ensembl chr 4:33,024,450...33,286,907
G
Pprc1
PPARG related coactivator 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of PPRC1 mRNA
CTD
PMID:27344345
NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587
G
Prc1
protein regulator of cytokinesis 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRC1 mRNA
CTD
PMID:30723492
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prdm4
PR/SET domain 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRDM4 mRNA
CTD
PMID:30723492
NCBI chr 7:17,953,832...17,980,489
Ensembl chr 7:17,954,019...17,980,489
G
Prdm9
PR/SET domain 9
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PRDM9 mRNA
CTD
PMID:30723492
NCBI chr 1:56,505,579...56,525,726
Ensembl chr 1:56,505,579...56,525,652
G
Prf1
perforin 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PRF1 mRNA
CTD
PMID:30723492
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
G
Prg2
proteoglycan 2, pro eosinophil major basic protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PRG2 mRNA
CTD
PMID:30723492
NCBI chr 3:70,062,535...70,066,102
Ensembl chr 3:70,062,535...70,066,101
G
Prkar1b
protein kinase cAMP-dependent type I regulatory subunit beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRKAR1B mRNA
CTD
PMID:30723492
NCBI chr12:15,492,233...15,624,942
Ensembl chr12:15,511,801...15,624,942
G
Prkar2b
protein kinase cAMP-dependent type II regulatory subunit beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRKAR2B mRNA
CTD
PMID:12832660
NCBI chr 6:48,563,659...48,653,933
Ensembl chr 6:48,563,662...48,653,933
G
Prkcb
protein kinase C, beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRKCB mRNA
CTD
PMID:25380136
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Prl8a7
prolactin family 8, subfamily A, member 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRL8A7 mRNA
CTD
PMID:12832660
NCBI chr17:37,558,822...37,564,724
Ensembl chr17:37,558,883...37,564,718
G
Prlr
prolactin receptor
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PRLR mRNA
CTD
PMID:25380136
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prnp
prion protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PRNP mRNA
CTD
PMID:25380136
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
Prodh
proline dehydrogenase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PRODH mRNA
CTD
PMID:25380136
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
G
Prodh2
proline dehydrogenase 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PRODH2 mRNA
CTD
PMID:25380136
NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162
G
Prok2
prokineticin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PROK2 mRNA
CTD
PMID:30723492
NCBI chr 4:132,346,681...132,361,754
Ensembl chr 4:132,347,103...132,361,385
G
Pros1
protein S
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of PROS1 mRNA
CTD
PMID:27344345
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Prr11
proline rich 11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRR11 mRNA
CTD
PMID:30723492
NCBI chr10:71,898,858...71,943,325
Ensembl chr10:71,901,202...71,921,012
G
Prr13
proline rich 13
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRR13 mRNA
CTD
PMID:25380136
NCBI chr 7:133,592,511...133,595,817
Ensembl chr 7:133,592,490...133,601,005
G
Prss22
serine protease 22
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRSS22 mRNA
CTD
PMID:30723492
NCBI chr10:13,029,153...13,033,863
Ensembl chr10:13,029,153...13,033,863
G
Prss35
serine protease 35
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRSS35 mRNA
CTD
PMID:30723492
NCBI chr 8:87,714,449...87,731,009
Ensembl chr 8:87,714,966...87,731,009
G
Prss8
serine protease 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRSS8 mRNA
CTD
PMID:30723492
NCBI chr 1:182,536,229...182,540,745
Ensembl chr 1:182,536,229...182,540,815
G
Prtfdc1
phosphoribosyl transferase domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRTFDC1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr17:83,549,608...83,654,517
Ensembl chr17:83,548,803...83,655,179
G
Prtg
protogenin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PRTG mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:73,548,440...73,657,945
Ensembl chr 8:73,548,466...73,653,259
G
Prune2
prune homolog 2 with BCH domain
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PRUNE2 mRNA
CTD
PMID:25380136
NCBI chr 1:214,352,586...214,624,848
Ensembl chr 1:214,352,955...214,622,650
G
Prxl2a
peroxiredoxin like 2A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PRXL2A mRNA
CTD
PMID:30723492
NCBI chr16:16,866,601...16,886,378
Ensembl chr16:16,866,603...16,886,433
G
Psat1
phosphoserine aminotransferase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PSAT1 mRNA
CTD
PMID:30723492
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psca
prostate stem cell antigen
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PSCA mRNA
CTD
PMID:30723492
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
G
Psma6
proteasome 20S subunit alpha 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PSMA6 mRNA
CTD
PMID:12832660
NCBI chr 6:72,765,534...72,796,554
Ensembl chr 6:72,765,473...72,796,554
G
Psmb9
proteasome 20S subunit beta 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PSMB9 mRNA
CTD
PMID:25380136
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Psors1c2
psoriasis susceptibility 1 candidate 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PSORS1C2 mRNA
CTD
PMID:30723492
NCBI chr20:3,202,178...3,203,599
Ensembl chr20:3,202,174...3,203,599
G
Psrc1
proline and serine rich coiled-coil 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PSRC1 mRNA
CTD
PMID:30723492
NCBI chr 2:196,022,361...196,026,874
Ensembl chr 2:196,022,361...196,026,874
G
Pstpip1
proline-serine-threonine phosphatase-interacting protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PSTPIP1 mRNA
CTD
PMID:25380136
NCBI chr 8:56,499,287...56,538,593
Ensembl chr 8:56,499,590...56,538,580
G
Ptafr
platelet-activating factor receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTAFR mRNA
CTD
PMID:25380136
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Pter
phosphotriesterase related
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTER mRNA
CTD
PMID:25380136
NCBI chr17:76,058,388...76,119,633
Ensembl chr17:76,058,503...76,119,627
G
Ptger2
prostaglandin E receptor 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTGER2 mRNA
CTD
PMID:25380136
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
G
Ptgs1
prostaglandin-endoperoxide synthase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTGS1 mRNA
CTD
PMID:25380136
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of PTGS2 mRNA
CTD
PMID:27344345
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2b
protein tyrosine kinase 2 beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTK2B mRNA
CTD
PMID:30723492
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
G
Ptk7
protein tyrosine kinase 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTK7 mRNA
CTD
PMID:30723492
NCBI chr 9:14,352,155...14,418,473
Ensembl chr 9:14,351,202...14,418,494
G
Ptma
prothymosin alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTMA mRNA
CTD
PMID:17522070
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
G
Ptn
pleiotrophin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PTN mRNA
CTD
PMID:25380136
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
G
Ptpn18
protein tyrosine phosphatase, non-receptor type 18
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTPN18 mRNA
CTD
PMID:25380136
NCBI chr 9:36,672,325...36,689,963
Ensembl chr 9:36,672,362...36,690,995
G
Ptpn4
protein tyrosine phosphatase, non-receptor type 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PTPN4 mRNA
CTD
PMID:30723492
NCBI chr13:30,772,012...30,952,340
Ensembl chr13:30,776,682...30,952,170
G
Ptprc
protein tyrosine phosphatase, receptor type, C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTPRC mRNA
CTD
PMID:25380136
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
G
Ptprd
protein tyrosine phosphatase, receptor type, D
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PTPRD mRNA
CTD
PMID:25380136
NCBI chr 5:90,046,993...90,698,977 NCBI chr 5:91,122,354...91,641,754
Ensembl chr 5:90,048,966...92,369,396
G
Ptpro
protein tyrosine phosphatase, receptor type, O
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTPRO mRNA
CTD
PMID:25380136
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTPRZ1 mRNA
CTD
PMID:30723492
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
G
Ptrh1
peptidyl-tRNA hydrolase 1 homolog
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTRH1 mRNA
CTD
PMID:25380136
NCBI chr 3:16,064,867...16,071,098
Ensembl chr 3:16,064,880...16,070,648
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTTG1 mRNA
CTD
PMID:30723492
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Ptx3
pentraxin 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PTX3 mRNA
CTD
PMID:30723492
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
G
Pvr
PVR cell adhesion molecule
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PVR mRNA
CTD
PMID:17522070 PMID:30723492
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
G
Pxdn
peroxidasin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PXDN mRNA
CTD
PMID:25380136
NCBI chr 6:46,580,749...46,658,345
Ensembl chr 6:46,580,761...46,658,345
G
Pycard
PYD and CARD domain containing
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PYCARD mRNA
CTD
PMID:25380136
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
G
Pycr1
pyrroline-5-carboxylate reductase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of PYCR1 mRNA
CTD
PMID:25380136
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Pygl
glycogen phosphorylase L
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of PYGL mRNA
CTD
PMID:17522070
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Qprt
quinolinate phosphoribosyltransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of QPRT mRNA
CTD
PMID:30723492
NCBI chr 1:181,718,189...181,733,486
Ensembl chr 1:181,718,190...181,733,486
G
R3hdm2
R3H domain containing 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of R3HDM2 mRNA
CTD
PMID:25380136
NCBI chr 7:63,212,519...63,340,574
Ensembl chr 7:63,232,346...63,340,540
G
Rab25
RAB25, member RAS oncogene family
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAB25 mRNA
CTD
PMID:30723492
NCBI chr 2:174,000,323...174,006,422
Ensembl chr 2:174,000,323...174,006,422
G
Rab30
RAB30, member RAS oncogene family
increases expression decreases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAB30 mRNA 1-Naphthylisothiocyanate results in decreased expression of RAB30 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:146,803,719...146,898,369
Ensembl chr 1:146,803,714...146,892,181
G
Rab31
RAB31, member RAS oncogene family
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAB31 mRNA
CTD
PMID:25380136
NCBI chr 9:105,246,712...105,382,973
Ensembl chr 9:105,246,709...105,381,253
G
Rab32
RAB32, member RAS oncogene family
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAB32 mRNA
CTD
PMID:25380136
NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934
G
Rab40b
Rab40b, member RAS oncogene family
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RAB40B mRNA
CTD
PMID:25380136
NCBI chr10:106,631,514...106,659,090
Ensembl chr10:106,631,514...106,659,090
G
Rab44
RAB44, member RAS oncogene family
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAB44 mRNA
CTD
PMID:30723492
NCBI chr20:7,164,576...7,198,473
Ensembl chr20:7,164,720...7,198,468
G
Rab7b
Rab7b, member RAS oncogene family
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAB7B mRNA
CTD
PMID:30723492
NCBI chr13:43,121,168...43,147,581
Ensembl chr13:43,121,226...43,147,581
G
Racgap1
Rac GTPase-activating protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RACGAP1 mRNA
CTD
PMID:30723492
NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831
G
Rad51
RAD51 recombinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAD51 mRNA
CTD
PMID:30723492
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Rad51ap1
RAD51 associated protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAD51AP1 mRNA
CTD
PMID:30723492
NCBI chr 4:159,759,454...159,772,473
Ensembl chr 4:159,759,459...159,772,524
G
Rad51b
RAD51 paralog B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAD51B mRNA
CTD
PMID:30723492
NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979
G
Rad54l
RAD54 like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RAD54L mRNA
CTD
PMID:30723492
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Rag1
recombination activating 1
multiple interactions decreases response to substance
ISO
RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ALPL protein]; RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA] RAG1 gene mutant form results in decreased susceptibility to 1-Naphthylisothiocyanate
CTD
PMID:28049044
NCBI chr 3:87,917,061...87,928,158
Ensembl chr 3:87,917,004...87,928,291
G
Ralgps1
Ral GEF with PH domain and SH3 binding motif 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RALGPS1 mRNA
CTD
PMID:30723492
NCBI chr 3:16,433,323...16,670,276
Ensembl chr 3:16,433,742...16,669,972
G
Rapgefl1
Rap guanine nucleotide exchange factor like 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RAPGEFL1 mRNA
CTD
PMID:30723492
NCBI chr10:83,793,711...83,810,373
Ensembl chr10:83,793,694...83,810,371
G
Rasl10b
RAS-like, family 10, member B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RASL10B mRNA
CTD
PMID:30723492
NCBI chr10:68,209,761...68,222,118
Ensembl chr10:68,210,275...68,220,376
G
Rasl11b
RAS-like family 11 member B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RASL11B mRNA
CTD
PMID:30723492
NCBI chr14:34,014,924...34,019,146
Ensembl chr14:34,014,509...34,019,152
G
Rasl12
RAS-like, family 12
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RASL12 mRNA
CTD
PMID:30723492
NCBI chr 8:65,917,840...65,931,885
Ensembl chr 8:65,917,840...65,932,741
G
Rassf4
Ras association domain family member 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RASSF4 mRNA
CTD
PMID:25380136
NCBI chr 4:149,897,525...149,932,658
Ensembl chr 4:149,897,543...149,932,411
G
Rbfox1
RNA binding fox-1 homolog 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RBFOX1 mRNA
CTD
PMID:30723492
NCBI chr10:8,152,198...10,248,120
Ensembl chr10:8,152,198...9,686,659
G
Rbl2
RB transcriptional corepressor like 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RBL2 mRNA
CTD
PMID:25380136
NCBI chr19:15,876,852...15,923,632
Ensembl chr19:15,876,853...15,923,572
G
Rbm3
RNA binding motif protein 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RBM3 mRNA
CTD
PMID:25380136
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
G
Rbm5
RNA binding motif protein 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RBM5 mRNA
CTD
PMID:30723492
NCBI chr 8:108,420,220...108,449,481
Ensembl chr 8:108,420,222...108,449,430
G
Rbpjl
recombination signal binding protein for immunoglobulin kappa J region-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RBPJL mRNA
CTD
PMID:30723492
NCBI chr 3:153,134,044...153,147,421
Ensembl chr 3:153,134,140...153,146,513
G
Rcn1
reticulocalbin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RCN1 mRNA
CTD
PMID:25380136
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rcn2
reticulocalbin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RCN2 mRNA
CTD
PMID:25380136
NCBI chr 8:56,449,206...56,466,253
Ensembl chr 8:56,449,206...56,466,251
G
Rdh10
retinol dehydrogenase 10
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RDH10 mRNA
CTD
PMID:25380136
NCBI chr 5:3,186,671...3,215,572
Ensembl chr 5:3,188,445...3,215,572
G
Reep5
receptor accessory protein 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of REEP5 mRNA
CTD
PMID:25380136
NCBI chr18:25,945,375...25,983,271
Ensembl chr18:25,945,381...25,976,509
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions increases phosphorylation increases expression affects localization increases localization
EXP ISO
Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased localization of RELA protein]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased localization of RELA protein] 1-Naphthylisothiocyanate results in increased phosphorylation of RELA protein 1-Naphthylisothiocyanate results in increased expression of RELA mRNA; 1-Naphthylisothiocyanate results in increased expression of RELA protein [Hypoxanthine co-treated with potassium oxonate] inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of RELA protein]; NR1H4 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA protein]; NR1H4 promotes the reaction [yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA protein]]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA mRNA]]; pregna-4,17-diene-3,16-dione promotes the reaction [1-Naphthylisothiocyanate results in increased expression of RELA mRNA]; Uric Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of RELA protein]; yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA mRNA]; yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA protein] 1-Naphthylisothiocyanate affects the localization of RELA protein
CTD
PMID:18590720 PMID:27853831 PMID:29660435 PMID:33749747
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RELB mRNA
CTD
PMID:30723492
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Rell1
RELT-like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RELL1 mRNA
CTD
PMID:25380136
NCBI chr14:44,318,640...44,378,541
Ensembl chr14:44,303,009...44,378,500
G
Rem2
RRAD and GEM like GTPase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of REM2 mRNA
CTD
PMID:30723492
NCBI chr15:27,933,950...27,938,429
Ensembl chr15:27,933,950...27,938,429
G
Ren
renin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of REN mRNA
CTD
PMID:30723492
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Rexo5
RNA exonuclease 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of REXO5 mRNA
CTD
PMID:30723492
NCBI chr 1:174,168,633...174,264,526
Ensembl chr 1:174,168,694...174,241,486
G
Rflnb
refilin B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RFLNB mRNA
CTD
PMID:30723492
NCBI chr10:60,893,693...60,899,970
Ensembl chr10:60,893,713...60,899,976
G
Rfx5
regulatory factor X5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RFX5 mRNA
CTD
PMID:30723492
NCBI chr 2:182,521,191...182,528,720
Ensembl chr 2:182,521,202...182,528,717
G
RGD1562699
RGD1562699
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RGD1562699 mRNA
CTD
PMID:30723492
NCBI chr18:57,826,815...57,831,464
Ensembl chr18:57,827,117...57,827,989
G
Rgma
repulsive guidance molecule BMP co-receptor a
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RGMA mRNA
CTD
PMID:30723492
NCBI chr 1:127,128,934...127,172,918
Ensembl chr 1:127,128,934...127,172,918
G
Rgn
regucalcin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RGN mRNA
CTD
PMID:25380136
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rgs10
regulator of G-protein signaling 10
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RGS10 mRNA
CTD
PMID:25380136
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
G
Rgs2
regulator of G-protein signaling 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RGS2 mRNA
CTD
PMID:25380136
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs3
regulator of G-protein signaling 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RGS3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894
G
Rgs5
regulator of G-protein signaling 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RGS5 mRNA
CTD
PMID:25380136
NCBI chr13:81,848,254...81,885,053
Ensembl chr13:81,836,304...81,885,518
G
Rgs6
regulator of G-protein signaling 6
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RGS6 mRNA
CTD
PMID:30723492
NCBI chr 6:102,264,451...102,796,311
Ensembl chr 6:102,264,447...102,824,753
G
Rgs9bp
regulator of G protein signaling 9 binding protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RGS9BP mRNA
CTD
PMID:30723492
NCBI chr 1:88,249,438...88,250,151
Ensembl chr 1:88,249,438...88,250,151
G
Rgsl2h
regulator of G-protein signaling like 2 homolog (mouse)
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RGSL2H mRNA
CTD
PMID:30723492
NCBI chr13:65,973,695...65,974,702
G
Rhbdf2
rhomboid 5 homolog 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RHBDF2 mRNA
CTD
PMID:30723492
NCBI chr10:101,833,157...101,860,283
Ensembl chr10:101,833,157...101,860,283
G
Rhbdl2
rhomboid like 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RHBDL2 mRNA
CTD
PMID:30723492
NCBI chr 5:136,037,560...136,081,970
Ensembl chr 5:136,037,305...136,081,969
G
Rhob
ras homolog family member B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RHOB mRNA
CTD
PMID:30723492
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
G
Rhoc
ras homolog family member C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RHOC mRNA
CTD
PMID:30723492
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
G
Rhoh
ras homolog family member H
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RHOH mRNA
CTD
PMID:30723492
NCBI chr14:42,341,135...42,371,971
Ensembl chr14:42,337,751...42,386,369
G
Rhoq
ras homolog family member Q
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RHOQ mRNA
CTD
PMID:25380136
NCBI chr 6:7,613,632...7,652,047
G
Rims2
regulating synaptic membrane exocytosis 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RIMS2 mRNA
CTD
PMID:30723492
NCBI chr 7:70,248,104...70,759,134
Ensembl chr 7:70,243,872...70,757,491
G
Ripk1
receptor interacting serine/threonine kinase 1
multiple interactions increases expression
ISO
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RIPK1 mRNA]
CTD
PMID:15913567
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
G
Rmdn2
regulator of microtubule dynamics 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RMDN2 mRNA
CTD
PMID:25380136
NCBI chr 6:15,372,569...15,443,000
Ensembl chr 6:15,375,496...15,441,480
G
Rmi2
RecQ mediated genome instability 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RMI2 mRNA
CTD
PMID:30723492
NCBI chr10:4,829,333...4,837,264
Ensembl chr10:4,830,553...4,837,235
G
Rnase13
ribonuclease A family member 13
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RNASE13 mRNA
CTD
PMID:30723492
NCBI chr15:24,618,209...24,618,670
Ensembl chr15:24,618,209...24,618,670
G
Rnd1
Rho family GTPase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RND1 mRNA
CTD
PMID:23558518 PMID:30723492
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnf144a
ring finger protein 144A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RNF144A mRNA
CTD
PMID:30723492
NCBI chr 6:42,899,767...43,019,769
Ensembl chr 6:42,903,174...43,020,012
G
Rnf39
ring finger protein 39
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RNF39 mRNA
CTD
PMID:25380136
NCBI chr20:1,604,794...1,610,283
Ensembl chr20:1,604,794...1,610,283
G
Rnft2
ring finger protein, transmembrane 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RNFT2 mRNA
CTD
PMID:30723492
NCBI chr12:38,329,217...38,387,303
Ensembl chr12:38,329,269...38,387,290
G
Robo2
roundabout guidance receptor 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ROBO2 mRNA
CTD
PMID:25380136
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
G
Ropn1l
rhophilin associated tail protein 1-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ROPN1L mRNA
CTD
PMID:30723492
NCBI chr 2:82,442,645...82,453,332
Ensembl chr 2:82,441,891...82,453,485
G
Rorc
RAR-related orphan receptor C
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of RORC mRNA
CTD
PMID:20594950
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
Ros1
ROS proto-oncogene 1 , receptor tyrosine kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ROS1 mRNA
CTD
PMID:30723492
NCBI chr20:31,432,636...31,583,998
Ensembl chr20:31,432,637...31,583,865
G
Rpl10a
ribosomal protein L10A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPL10A mRNA
CTD
PMID:20551477
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357
G
Rpl13
ribosomal protein L13
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPL13 mRNA
CTD
PMID:20551477
NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014
G
Rpl18a
ribosomal protein L18A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPL18A mRNA
CTD
PMID:20551477
NCBI chr16:18,542,555...18,544,578
Ensembl chr16:18,542,566...18,545,546
G
Rpl26
ribosomal protein L26
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPL26 mRNA
CTD
PMID:20551477
NCBI chr10:53,610,836...53,613,966
Ensembl chr10:53,610,421...53,613,966
G
Rpl28
ribosomal protein L28
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPL28 mRNA
CTD
PMID:20551477
NCBI chr 1:69,052,148...69,054,735
Ensembl chr 1:69,053,203...69,055,032
G
Rpl30
ribosomal protein L30
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPL30 mRNA
CTD
PMID:20551477
NCBI chr 7:65,648,266...65,651,401
Ensembl chr 7:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363
G
Rpl34
ribosomal protein L34
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPL34 mRNA
CTD
PMID:20551477
NCBI chr 2:219,284,373...219,288,108
Ensembl chr 2:219,284,382...219,288,111
G
Rplp0
ribosomal protein lateral stalk subunit P0
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPLP0 mRNA
CTD
PMID:12883083 PMID:20551477
NCBI chr12:41,054,363...41,057,632
Ensembl chr12:41,054,179...41,057,632
G
Rps15
ribosomal protein S15
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPS15 mRNA
CTD
PMID:20551477
NCBI chr 7:9,416,003...9,417,442
Ensembl chr 7:9,416,004...9,417,450
G
Rps16
ribosomal protein S16
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPS16 mRNA
CTD
PMID:20551477
NCBI chr 1:83,643,066...83,646,056
Ensembl chr 1:83,643,130...83,646,206
G
Rps18
ribosomal protein S18
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPS18 mRNA
CTD
PMID:20551477
NCBI chr20:4,931,427...4,935,538
Ensembl chr10:101,204,500...101,205,146 Ensembl chr20:101,204,500...101,205,146
G
Rps19
ribosomal protein S19
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPS19 mRNA
CTD
PMID:20551477
NCBI chr 1:80,480,718...80,486,511
Ensembl chr 1:80,480,951...80,486,508
G
Rps20
ribosomal protein S20
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPS20 mRNA
CTD
PMID:20551477
NCBI chr 5:16,819,095...16,820,476
Ensembl chr 5:16,819,304...16,820,475 Ensembl chr 9:16,819,304...16,820,475 Ensembl chr 3:16,819,304...16,820,475
G
Rps21-ps1
ribosomal protein S21, pseudogene 1
affects expression
EXP
1-Naphthylisothiocyanate affects the expression of RPS21 mRNA
CTD
PMID:20551477
NCBI chr 5:153,387,133...153,387,476
Ensembl chr 5:153,387,176...153,387,427
G
Rps27
ribosomal protein S27
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPS27 mRNA
CTD
PMID:20551477
NCBI chr 2:175,665,858...175,666,963
Ensembl chr 2:175,665,853...175,666,964
G
Rps5
ribosomal protein S5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPS5 mRNA
CTD
PMID:20551477
NCBI chr 1:73,538,776...73,543,073
Ensembl chr 1:73,538,776...73,543,073
G
Rps8
ribosomal protein S8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPS8 mRNA
CTD
PMID:20551477
NCBI chr 5:130,630,362...130,632,932
Ensembl chr 5:130,629,716...130,633,268
G
Rpsa
ribosomal protein SA
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RPSA mRNA
CTD
PMID:20551477
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
G
Rras
RAS related
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RRAS mRNA
CTD
PMID:30723492
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
G
Rras2
RAS related 2
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of RRAS2 mRNA
CTD
PMID:27344345
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
G
Rrm2
ribonucleotide reductase regulatory subunit M2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RRM2 mRNA
CTD
PMID:30723492
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rsrp1
arginine and serine rich protein 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RSRP1 mRNA
CTD
PMID:25380136
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
RT1-Ba
RT1 class II, locus Ba
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RT1-BA mRNA
CTD
PMID:25380136
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-CE5
RT1 class I, locus CE5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RT1-CE5 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr20:3,403,418...3,479,476
G
RT1-Da
RT1 class II, locus Da
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RT1-DA mRNA
CTD
PMID:25380136
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
G
RT1-Db1
RT1 class II, locus Db1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RT1-DB1 mRNA
CTD
PMID:25380136
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-DMa
RT1 class II, locus DMa
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RT1-DMA mRNA
CTD
PMID:25380136
NCBI chr20:4,707,028...4,710,432
Ensembl chr20:4,707,028...4,710,432
G
RT1-DMb
RT1 class II, locus DMb
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RT1-DMB mRNA
CTD
PMID:25380136
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
G
RT1-DOa
RT1 class II, locus DOa
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RT1-DOA mRNA
CTD
PMID:30723492
NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,753,598...4,756,577
G
RT1-DOb
RT1 class II, locus DOb
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RT1-DOB mRNA
CTD
PMID:30723492
NCBI chr20:4,619,418...4,625,627
Ensembl chr20:4,619,816...4,625,667
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RT1-M3-1 mRNA
CTD
PMID:25380136
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Rtn4
reticulon 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of RTN4 mRNA
CTD
PMID:25380136
NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686
G
Rtn4rl1
reticulon 4 receptor-like 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RTN4RL1 mRNA
CTD
PMID:30723492
NCBI chr10:60,043,246...60,116,977
Ensembl chr10:60,043,002...60,116,978
G
Rtp3
receptor (chemosensory) transporter protein 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of RTP3 mRNA
CTD
PMID:25380136
NCBI chr 8:110,970,154...110,975,000
Ensembl chr 8:110,970,160...110,974,699
G
Rxra
retinoid X receptor alpha
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of RXRA mRNA
CTD
PMID:27344345
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
S100a10
S100 calcium binding protein A10
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of S100A10 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
G
S100a11
S100 calcium binding protein A11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of S100A11 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
S100a6
S100 calcium binding protein A6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of S100A6 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
S100a8
S100 calcium binding protein A8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of S100A8 mRNA
CTD
PMID:17522070 PMID:30723492
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of S100A9 mRNA
CTD
PMID:17522070 PMID:25380136
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
S1pr1
sphingosine-1-phosphate receptor 1
decreases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of S1PR1 mRNA 1-Naphthylisothiocyanate results in decreased expression of S1PR1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of S1PR1 protein [dorsomorphin co-treated with SEW2871] inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of S1PR1 protein]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of S1PR1 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of S1PR1 protein]
CTD
PMID:25380136 PMID:32579994 PMID:33400020
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
G
Samd11
sterile alpha motif domain containing 11
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SAMD11 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 5:166,831,681...166,859,805
Ensembl chr 5:166,831,663...166,850,009
G
Sapcd1
suppressor APC domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SAPCD1 mRNA
CTD
PMID:30723492
NCBI chr20:3,793,980...3,795,767
Ensembl chr20:3,793,967...3,795,790
G
Sapcd2
suppressor APC domain containing 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SAPCD2 mRNA
CTD
PMID:30723492
NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546
G
Sass6
SAS-6 centriolar assembly protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SASS6 mRNA
CTD
PMID:30723492
NCBI chr 2:204,546,660...204,578,930
Ensembl chr 2:204,546,660...204,578,927
G
Sat2
spermidine/spermine N1-acetyltransferase family member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SAT2 mRNA
CTD
PMID:30723492
NCBI chr10:54,340,756...54,343,507
Ensembl chr10:54,340,372...54,343,224
G
Scara3
scavenger receptor class A, member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SCARA3 mRNA
CTD
PMID:30723492
NCBI chr15:40,139,873...40,172,866
Ensembl chr15:40,140,161...40,172,894
G
Scarb1
scavenger receptor class B, member 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SCARB1 mRNA
CTD
PMID:27344345
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Scarb2
scavenger receptor class B, member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SCARB2 mRNA
CTD
PMID:30723492
NCBI chr14:15,558,271...15,609,813
Ensembl chr14:15,558,236...15,609,813
G
Scd
stearoyl-CoA desaturase
multiple interactions increases expression decreases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SCD mRNA 1-Naphthylisothiocyanate results in increased expression of SCD1 mRNA 1-Naphthylisothiocyanate results in decreased expression of SCD1 mRNA
CTD
PMID:27344345 PMID:27853831 PMID:29737914 PMID:30723492
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scd2
stearoyl-Coenzyme A desaturase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SCD2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232
G
Scn1a
sodium voltage-gated channel alpha subunit 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SCN1A mRNA
CTD
PMID:12832660
NCBI chr 3:50,952,790...51,071,804
Ensembl chr 3:50,952,791...51,071,699
G
Scn2a
sodium voltage-gated channel alpha subunit 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SCN2A mRNA
CTD
PMID:30723492
NCBI chr 3:50,302,781...50,437,504
Ensembl chr 3:50,302,877...50,437,214
G
Scn2b
sodium voltage-gated channel beta subunit 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SCN2B mRNA
CTD
PMID:30723492
NCBI chr 8:45,425,629...45,437,765
Ensembl chr 8:45,425,629...45,437,765
G
Scn3b
sodium voltage-gated channel beta subunit 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SCN3B mRNA
CTD
PMID:30723492
NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:40,630,455...40,652,868
G
Scrn3
secernin 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SCRN3 mRNA
CTD
PMID:30723492
NCBI chr 3:58,188,820...58,213,623
Ensembl chr 3:58,188,889...58,213,623
G
Sctr
secretin receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SCTR mRNA
CTD
PMID:30723492
NCBI chr13:31,127,781...31,190,162
Ensembl chr13:31,127,858...31,180,189
G
Sdc1
syndecan 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SDC1 mRNA
CTD
PMID:27344345
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
G
Sdcbp2
syndecan binding protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SDCBP2 mRNA
CTD
PMID:30723492
NCBI chr 3:140,060,746...140,098,063
Ensembl chr 3:140,070,540...140,098,057
G
Sdr42e1
short chain dehydrogenase/reductase family 42E, member 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SDR42E1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr19:45,715,366...45,727,901
Ensembl chr19:45,715,399...45,727,901
G
Sds
serine dehydratase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SDS mRNA
CTD
PMID:25380136
NCBI chr12:36,083,226...36,090,540
Ensembl chr12:36,083,229...36,088,203
G
Sec14l3
SEC14-like lipid binding 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SEC14L3 mRNA
CTD
PMID:30723492
NCBI chr14:78,944,568...78,955,608
Ensembl chr14:78,912,750...78,956,099
G
Selenom
selenoprotein M
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SELENOM mRNA
CTD
PMID:25380136
NCBI chr14:78,395,826...78,398,429
Ensembl chr14:78,395,826...78,398,429
G
Selenop
selenoprotein P
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SELENOP mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Selenow
selenoprotein W
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SELENOW mRNA
CTD
PMID:25380136
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Sema3c
semaphorin 3C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SEMA3C mRNA
CTD
PMID:30723492
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
G
Sema6d
semaphorin 6D
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SEMA6D mRNA
CTD
PMID:25380136
NCBI chr 3:111,883,415...111,941,100
Ensembl chr 3:111,883,872...111,941,094
G
Septin5
septin 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SEPTIN5 mRNA
CTD
PMID:30723492
NCBI chr11:82,373,601...82,379,393
Ensembl chr11:82,369,754...82,379,393
G
Serinc2
serine incorporator 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SERINC2 mRNA
CTD
PMID:30723492
NCBI chr 5:142,592,308...142,614,628
Ensembl chr 5:142,592,309...142,618,364
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of SERPINA3 mRNA
CTD
PMID:17175557
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serpina4
serpin family A member 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SERPINA4 mRNA
CTD
PMID:25380136
NCBI chr 6:122,999,970...123,009,083
Ensembl chr 6:122,999,900...123,009,082
G
Serpina5
serpin family A member 5
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of SERPINA5 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SERPINA5 mRNA
CTD
PMID:12832660 PMID:27344345
NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407
G
Serpina6
serpin family A member 6
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SERPINA6 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
G
Serpina7
serpin family A member 7
increases expression decreases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SERPINA7 mRNA 1-Naphthylisothiocyanate results in decreased expression of SERPINA7 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr X:102,663,242...102,722,319
Ensembl chr X:102,663,405...102,669,040
G
Serpinb9
serpin family B member 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SERPINB9 mRNA
CTD
PMID:25380136
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
G
Serpine1
serpin family E member 1
increases expression multiple interactions increases response to substance
EXP ISO
1-Naphthylisothiocyanate results in increased expression of SERPINE1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SERPINE1 mRNA SERPINE1 gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate
CTD
PMID:23558518 PMID:24633426 PMID:27344345 PMID:30723492
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpinf2
serpin family F member 2
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SERPINF2 mRNA
CTD
PMID:27344345
NCBI chr10:60,272,400...60,280,506
Ensembl chr10:60,272,400...60,281,243
G
Serpinh1
serpin family H member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SERPINH1 mRNA
CTD
PMID:20551477 PMID:25380136
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
G
Setd1b
SET domain containing 1B, histone lysine methyltransferase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SETD1B mRNA
CTD
PMID:30723492
NCBI chr12:33,395,963...33,421,671
Ensembl chr12:33,396,120...33,426,934
G
Sez6
seizure related 6 homolog
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SEZ6 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr10:62,818,931...62,868,686
Ensembl chr10:62,819,069...62,868,671
G
Sfn
stratifin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SFN mRNA
CTD
PMID:30723492
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
G
Sfrp1
secreted frizzled-related protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SFRP1 mRNA
CTD
PMID:30723492
NCBI chr16:68,575,763...68,614,180
Ensembl chr16:68,575,763...68,614,286
G
Sgcb
sarcoglycan, beta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SGCB mRNA
CTD
PMID:25380136
NCBI chr14:34,563,614...34,578,614
Ensembl chr14:34,563,608...34,578,583
G
Sgcg
sarcoglycan, gamma
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SGCG mRNA
CTD
PMID:30723492
NCBI chr15:35,388,836...35,435,072
Ensembl chr15:35,386,534...35,435,148
G
Sgo2
shugoshin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SGO2 mRNA
CTD
PMID:30723492
NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229
G
Sh3bgr
SH3 domain binding glutamate-rich protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SH3BGR mRNA
CTD
PMID:30723492
NCBI chr11:35,503,663...35,527,853
Ensembl chr11:35,503,725...35,527,853
G
Sh3bgrl3
SH3 domain binding glutamate-rich protein like 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SH3BGRL3 mRNA
CTD
PMID:25380136
NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:146,354,152...146,355,331
G
Sh3pxd2b
SH3 and PX domains 2B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SH3PXD2B mRNA
CTD
PMID:30723492
NCBI chr10:16,918,611...17,027,499
Ensembl chr10:16,918,679...17,005,170
G
Shcbp1
SHC binding and spindle associated 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SHCBP1 mRNA
CTD
PMID:30723492
NCBI chr16:84,672,277...84,703,843
Ensembl chr16:84,672,321...84,703,844
G
Shd
src homology 2 domain-containing transforming protein D
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SHD mRNA
CTD
PMID:30723492
NCBI chr 9:799,652...809,769
Ensembl chr 9:795,674...808,371
G
Shisa3
shisa family member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SHISA3 mRNA
CTD
PMID:25380136
NCBI chr14:40,563,672...40,568,244
Ensembl chr14:40,563,673...40,568,244
G
Shq1
SHQ1, H/ACA ribonucleoprotein assembly factor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SHQ1 mRNA
CTD
PMID:30723492
NCBI chr 4:133,213,357...133,305,586
Ensembl chr 4:133,213,361...133,305,586
G
Shtn1
shootin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SHTN1 mRNA
CTD
PMID:30723492
NCBI chr 1:258,121,966...258,225,861
Ensembl chr 1:258,121,968...258,228,265
G
Siglec5
sialic acid binding Ig-like lectin 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SIGLEC5 mRNA
CTD
PMID:25380136
NCBI chr 1:93,768,190...93,776,696
Ensembl chr 1:93,768,319...93,776,694
G
Sirt1
sirtuin 1
multiple interactions decreases expression
ISO
liquiritin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SIRT1 mRNA]; liquiritin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SIRT1 protein] 1-Naphthylisothiocyanate results in decreased expression of SIRT1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of SIRT1 protein
CTD
PMID:36008890
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Ska1
spindle and kinetochore associated complex subunit 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SKA1 mRNA
CTD
PMID:30723492
NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037
G
Ska3
spindle and kinetochore associated complex subunit 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SKA3 mRNA
CTD
PMID:30723492
NCBI chr15:31,951,812...31,971,010
Ensembl chr15:31,951,825...31,971,010
G
Skap2
src kinase associated phosphoprotein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SKAP2 mRNA
CTD
PMID:25380136
NCBI chr 4:80,948,832...81,100,900
Ensembl chr 4:80,950,580...81,100,891
G
Slc10a1
solute carrier family 10 member 1
multiple interactions decreases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with obeticholic acid] results in decreased expression of SLC10A1 protein; [1-Naphthylisothiocyanate co-treated with ursodoxicoltaurine] results in decreased expression of SLC10A1 protein; [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of SLC10A1 mRNA; alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; liquiritin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; NFE2L2 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; NR1H4 promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 protein]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 protein]; Uric Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 protein] 1-naphthyl isothiocyanate decreases expression of Slc10a1 protein in rat liver 1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of SLC10A1 protein dioscin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 protein]
CTD RGD
PMID:14623915 PMID:19181614 PMID:24120425 PMID:25418378 PMID:25655198 PMID:26365562 PMID:27317372 PMID:27702592 PMID:27765674 PMID:29660435 PMID:29968724 PMID:30517764 PMID:30723492 PMID:32198087 PMID:32579994 PMID:32976922 PMID:33749747 PMID:36008890 PMID:36787806 PMID:29655695 More...
RGD:15090803
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc12a3
solute carrier family 12 member 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC12A3 mRNA
CTD
PMID:30723492
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
G
Slc13a2
solute carrier family 13 member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC13A2 mRNA
CTD
PMID:30723492
NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,291,815...63,319,127
G
Slc13a4
solute carrier family 13 member 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC13A4 mRNA
CTD
PMID:30723492
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
G
Slc15a3
solute carrier family 15 member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC15A3 mRNA
CTD
PMID:25380136
NCBI chr 1:207,492,365...207,507,158
Ensembl chr 1:207,492,365...207,507,157
G
Slc17a1
solute carrier family 17 member 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC17A1 mRNA
CTD
PMID:25380136
NCBI chr17:41,219,461...41,255,199
Ensembl chr17:41,222,049...41,253,304
G
Slc17a2
solute carrier family 17, member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC17A2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
G
Slc19a2
solute carrier family 19 member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC19A2 mRNA
CTD
PMID:25380136
NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172
G
Slc1a1
solute carrier family 1 member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC1A1 mRNA
CTD
PMID:12832660
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
G
Slc1a3
solute carrier family 1 member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC1A3 mRNA
CTD
PMID:12832660
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
G
Slc1a5
solute carrier family 1 member 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC1A5 mRNA
CTD
PMID:20551477
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc1a7
solute carrier family 1 member 7
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC1A7 mRNA
CTD
PMID:30723492
NCBI chr 5:122,731,003...122,775,139
Ensembl chr 5:122,731,003...122,775,134
G
Slc20a1
solute carrier family 20 member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC20A1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
G
Slc22a1
solute carrier family 22 member 1
decreases expression
ISO
1-Naphthylisothiocyanate results in decreased expression of SLC22A1 mRNA
CTD
PMID:15913567
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of SLC22A2 mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC22A2 mRNA]
CTD
PMID:15913567
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a23
solute carrier family 22, member 23
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC22A23 mRNA
CTD
PMID:25380136
NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790
G
Slc22a5
solute carrier family 22 member 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC22A5 mRNA
CTD
PMID:30723492
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc22a6
solute carrier family 22 member 6
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC22A6 mRNA
CTD
PMID:30723492
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a7
solute carrier family 22 member 7
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SLC22A7 mRNA
CTD
PMID:27344345
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc22a8
solute carrier family 22 member 8
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC22A8 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Slc23a1
solute carrier family 23 member 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC23A1 mRNA
CTD
PMID:25380136
NCBI chr18:27,214,940...27,230,564
Ensembl chr18:27,216,281...27,230,697
G
Slc24a4
solute carrier family 24 member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC24A4 mRNA
CTD
PMID:30723492
NCBI chr 6:121,279,590...121,419,811
Ensembl chr 6:121,280,031...121,414,949
G
Slc25a13
solute carrier family 25 member 13
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC25A13 mRNA
CTD
PMID:25380136
NCBI chr 4:34,179,224...34,361,912
Ensembl chr 4:34,179,224...34,361,902
G
Slc25a30
solute carrier family 25, member 30
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC25A30 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr15:51,076,998...51,099,613
Ensembl chr15:51,077,002...51,099,613
G
Slc25a4
solute carrier family 25 member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC25A4 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr16:46,072,935...46,076,730
Ensembl chr16:46,072,939...46,076,733
G
Slc25a48
solute carrier family 25, member 48
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC25A48 mRNA
CTD
PMID:30723492
NCBI chr17:8,119,964...8,161,293
Ensembl chr17:8,121,175...8,160,748
G
Slc27a5
solute carrier family 27 member 5
increases expression decreases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of SLC27A5 mRNA 1-Naphthylisothiocyanate results in decreased expression of SLC27A5 mRNA alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of SLC27A5 mRNA]
CTD
PMID:25655198 PMID:37348807
NCBI chr 1:73,616,556...73,627,149
Ensembl chr 1:73,616,564...73,627,172
G
Slc29a4
solute carrier family 29 member 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC29A4 mRNA
CTD
PMID:30723492
NCBI chr12:11,853,540...11,884,660
Ensembl chr12:11,853,540...11,874,834
G
Slc2a1
solute carrier family 2 member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC2A1 mRNA
CTD
PMID:17522070
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a2
solute carrier family 2 member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC2A2 mRNA
CTD
PMID:30723492
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
G
Slc30a3
solute carrier family 30 member 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC30A3 mRNA
CTD
PMID:30723492
NCBI chr 6:25,264,310...25,284,720
Ensembl chr 6:25,275,528...25,284,720
G
Slc36a3
solute carrier family 36, member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC36A3 mRNA
CTD
PMID:30723492
NCBI chr10:39,243,531...39,273,433
Ensembl chr10:39,243,595...39,270,567
G
Slc39a6
solute carrier family 39 member 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC39A6 mRNA
CTD
PMID:25380136
NCBI chr18:15,864,874...15,885,417
Ensembl chr18:15,864,875...15,885,417
G
Slc39a8
solute carrier family 39 member 8
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC39A8 mRNA
CTD
PMID:25380136
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
G
Slc3a2
solute carrier family 3 member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC3A2 mRNA
CTD
PMID:20551477
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc41a3
solute carrier family 41, member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC41A3 mRNA
CTD
PMID:30723492
NCBI chr 4:123,109,555...123,154,766
Ensembl chr 4:123,112,748...123,154,766
G
Slc43a2
solute carrier family 43 member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC43A2 mRNA
CTD
PMID:25380136
NCBI chr10:60,375,462...60,420,838
Ensembl chr10:60,376,559...60,418,244
G
Slc44a3
solute carrier family 44, member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC44A3 mRNA
CTD
PMID:30723492
NCBI chr 2:209,552,138...209,628,182
Ensembl chr 2:209,552,144...209,629,044
G
Slc44a5
solute carrier family 44, member 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC44A5 mRNA
CTD
PMID:30723492
NCBI chr 2:242,911,050...243,208,018
Ensembl chr 2:242,911,325...243,206,404
G
Slc46a1
solute carrier family 46 member 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC46A1 mRNA
CTD
PMID:25380136
NCBI chr10:63,361,504...63,367,940
Ensembl chr10:63,361,486...63,368,848
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC4A1 mRNA
CTD
PMID:30723492
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
G
Slc4a2
solute carrier family 4 member 2
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with ursodoxicoltaurine] results in increased expression of SLC4A2 protein
CTD
PMID:36787806
NCBI chr 4:10,736,419...10,754,407
Ensembl chr 4:10,736,425...10,752,965
G
Slc4a3
solute carrier family 4 member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC4A3 mRNA
CTD
PMID:30723492
NCBI chr 9:77,036,243...77,053,940
Ensembl chr 9:77,037,016...77,049,105
G
Slc4a4
solute carrier family 4 member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC4A4 mRNA
CTD
PMID:25380136
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Slc51a
solute carrier family 51 member A
decreases expression
ISO
1-Naphthylisothiocyanate results in decreased expression of SLC51A mRNA
CTD
PMID:28549656 PMID:30517764
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Slc51b
SLC51 subunit beta
increases expression multiple interactions
ISO
1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA]; [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of SLC51B mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of SLC51B mRNA; [ursodoxicoltaurine co-treated with 1-Naphthylisothiocyanate] results in increased expression of SLC51B protein; Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SLC51B mRNA
CTD
PMID:19407337 PMID:27344345 PMID:27853831 PMID:28549656 PMID:30352267 PMID:30517764 PMID:33749747 PMID:36787806 More...
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Slc5a9
solute carrier family 5 member 9
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC5A9 mRNA
CTD
PMID:30723492
NCBI chr 5:126,709,762...126,733,468
Ensembl chr 5:126,709,769...126,733,468
G
Slc66a3
solute carrier family 66 member 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC66A3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 6:39,774,801...39,786,554
Ensembl chr 6:39,774,808...39,786,303
G
Slc7a1
solute carrier family 7 member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLC7A1 mRNA
CTD
PMID:20551477 PMID:25380136 PMID:30723492
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slc8b1
solute carrier family 8 member B1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLC8B1 mRNA
CTD
PMID:30723492
NCBI chr12:36,029,759...36,053,087
Ensembl chr12:36,029,760...36,053,031
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
decreases expression multiple interactions increases expression
ISO EXP
1-Naphthylisothiocyanate results in decreased expression of SLCO1A4 mRNA dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1A2 mRNA] 1-Naphthylisothiocyanate results in increased expression of SLCO1A4 mRNA 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLCO1A4 mRNA]; Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLCO1A4 mRNA]
CTD
PMID:19407337 PMID:24120425 PMID:27702592 PMID:28549656 PMID:30723492
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slco1a5
solute carrier organic anion transporter family, member 1A5
multiple interactions
ISO
[NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in decreased expression of SLCO1A2 mRNA
CTD
PMID:29968724
NCBI chr 4:175,172,390...175,254,598
Ensembl chr 4:174,710,004...175,254,573
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions decreases expression
ISO EXP
[1-Naphthylisothiocyanate co-treated with Allopurinol] results in decreased expression of SLCO1B2 mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of SLCO1B2 mRNA; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA]; NFE2L2 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA] dioscin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA]; dioscin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 protein] 1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA; 1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 protein
CTD
PMID:17522070 PMID:19181614 PMID:19407337 PMID:25655198 PMID:27317372 PMID:30517764 PMID:33749747 More...
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Slfn2
schlafen family member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SLFN2 mRNA
CTD
PMID:25380136
NCBI chr10:67,953,322...67,959,659
Ensembl chr10:67,953,171...67,959,458
G
Slit3
slit guidance ligand 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SLIT3 mRNA
CTD
PMID:30723492
NCBI chr10:19,571,798...20,156,634
Ensembl chr10:19,571,684...20,156,634
G
Smad2
SMAD family member 2
multiple interactions increases phosphorylation
ISO
[ITGA5 protein co-treated with ITGB6 protein] promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein]; TGFB1 protein promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein]
CTD
PMID:21037076
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
G
Smc2
structural maintenance of chromosomes 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SMC2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
G
Smim20
small integral membrane protein 20
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SMIM20 mRNA
CTD
PMID:30723492
NCBI chr14:57,711,304...57,722,681
Ensembl chr14:57,711,307...57,722,681
G
Smim22
small integral membrane protein 22
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SMIM22 mRNA
CTD
PMID:30723492
NCBI chr10:10,572,146...10,574,339
G
Smoc1
SPARC related modular calcium binding 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SMOC1 mRNA
CTD
PMID:25380136
NCBI chr 6:100,701,330...100,897,441
Ensembl chr 6:100,701,346...100,862,699
G
Smoc2
SPARC related modular calcium binding 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SMOC2 mRNA
CTD
PMID:25380136
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:55,262,530...55,391,693
G
Smpd3
sphingomyelin phosphodiesterase 3
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of SMPD3 mRNA
CTD
PMID:27853831 PMID:29737914
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
G
Snap23
synaptosome associated protein 23
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SNAP23 mRNA
CTD
PMID:25380136
NCBI chr 3:107,514,088...107,546,177
Ensembl chr 3:107,514,131...107,544,320
G
Snap29
synaptosome associated protein 29
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SNAP29 mRNA
CTD
PMID:25380136
NCBI chr11:83,578,479...83,608,953
Ensembl chr11:83,578,489...83,608,958
G
Snap91
synaptosome associated protein 91
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SNAP91 mRNA
CTD
PMID:30723492
NCBI chr 8:87,738,056...87,852,690
Ensembl chr 8:87,738,824...87,852,367
G
Soat1
sterol O-acyltransferase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SOAT1 mRNA
CTD
PMID:25380136
NCBI chr13:68,552,274...68,597,529
Ensembl chr13:68,552,317...68,597,494
G
Socs2
suppressor of cytokine signaling 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SOCS2 mRNA
CTD
PMID:30723492
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
G
Socs3
suppressor of cytokine signaling 3
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of SOCS3 mRNA 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SOCS3 mRNA]; [PPARA protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the expression of SOCS3 mRNA; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SOCS3 mRNA]
CTD
PMID:12832660 PMID:30352267 PMID:36460194
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SOD2 mRNA
CTD
PMID:12883083
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sorl1
sortilin related receptor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SORL1 mRNA
CTD
PMID:30723492
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
G
Sox4
SRY-box transcription factor 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SOX4 mRNA
CTD
PMID:25380136
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
G
Sp4
Sp4 transcription factor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SP4 mRNA
CTD
PMID:12832660
NCBI chr 6:139,187,458...139,252,741
Ensembl chr 6:139,192,147...139,252,126
G
Spag5
sperm associated antigen 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPAG5 mRNA
CTD
PMID:30723492
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
G
Sparc
secreted protein acidic and cysteine rich
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPARC mRNA
CTD
PMID:25380136
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Spata2L
spermatogenesis associated 2-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPATA2L mRNA
CTD
PMID:30723492
NCBI chr19:51,269,078...51,273,605
Ensembl chr19:51,269,078...51,273,510
G
Spc24
SPC24 component of NDC80 kinetochore complex
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPC24 mRNA
CTD
PMID:30723492
NCBI chr 8:20,300,315...20,305,354
Ensembl chr 8:20,300,319...20,305,310
G
Spc25
SPC25 component of NDC80 kinetochore complex
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPC25 mRNA
CTD
PMID:30723492
NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959
G
Spdl1
spindle apparatus coiled-coil protein 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPDL1 mRNA
CTD
PMID:30723492
NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127
G
Specc1
sperm antigen with calponin homology and coiled-coil domains 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPECC1 mRNA
CTD
PMID:30723492
NCBI chr10:46,638,947...46,912,989
Ensembl chr10:46,638,809...46,912,802
G
Spin2b
spindlin family member 2B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SPIN2B mRNA
CTD
PMID:17522070
NCBI chr X:17,190,573...17,192,351
Ensembl chr X:17,180,474...17,192,351
G
Spint1
serine peptidase inhibitor, Kunitz type 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPINT1 mRNA
CTD
PMID:30723492
NCBI chr 3:106,231,082...106,244,121
Ensembl chr 3:106,231,444...106,244,119
G
Spmip11
sperm microtubule inner protein 11
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of NPHS1 mRNA
CTD
PMID:30723492
NCBI chr 7:129,720,950...129,742,485
Ensembl chr 7:129,720,950...129,742,485
G
Spon1
spondin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPON1 mRNA
CTD
PMID:30723492
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Spp1
secreted phosphoprotein 1
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of SPP1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SPP1 mRNA
CTD
PMID:18289764 PMID:23558518 PMID:27344345
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Spsb4
splA/ryanodine receptor domain and SOCS box containing 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPSB4 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:97,536,519...97,609,757
Ensembl chr 8:97,536,520...97,609,787
G
Sptan1
spectrin, alpha, non-erythrocytic 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SPTAN1 mRNA
CTD
PMID:25380136
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
G
Sqle
squalene epoxidase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SQLE mRNA
CTD
PMID:30723492
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srd5a1
steroid 5 alpha-reductase 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SRD5A1 mRNA
CTD
PMID:25380136
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SREBF1 mRNA 1-Naphthylisothiocyanate results in increased expression of SREBF1 mRNA
CTD
PMID:17522070 PMID:25380136 PMID:30723492
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Sri
sorcin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SRI mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077
G
Srpx2
sushi-repeat-containing protein, X-linked 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SRPX2 mRNA
CTD
PMID:30723492
NCBI chr X:97,106,455...97,132,197
Ensembl chr X:97,106,561...97,132,195
G
Srr
serine racemase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SRR mRNA
CTD
PMID:25380136
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
G
Srxn1
sulfiredoxin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SRXN1 mRNA
CTD
PMID:20551477
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Sstr3
somatostatin receptor 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SSTR3 mRNA
CTD
PMID:30723492
NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
G
St14
ST14 transmembrane serine protease matriptase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ST14 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:29,540,805...29,581,704
Ensembl chr 8:29,540,811...29,581,517
G
St6galnac4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ST6GALNAC4 mRNA
CTD
PMID:30723492
NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243
G
Stac2
SH3 and cysteine rich domain 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of STAC2 mRNA
CTD
PMID:30723492
NCBI chr10:83,032,418...83,048,260
Ensembl chr10:83,032,417...83,048,260
G
Stac3
SH3 and cysteine rich domain 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of STAC3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
G
Stap1
signal transducing adaptor family member 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of STAP1 mRNA
CTD
PMID:30723492
NCBI chr14:21,950,466...21,981,395
Ensembl chr14:21,952,496...21,981,245
G
Stard13
StAR-related lipid transfer domain containing 13
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of STARD13 mRNA
CTD
PMID:25380136
NCBI chr12:566,282...959,372
Ensembl chr12:566,310...959,421
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of STAT1 mRNA
CTD
PMID:27344345
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
increases expression increases phosphorylation multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of STAT3 mRNA 1-Naphthylisothiocyanate results in increased phosphorylation of STAT3 protein 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STAT3 protein]; C188-9 compound inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STAT3 protein]; pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STAT3 protein]; PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STAT3 protein]]
CTD
PMID:15913567 PMID:17522070 PMID:27853831 PMID:30723492 PMID:36460194
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stau2
staufen double-stranded RNA binding protein 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of STAU2 mRNA
CTD
PMID:25380136
NCBI chr 5:2,840,741...3,084,935
Ensembl chr 5:2,840,765...3,084,929
G
Steap1
STEAP family member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of STEAP1 mRNA
CTD
PMID:30723492
NCBI chr 4:28,276,972...28,287,484
Ensembl chr 4:28,276,909...28,287,479
G
Steap4
STEAP4 metalloreductase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of STEAP4 mRNA
CTD
PMID:25380136
NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859
G
Stil
STIL, centriolar assembly protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of STIL mRNA
CTD
PMID:30723492
NCBI chr 5:128,520,837...128,573,732
Ensembl chr 5:128,520,953...128,573,730
G
Stk10
serine/threonine kinase 10
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of STK10 mRNA
CTD
PMID:25380136
NCBI chr10:17,117,860...17,212,065
Ensembl chr10:17,117,878...17,212,061
G
Stk11
serine/threonine kinase 11
multiple interactions increases phosphorylation
EXP ISO
U 0126 inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STK11 protein] Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STK11 protein]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STK11 protein]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STK11 protein]; U 0126 promotes the reaction [picroside II inhibits the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of STK11 protein]]
CTD
PMID:27702592 PMID:32976922 PMID:33400020
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
G
Stk32b
serine/threonine kinase 32B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of STK32B mRNA
CTD
PMID:30723492
NCBI chr14:73,077,944...73,337,976
Ensembl chr14:73,078,061...73,336,458
G
Stmn1
stathmin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of STMN1 mRNA
CTD
PMID:30723492
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Stmn3
stathmin 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of STMN3 mRNA
CTD
PMID:30723492
NCBI chr 3:168,416,810...168,424,946
Ensembl chr 3:168,416,810...168,425,056
G
Sult1c2a
sulfotransferase family 1C member 2A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SULT1C2 mRNA; 1-Naphthylisothiocyanate results in decreased expression of SULT1C2A mRNA
CTD
PMID:30723492
NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734
G
Sult1c3
sulfotransferase family 1C member 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SULT1C3 mRNA
CTD
PMID:30723492
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
G
Sult1e1
sulfotransferase family 1E member 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SULT1E1 mRNA
CTD
PMID:30723492
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Sult2a1
sulfotransferase family 2A member 1
increases expression multiple interactions decreases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of SULT2A1 mRNA; 1-Naphthylisothiocyanate results in increased expression of SULT2A1 protein ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SULT2A1 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SULT2A1 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SULT2A1 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SULT2A1 protein] 1-Naphthylisothiocyanate results in decreased expression of SULT2A1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of SULT2A1 protein [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SULT2A1 mRNA alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of SULT2A1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of SULT2A1 mRNA]; yangonin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of SULT2A1 mRNA]
CTD
PMID:25655198 PMID:27344345 PMID:28549656 PMID:29660435 PMID:32198087
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
G
Sult2b1
sulfotransferase family 2B member 1
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of SULT2B1 mRNA
CTD
PMID:27052460
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
G
Sult4a1
sulfotransferase family 4A, member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SULT4A1 mRNA
CTD
PMID:30723492
NCBI chr 7:115,216,066...115,240,156
Ensembl chr 7:115,216,066...115,240,085
G
Sult6b2
sulfotransferase family 6B, member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SULT6B2 mRNA
CTD
PMID:30723492
NCBI chr 4:175,745,824...175,764,400
Ensembl chr 4:175,745,824...175,764,358
G
Sun3
Sad1 and UNC84 domain containing 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SUN3 mRNA
CTD
PMID:30723492
NCBI chr14:83,710,136...83,748,982
Ensembl chr14:83,710,140...83,735,830
G
Svep1
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SVEP1 mRNA
CTD
PMID:30723492
NCBI chr 5:72,811,200...72,988,185
Ensembl chr 5:72,811,410...72,988,525
G
Sycp3
synaptonemal complex protein 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SYCP3 mRNA
CTD
PMID:30723492
NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511
G
Syne4
spectrin repeat containing nuclear envelope family member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SYNE4 mRNA
CTD
PMID:30723492
NCBI chr 1:85,569,409...85,573,775
Ensembl chr 1:85,569,545...85,573,760
G
Synj2
synaptojanin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SYNJ2 mRNA
CTD
PMID:30723492
NCBI chr 1:46,518,594...46,621,919
Ensembl chr 1:46,518,709...46,633,687
G
Synj2bp
synaptojanin 2 binding protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SYNJ2BP mRNA
CTD
PMID:30723492
NCBI chr 6:101,189,714...101,227,400
Ensembl chr 6:101,189,714...101,227,406
G
Synpo
synaptopodin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SYNPO mRNA
CTD
PMID:30723492
NCBI chr18:54,048,299...54,106,388
Ensembl chr18:54,026,152...54,102,126
G
Synrg
synergin, gamma
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of SYNRG mRNA
CTD
PMID:25380136
NCBI chr10:68,848,828...68,931,252
Ensembl chr10:68,849,642...68,931,250
G
Syt1
synaptotagmin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of SYT1 mRNA
CTD
PMID:30723492
NCBI chr 7:43,813,204...44,358,020
Ensembl chr 7:43,815,785...44,357,803
G
Syvn1
synoviolin 1
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SYVN1 mRNA
CTD
PMID:27344345
NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
G
Tacc3
transforming, acidic coiled-coil containing protein 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TACC3 mRNA
CTD
PMID:30723492
NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219
G
Tafa2
TAFA chemokine like family member 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TAFA2 mRNA
CTD
PMID:30723492
NCBI chr 7:58,942,598...59,418,640
Ensembl chr 7:58,942,610...59,417,299
G
Tafa4
TAFA chemokine like family member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TAFA4 mRNA
CTD
PMID:30723492
NCBI chr 4:129,437,466...129,671,320
Ensembl chr 4:129,437,467...129,671,249
G
Tagln
transgelin
increases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of TAGLN mRNA
CTD
PMID:17175557 PMID:30723492
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tagln2
transgelin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TAGLN2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
G
Tat
tyrosine aminotransferase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TAT mRNA
CTD
PMID:30723492
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tax1bp3
Tax1 binding protein 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TAX1BP3 mRNA
CTD
PMID:25380136
NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363
G
Tbx21
T-box transcription factor 21
decreases expression
ISO EXP
1-Naphthylisothiocyanate results in decreased expression of TBX21 mRNA
CTD
PMID:20594950 PMID:30723492
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
G
Tcf19
transcription factor 19
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TCF19 mRNA
CTD
PMID:30723492
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
G
Tcf20
transcription factor 20
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TCF20 mRNA
CTD
PMID:25380136
NCBI chr 7:113,953,449...114,104,166
Ensembl chr 7:113,954,089...114,051,839
G
Tcf24
transcription factor 24
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TCF24 mRNA
CTD
PMID:30723492
NCBI chr 5:9,274,659...9,282,876
Ensembl chr 5:9,227,131...9,279,636
G
Tchh
trichohyalin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TCHH mRNA
CTD
PMID:30723492
NCBI chr 2:179,103,660...179,112,014
Ensembl chr 2:179,109,609...179,110,985 Ensembl chr 2:179,109,609...179,110,985
G
Tcim
transcriptional and immune response regulator
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TCIM mRNA
CTD
PMID:30723492
NCBI chr16:67,595,762...67,597,055
Ensembl chr16:67,593,410...67,597,581
G
Tcp11
t-complex 11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TCP11 mRNA
CTD
PMID:30723492
NCBI chr20:6,126,267...6,138,408
Ensembl chr20:6,126,269...6,136,055
G
Tedc1
tubulin epsilon and delta complex 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TEDC1 mRNA
CTD
PMID:30723492
NCBI chr 6:132,234,764...132,245,164
Ensembl chr 6:132,236,925...132,244,928
G
Tes
testin LIM domain protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TES mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:45,365,304...45,403,829
Ensembl chr 4:45,365,285...45,403,829
G
Tff3
trefoil factor 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TFF3 mRNA
CTD
PMID:20551477
NCBI chr20:9,193,259...9,197,969
Ensembl chr20:9,193,262...9,198,054
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TFPI2 mRNA
CTD
PMID:25380136
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
G
Tfrc
transferrin receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TFRC mRNA
CTD
PMID:30723492
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfb1
transforming growth factor, beta 1
multiple interactions increases expression
ISO
[1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] which results in increased activity of TGFB1 protein 1-Naphthylisothiocyanate results in increased expression of TGFB1 mRNA; 1-Naphthylisothiocyanate results in increased expression of TGFB1 protein FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB1 mRNA]]; TGFB1 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of COL1A1 mRNA]; TGFB1 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; TGFB1 protein promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein]
CTD
PMID:21037076 PMID:22094456 PMID:24633426 PMID:26921287
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb2
transforming growth factor, beta 2
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]; leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]; RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]; Tranexamic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TGFB2 mRNA]
CTD
PMID:23558518 PMID:24633426 PMID:26921287 PMID:28049044
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Tgm1
transglutaminase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TGM1 mRNA
CTD
PMID:30723492
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Tgm4
transglutaminase 4
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TGM4 mRNA
CTD
PMID:30723492
NCBI chr 8:122,689,429...122,726,463
Ensembl chr 8:122,689,429...122,726,463
G
Tgoln2
trans-golgi network protein 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TGOLN2 mRNA
CTD
PMID:30723492
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
G
Thbd
thrombomodulin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of THBD mRNA
CTD
PMID:25380136
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
increases expression multiple interactions
ISO EXP
1-Naphthylisothiocyanate results in increased expression of THBS1 mRNA O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of THBS1 mRNA]
CTD
PMID:15913567 PMID:30723492
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thbs3
thrombospondin 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of THBS3 mRNA
CTD
PMID:30723492
NCBI chr 2:174,621,788...174,633,594
Ensembl chr 2:174,621,812...174,633,594
G
Thoc1
THO complex subunit 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of THOC1 mRNA
CTD
PMID:30723492
NCBI chr18:983,824...1,019,123
Ensembl chr18:983,824...1,019,114
G
Thrsp
thyroid hormone responsive
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of THRSP mRNA 1-Naphthylisothiocyanate results in increased expression of THRSP mRNA
CTD
PMID:17522070 PMID:30723492
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TICRR mRNA
CTD
PMID:30723492
NCBI chr 1:133,597,618...133,639,513
Ensembl chr 1:133,597,716...133,639,523
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of TIMP1 mRNA F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of TIMP1 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of TIMP1 mRNA]; Tranexamic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TIMP1 mRNA] 1-Naphthylisothiocyanate results in increased expression of TIMP1 mRNA; 1-Naphthylisothiocyanate results in increased expression of TIMP1 protein
CTD
PMID:17522070 PMID:21037076 PMID:22094456 PMID:23558518 PMID:24633426 PMID:25380136 PMID:30723492 More...
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Timp2
TIMP metallopeptidase inhibitor 2
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of TIMP2 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of TIMP2 mRNA
CTD
PMID:25380136 PMID:27344345
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
G
Tjp1
tight junction protein 1
multiple interactions decreases expression
ISO
acadesine inhibits the reaction [SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]]; acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]; dorsomorphin promotes the reaction [SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein] 1-Naphthylisothiocyanate results in decreased expression of TJP1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of TJP1 protein
CTD
PMID:32579994 PMID:33400020
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tk1
thymidine kinase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TK1 mRNA
CTD
PMID:30723492
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tkfc
triokinase and FMN cyclase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TKFC mRNA
CTD
PMID:25380136
NCBI chr 1:207,238,230...207,253,035
Ensembl chr 1:207,236,557...207,252,737
G
Tkt
transketolase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TKT mRNA
CTD
PMID:30723492
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
G
Tlcd2
TLC domain containing 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TLCD2 mRNA
CTD
PMID:30723492
NCBI chr10:60,310,577...60,314,263
Ensembl chr10:60,311,099...60,313,622
G
Tm6sf1
transmembrane 6 superfamily member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TM6SF1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:135,799,844...135,828,515
Ensembl chr 1:135,786,381...135,828,443
G
Tm7sf2
transmembrane 7 superfamily member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TM7SF2 mRNA
CTD
PMID:30723492
NCBI chr 1:203,355,930...203,360,287
Ensembl chr 1:203,355,931...203,360,270
G
Tmbim1
transmembrane BAX inhibitor motif containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMBIM1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 9:75,871,835...75,889,366
Ensembl chr 9:75,871,835...75,889,069
G
Tmed3
transmembrane p24 trafficking protein 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMED3 mRNA
CTD
PMID:30723492
NCBI chr 8:90,241,516...90,249,429
Ensembl chr 8:90,241,516...90,249,346
G
Tmeff2
transmembrane protein with EGF-like and two follistatin-like domains 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TMEFF2 mRNA
CTD
PMID:30723492
NCBI chr 9:50,445,947...50,733,473
Ensembl chr 9:50,436,079...50,733,475
G
Tmem106a
transmembrane protein 106A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMEM106A mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr10:86,506,908...86,515,915
Ensembl chr10:86,506,936...86,515,892
G
Tmem132b
transmembrane protein 132B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TMEM132B mRNA
CTD
PMID:30723492
NCBI chr12:30,829,831...31,093,841
Ensembl chr12:30,832,605...31,093,896
G
Tmem140
transmembrane protein 140
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TMEM140 mRNA
CTD
PMID:30723492
NCBI chr 4:63,536,477...63,547,478
Ensembl chr 4:63,536,168...63,548,455
G
Tmem165
transmembrane protein 165
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMEM165 mRNA
CTD
PMID:25380136
NCBI chr14:31,993,489...32,018,717
Ensembl chr14:31,993,493...32,018,717
G
Tmem169
transmembrane protein 169
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMEM169 mRNA
CTD
PMID:30723492
NCBI chr 9:73,926,553...73,950,679
Ensembl chr 9:73,926,568...73,950,576
G
Tmem178a
transmembrane protein 178A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMEM178 mRNA
CTD
PMID:25380136
NCBI chr 6:14,004,629...14,063,677
Ensembl chr 6:14,004,630...14,063,549
G
Tmem184b
transmembrane protein 184B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMEM184B mRNA
CTD
PMID:25380136
NCBI chr 7:110,925,092...110,967,975
Ensembl chr 7:110,925,092...110,967,943
G
Tmem43
transmembrane protein 43
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMEM43 mRNA
CTD
PMID:25380136
NCBI chr 4:123,977,680...123,992,823
Ensembl chr 4:123,977,625...123,992,825
G
Tmem59l
transmembrane protein 59-like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMEM59L mRNA
CTD
PMID:30723492
NCBI chr16:18,941,370...18,945,381
Ensembl chr16:18,941,567...18,945,381
G
Tmem64
transmembrane protein 64
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TMEM64 mRNA
CTD
PMID:30723492
NCBI chr 5:28,698,947...28,745,384
Ensembl chr 5:28,698,918...28,745,330
G
Tmem97
transmembrane protein 97
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMEM97 mRNA
CTD
PMID:30723492
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
G
Tmigd1
transmembrane and immunoglobulin domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMIGD1 mRNA
CTD
PMID:30723492
NCBI chr10:61,739,071...61,751,025
Ensembl chr10:61,736,462...61,751,025
G
Tmsb10
thymosin, beta 10
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TMSB10 mRNA
CTD
PMID:25380136
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
G
Tnc
tenascin C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TNC mRNA
CTD
PMID:30723492
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
multiple interactions increases expression
EXP ISO
Dexamethasone inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein]; Resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein]; Ursodeoxycholic Acid affects the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein] [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of TNF mRNA; [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of TNF protein; [Hypoxanthine co-treated with potassium oxonate] inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]; liquiritin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein]; NR1H4 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]; NR1H4 promotes the reaction [yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]]; pregna-4,17-diene-3,16-dione promotes the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein]; Uric Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]; Uric Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein]; yangonin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA] 1-Naphthylisothiocyanate results in increased expression of TNF mRNA; 1-Naphthylisothiocyanate results in increased expression of TNF protein
CTD
PMID:15135310 PMID:18364083 PMID:18590720 PMID:25051504 PMID:25418378 PMID:29660435 PMID:30517764 PMID:32198087 PMID:33400020 PMID:33749747 PMID:36008890 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TNFAIP3 mRNA
CTD
PMID:30723492
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip6
TNF alpha induced protein 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TNFAIP6 mRNA
CTD
PMID:30723492
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TNFRSF10B mRNA
CTD
PMID:14623915
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TNFRSF12A mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of TNFRSF1A mRNA
CTD
PMID:15913567 PMID:17522070
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of TNFRSF1B mRNA
CTD
PMID:27344345
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfrsf21
TNF receptor superfamily member 21
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TNFRSF21 mRNA
CTD
PMID:30723492
NCBI chr 9:17,879,156...17,954,085
Ensembl chr 9:17,879,156...17,954,085
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of TNFSF10 mRNA
CTD
PMID:27344345
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf11
TNF superfamily member 11
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TNFSF11 protein
CTD
PMID:25051504
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Tnfsf8
TNF superfamily member 8
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TNFSF8 mRNA
CTD
PMID:30723492
NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
G
Tnnt2
troponin T2, cardiac type
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TNNT2 mRNA
CTD
PMID:30723492
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Togaram2
TOG array regulator of axonemal microtubules 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TOGARAM2 mRNA
CTD
PMID:30723492
NCBI chr 6:23,770,979...23,828,884
Ensembl chr 6:23,771,052...23,828,499
G
Tonsl
tonsoku-like, DNA repair protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TONSL mRNA
CTD
PMID:30723492
NCBI chr 7:108,345,704...108,360,792
Ensembl chr 7:108,346,047...108,360,750
G
Top2a
DNA topoisomerase II alpha
affects expression increases expression
EXP
1-Naphthylisothiocyanate affects the expression of TOP2A protein 1-Naphthylisothiocyanate results in increased expression of TOP2A mRNA
CTD
PMID:26011634 PMID:30723492
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Topaz1
testis and ovary specific TOPAZ 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TOPAZ1 mRNA
CTD
PMID:30723492
NCBI chr 8:122,358,243...122,412,875
Ensembl chr 8:122,358,243...122,412,875
G
Tor4a
torsin family 4, member A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TOR4A mRNA
CTD
PMID:25380136
NCBI chr 3:8,004,292...8,007,979
Ensembl chr 3:8,002,023...8,008,042
G
Tp53
tumor protein p53
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TP53 mRNA
CTD
PMID:17522070
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53tg5
TP53 target 5
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TP53TG5 mRNA
CTD
PMID:30723492
NCBI chr 3:153,200,792...153,204,337
Ensembl chr 3:153,200,789...153,204,349
G
Tp73
tumor protein p73
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TP73 mRNA
CTD
PMID:30723492
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
G
Tpm1
tropomyosin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TPM1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
G
Tpm3
tropomyosin 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TPM3 mRNA
CTD
PMID:25380136
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
G
Tpm4
tropomyosin 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TPM4 mRNA
CTD
PMID:25380136
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Tpx2
TPX2, microtubule nucleation factor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TPX2 mRNA
CTD
PMID:30723492
NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468
G
Tra2a
transformer 2 alpha
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRA2A mRNA
CTD
PMID:30723492
NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712
G
Trafd1
TRAF type zinc finger domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRAFD1 mRNA
CTD
PMID:25380136
NCBI chr12:35,165,606...35,179,525
Ensembl chr12:35,165,606...35,179,525
G
Traip
TRAF-interacting protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRAIP mRNA
CTD
PMID:30723492
NCBI chr 8:108,641,860...108,661,640
Ensembl chr 8:108,641,852...108,661,638
G
Trak2
trafficking kinesin protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRAK2 mRNA
CTD
PMID:25380136
NCBI chr 9:60,348,531...60,414,036
Ensembl chr 9:60,350,012...60,413,996
G
Trhde
thyrotropin-releasing hormone degrading enzyme
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TRHDE mRNA
CTD
PMID:30723492
NCBI chr 7:49,943,271...50,350,613
Ensembl chr 7:49,945,766...50,367,371
G
Trib3
tribbles pseudokinase 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRIB3 mRNA
CTD
PMID:25380136
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim2
tripartite motif-containing 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TRIM2 mRNA
CTD
PMID:30723492
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trim24
tripartite motif-containing 24
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRIM24 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 4:66,567,342...66,692,029
Ensembl chr 4:66,566,686...66,717,241
G
Trim36
tripartite motif-containing 36
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRIM36 mRNA
CTD
PMID:30723492
NCBI chr18:38,859,604...38,912,859
Ensembl chr18:38,861,018...38,912,859
G
Trim43a
tripartite motif-containing 43A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TRIM43A mRNA
CTD
PMID:30723492
NCBI chr 8:89,562,568...89,568,716
Ensembl chr 8:89,562,568...89,568,716
G
Trim55
tripartite motif-containing 55
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRIM55 mRNA
CTD
PMID:30723492
NCBI chr 2:102,100,229...102,142,173
Ensembl chr 2:102,088,443...102,142,168
G
Trim59
tripartite motif-containing 59
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TRIM59 mRNA
CTD
PMID:25380136
NCBI chr 2:153,269,210...153,281,185
Ensembl chr 2:153,268,584...153,281,031
G
Trim7
tripartite motif-containing 7
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRIM7 mRNA
CTD
PMID:30723492
NCBI chr10:33,205,491...33,221,482
Ensembl chr10:33,205,491...33,221,468
G
Trip13
thyroid hormone receptor interactor 13
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRIP13 mRNA
CTD
PMID:30723492
NCBI chr 1:29,357,093...29,402,078
Ensembl chr 1:29,357,130...29,402,074
G
Trmt9b
tRNA methyltransferase 9B (putative)
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRMT9B mRNA
CTD
PMID:30723492
NCBI chr16:55,740,551...55,792,198
Ensembl chr16:55,743,018...55,792,144
G
Troap
trophinin associated protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TROAP mRNA
CTD
PMID:30723492
NCBI chr 7:130,233,534...130,242,369
Ensembl chr 7:130,234,544...130,242,365
G
Trpc3
transient receptor potential cation channel, subfamily C, member 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TRPC3 mRNA
CTD
PMID:30723492
NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRPM2 mRNA
CTD
PMID:30723492
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
G
Trpm4
transient receptor potential cation channel, subfamily M, member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TRPM4 mRNA
CTD
PMID:30723492
NCBI chr 1:95,781,805...95,812,095
Ensembl chr 1:95,782,000...95,812,532
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TRPM6 mRNA
CTD
PMID:30723492
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
G
Tsc22d1
TSC22 domain family, member 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TSC22D1 mRNA
CTD
PMID:25380136
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Tsc22d4
TSC22 domain family, member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TSC22D4 mRNA
CTD
PMID:30723492
NCBI chr12:18,939,150...18,952,008
Ensembl chr12:18,914,398...18,952,008
G
Tspan17
tetraspanin 17
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TSPAN17 mRNA
CTD
PMID:30723492
NCBI chr17:9,819,212...9,826,851
Ensembl chr17:9,819,202...9,826,834
G
Tspan8
tetraspanin 8
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TSPAN8 mRNA
CTD
PMID:25380136
NCBI chr 7:51,444,946...51,479,360
Ensembl chr 7:51,445,074...51,479,356
G
Tspo
translocator protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TSPO mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
G
Tspo2
translocator protein 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TSPO2 mRNA
CTD
PMID:30723492
NCBI chr 9:12,544,615...12,548,563
Ensembl chr 9:12,545,015...12,548,573
G
Tstd1
thiosulfate sulfurtransferase like domain containing 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TSTD1 mRNA
CTD
PMID:30723492
NCBI chr13:83,853,421...83,854,875
Ensembl chr13:83,822,035...83,854,885
G
Ttc36
tetratricopeptide repeat domain 36
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TTC36 mRNA
CTD
PMID:25380136
NCBI chr 8:45,112,737...45,116,345
G
Ttc39a
tetratricopeptide repeat domain 39A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TTC39A mRNA
CTD
PMID:30723492
NCBI chr 5:124,165,102...124,204,740
Ensembl chr 5:124,151,760...124,204,973
G
Ttk
Ttk protein kinase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TTK mRNA
CTD
PMID:30723492
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
G
Ttll10
tubulin tyrosine ligase like 10
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TTLL10 mRNA
CTD
PMID:30723492
NCBI chr 5:166,630,147...166,644,114
Ensembl chr 5:166,630,152...166,653,707
G
Ttll6
tubulin tyrosine ligase like 6
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TTLL6 mRNA
CTD
PMID:30723492
NCBI chr10:81,081,985...81,118,009
Ensembl chr10:81,091,975...81,127,234
G
Ttr
transthyretin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TTR mRNA
CTD
PMID:17522070
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Tuba1a
tubulin, alpha 1A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TUBA1A mRNA
CTD
PMID:30723492
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1b
tubulin, alpha 1B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TUBA1B mRNA
CTD
PMID:30723492
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1c
tubulin, alpha 1C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TUBA1C mRNA
CTD
PMID:30723492
NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tubb2b
tubulin, beta 2B class IIb
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TUBB2B mRNA
CTD
PMID:12832660
NCBI chr17:30,747,734...30,750,781
Ensembl chr17:30,747,734...30,750,638
G
Tubb4a
tubulin, beta 4A class IVa
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TUBB4A mRNA
CTD
PMID:30723492
NCBI chr 9:1,917,841...1,925,286
Ensembl chr 9:1,917,845...1,925,291
G
Tubb4b
tubulin, beta 4B class IVb
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TUBB4B mRNA
CTD
PMID:30723492
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TUBB5 mRNA
CTD
PMID:30723492
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tubb6
tubulin, beta 6 class V
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TUBB6 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
G
Tusc3
tumor suppressor candidate 3
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TUSC3 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr16:53,196,195...53,345,241
Ensembl chr16:53,196,195...53,344,781
G
Txn1
thioredoxin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TXN mRNA
CTD
PMID:17522070
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txnip
thioredoxin interacting protein
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TXNIP mRNA
CTD
PMID:20551477
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Txnl1
thioredoxin-like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TXNL1 mRNA
CTD
PMID:20551477
NCBI chr18:57,125,362...57,155,167
Ensembl chr18:57,125,369...57,165,266
G
Txnrd1
thioredoxin reductase 1
decreases expression multiple interactions increases expression
EXP ISO
1-Naphthylisothiocyanate results in decreased expression of TXNRD1 mRNA [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA 1-Naphthylisothiocyanate results in increased expression of TXNRD1 mRNA
CTD
PMID:17522070 PMID:20551477 PMID:27344345
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Tymp
thymidine phosphorylase
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TYMP mRNA
CTD
PMID:30723492
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Tyms
thymidylate synthetase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TYMS mRNA
CTD
PMID:30723492
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Tyrobp
transmembrane immune signaling adaptor Tyrobp
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of TYROBP mRNA
CTD
PMID:25380136
NCBI chr 1:85,672,931...85,676,856
Ensembl chr 1:85,672,994...85,676,848
G
Tyw1
tRNA-yW synthesizing protein 1 homolog
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of TYW1 mRNA
CTD
PMID:30723492
NCBI chr12:26,332,020...26,418,286
Ensembl chr12:26,330,351...26,418,208
G
U2surp-ps1
U2 snRNP-associated SURP domain containing, pseudogene 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of U2SURP-PS1 mRNA
CTD
PMID:25380136
NCBI chr 4:47,005,884...47,008,963
G
Ubd
ubiquitin D
increases expression affects expression
EXP
1-Naphthylisothiocyanate results in increased expression of UBD mRNA 1-Naphthylisothiocyanate affects the expression of UBD protein
CTD
PMID:25380136 PMID:26011634 PMID:30723492
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Ube2c
ubiquitin-conjugating enzyme E2C
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UBE2C mRNA
CTD
PMID:30723492
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2e3
ubiquitin-conjugating enzyme E2E 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of UBE2E3 mRNA
CTD
PMID:30723492
NCBI chr 3:63,786,976...63,851,400
Ensembl chr 3:63,786,650...63,843,237
G
Ube2t
ubiquitin-conjugating enzyme E2T
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UBE2T mRNA
CTD
PMID:30723492
NCBI chr13:46,403,352...46,413,854
Ensembl chr13:46,403,375...46,414,835
G
Ubqln1
ubiquilin 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of UBQLN1 mRNA
CTD
PMID:30723492
NCBI chr17:6,439,002...6,477,096
Ensembl chr17:6,439,002...6,477,090
G
Ubr2
ubiquitin protein ligase E3 component n-recognin 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of UBR2 mRNA
CTD
PMID:30723492
NCBI chr 9:13,982,427...14,062,315
Ensembl chr 9:13,982,329...14,062,139
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UCHL1 mRNA
CTD
PMID:30723492
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Ugcg
UDP-glucose ceramide glucosyltransferase
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UGCG mRNA
CTD
PMID:25380136
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression multiple interactions decreases expression
ISO EXP
1-Naphthylisothiocyanate results in increased expression of UGT1A1 protein Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of UGT1A1 mRNA]; Chenodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of UGT1A1 protein]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of UGT1A1 mRNA]; picroside II inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of UGT1A1 protein] 1-Naphthylisothiocyanate results in decreased expression of UGT1A1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of UGT1A1 protein ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of UGT1A1 mRNA]; ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of UGT1A1 protein]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of UGT1A1 mRNA]; Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of UGT1A1 protein]
CTD
PMID:28549656 PMID:32198087 PMID:32976922
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b
UDP glycosyltransferase 2 family, polypeptide B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of UGT2B mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr14:20,630,572...20,665,062
Ensembl chr14:20,630,250...20,651,776
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UGT2B1 mRNA
CTD
PMID:30723492
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b10
UDP glucuronosyltransferase 2 family, polypeptide B10
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UGT2B10 mRNA
CTD
PMID:30723492
NCBI chr14:21,107,996...21,128,648
Ensembl chr14:21,108,006...21,127,828
G
Ugt2b34l1
UDP glucuronosyltransferase 2 family, polypeptide B34 like 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UGT2B34L1 mRNA
CTD
PMID:30723492
NCBI chr14:21,146,140...21,167,706
Ensembl chr14:21,145,827...21,167,704
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UHRF1 mRNA
CTD
PMID:30723492
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
G
Unc119b
unc-119 lipid binding chaperone B
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of UNC119B mRNA
CTD
PMID:30723492
NCBI chr12:41,478,808...41,491,432
Ensembl chr12:41,478,808...41,491,432
G
Unc5b
unc-5 netrin receptor B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UNC5B mRNA
CTD
PMID:30723492
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
G
Unc5cl
unc-5 family C-terminal like
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of UNC5CL mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 9:12,528,109...12,543,382
Ensembl chr 9:12,528,246...12,542,233
G
Ush2a
usherin
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of USH2A mRNA
CTD
PMID:30723492
NCBI chr13:99,837,445...100,503,935
Ensembl chr13:99,837,445...100,503,922
G
Usp24
ubiquitin specific peptidase 24
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of USP24 mRNA
CTD
PMID:30723492
NCBI chr 5:121,080,687...121,210,321
Ensembl chr 5:121,080,470...121,210,311
G
Ust5r
integral membrane transport protein UST5r
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of UST5R mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 1:205,210,558...205,286,868
Ensembl chr 1:205,211,034...205,286,718
G
Vars1
valyl-tRNA synthetase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VARS1 mRNA
CTD
PMID:20551477
NCBI chr20:3,805,774...3,820,468
Ensembl chr20:3,805,776...3,820,298
G
Vash2
vasohibin 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VASH2 mRNA
CTD
PMID:30723492
NCBI chr13:102,529,718...102,561,204
Ensembl chr13:102,529,719...102,560,391
G
Vasp
vasodilator-stimulated phosphoprotein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VASP mRNA
CTD
PMID:25380136
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
G
Vcam1
vascular cell adhesion molecule 1
increases expression multiple interactions
EXP ISO
1-Naphthylisothiocyanate results in increased expression of VCAM1 protein [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of VCAM1 mRNA
CTD
PMID:25051504 PMID:27344345
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vcan
versican
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VCAN mRNA
CTD
PMID:30723492
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
G
Vegfa
vascular endothelial growth factor A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VEGFA protein
CTD
PMID:25051504
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfb
vascular endothelial growth factor B
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VEGFB mRNA
CTD
PMID:30723492
NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944
G
Vil1
villin 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VIL1 mRNA
CTD
PMID:30723492
NCBI chr 9:75,991,141...76,018,860
Ensembl chr 9:75,991,141...76,018,858
G
Vim
vimentin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VIM mRNA
CTD
PMID:25380136
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vipr1
vasoactive intestinal peptide receptor 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of VIPR1 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585
G
Vnn1
vanin 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of VNN1 mRNA
CTD
PMID:30723492
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
G
Vnn3
vanin 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of VNN3 mRNA
CTD
PMID:30723492
NCBI chr 1:21,571,364...21,583,626
Ensembl chr 1:21,571,364...21,583,626
G
Vom2r40
vomeronasal 2 receptor, 40
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VOM2R40 mRNA
CTD
PMID:12832660
NCBI chr 1:139,409,429...139,457,552
Ensembl chr 1:139,409,430...139,457,552
G
Vsir
V-set immunoregulatory receptor
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VSIR mRNA
CTD
PMID:25380136
NCBI chr20:28,281,582...28,307,262
Ensembl chr20:28,281,596...28,303,878
G
Vtcn1
V-set domain containing T cell activation inhibitor 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VTCN1 mRNA
CTD
PMID:30723492
NCBI chr 2:188,253,594...188,321,658
Ensembl chr 2:188,253,594...188,321,658
G
Vwf
von Willebrand factor
affects response to substance multiple interactions
ISO
VWF protein affects the susceptibility to 1-Naphthylisothiocyanate 1-Naphthylisothiocyanate results in increased expression of and results in increased activity of VWF protein; [VWF protein affects the susceptibility to 1-Naphthylisothiocyanate] which affects the abundance of Bilirubin; VWF protein affects the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]
CTD
PMID:34619301
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Vxn
vexin
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of VXN mRNA
CTD
PMID:30723492
NCBI chr 5:9,659,213...9,684,684
Ensembl chr 5:9,659,213...9,684,684
G
Wdr62
WD repeat domain 62
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of WDR62 mRNA
CTD
PMID:30723492
NCBI chr 1:85,491,531...85,530,643
Ensembl chr 1:85,491,533...85,530,637
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression increases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of WEE1 protein modified form 1-Naphthylisothiocyanate results in increased expression of WEE1 mRNA
CTD
PMID:23411599 PMID:30723492
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Wfdc3
WAP four-disulfide core domain 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of WFDC3 mRNA
CTD
PMID:30723492
NCBI chr 3:153,464,862...153,478,952
Ensembl chr 3:153,464,862...153,478,952
G
Wipf1
WAS/WASL interacting protein family, member 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of WIPF1 mRNA
CTD
PMID:25380136
NCBI chr 3:58,314,521...58,416,668
Ensembl chr 3:58,314,542...58,372,742
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
1-Naphthylisothiocyanate results in increased expression of WIPI1 mRNA
CTD
PMID:17175557
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Wls
Wnt ligand secretion mediator
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of WLS mRNA
CTD
PMID:25380136
NCBI chr 2:248,931,885...249,047,248
Ensembl chr 2:248,931,903...249,048,298
G
Wnt4
Wnt family member 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of WNT4 mRNA
CTD
PMID:30723492
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
G
Wnt7a
Wnt family member 7A
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of WNT7A mRNA
CTD
PMID:30723492
NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981
G
Xcl1
X-C motif chemokine ligand 1
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of XCL1 mRNA
CTD
PMID:30723492
NCBI chr13:77,248,687...77,252,343
Ensembl chr13:77,248,717...77,252,329
G
Xdh
xanthine dehydrogenase
multiple interactions increases expression
ISO
[1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of XDH mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of XDH mRNA 1-Naphthylisothiocyanate results in increased expression of XDH mRNA
CTD
PMID:33749747
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xkr5
XK related 5
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of XKR5 mRNA
CTD
PMID:30723492
NCBI chr16:70,874,983...70,892,972
Ensembl chr16:70,875,093...70,892,967
G
Xpnpep2
X-prolyl aminopeptidase 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of XPNPEP2 mRNA
CTD
PMID:25380136
NCBI chr X:127,287,765...127,317,036
Ensembl chr X:127,287,979...127,317,223
G
Yars1
tyrosyl-tRNA synthetase 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of YARS1 mRNA
CTD
PMID:20551477
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Ywhag
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of YWHAG mRNA
CTD
PMID:25380136
NCBI chr12:20,744,500...20,772,828
Ensembl chr12:20,744,535...20,772,827
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of YWHAZ mRNA
CTD
PMID:25380136
NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
G
Zbtb16
zinc finger and BTB domain containing 16
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZBTB16 mRNA
CTD
PMID:30723492
NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
G
Zbtb4
zinc finger and BTB domain containing 4
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZBTB4 mRNA
CTD
PMID:25380136
NCBI chr10:54,480,698...54,501,492
Ensembl chr10:54,485,071...54,501,492
G
Zbtb8b
zinc finger and BTB domain containing 8b
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ZBTB8B mRNA
CTD
PMID:30723492
NCBI chr 5:141,765,925...141,781,619
Ensembl chr 5:141,766,309...141,781,600
G
Zdhhc13
zinc finger DHHC-type palmitoyltransferase 13
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZDHHC13 mRNA
CTD
PMID:25380136
NCBI chr 1:98,487,319...98,525,906
Ensembl chr 1:98,487,358...98,525,905
G
Zdhhc2
zinc finger DHHC-type palmitoyltransferase 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZDHHC2 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr16:51,808,465...51,878,060
Ensembl chr16:51,808,468...51,878,060
G
Zdhhc23
zinc finger DHHC-type palmitoyltransferase 23
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ZDHHC23 mRNA
CTD
PMID:30723492
NCBI chr11:56,718,702...56,735,063
Ensembl chr11:56,718,826...56,734,194
G
Zeb2
zinc finger E-box binding homeobox 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ZEB2 mRNA
CTD
PMID:25380136
NCBI chr 3:29,214,581...29,344,890
Ensembl chr 3:29,218,301...29,345,157
G
Zfp189
zinc finger protein 189
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZFP189 mRNA
CTD
PMID:30723492
NCBI chr 5:63,872,596...63,884,348
Ensembl chr 5:63,872,738...63,884,121
G
Zfp354a
zinc finger protein 354A
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ZFP354A mRNA
CTD
PMID:30723492
NCBI chr10:35,396,242...35,408,069
Ensembl chr10:35,396,231...35,408,068
G
Zfp37
zinc finger protein 37
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ZFP37 mRNA
CTD
PMID:25380136 PMID:30723492
NCBI chr 5:75,598,732...75,638,896
Ensembl chr 5:75,598,732...75,638,942
G
Zfp541
zinc finger protein 541
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ZFP541 mRNA
CTD
PMID:30723492
NCBI chr 1:76,750,236...76,786,567
Ensembl chr 1:76,750,236...76,786,567
G
Zfp69
zinc finger protein 69
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ZFP69 mRNA
CTD
PMID:30723492
NCBI chr 5:134,502,002...134,516,428
Ensembl chr 5:134,501,998...134,514,358
G
Zg16
zymogen granule protein 16
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZG16 mRNA
CTD
PMID:12832660
NCBI chr 1:181,657,722...181,660,079
Ensembl chr 1:181,657,722...181,660,079
G
Zkscan1
zinc finger with KRAB and SCAN domains 1
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZKSCAN1 mRNA
CTD
PMID:30723492
NCBI chr12:16,966,287...16,987,680
Ensembl chr12:16,966,654...16,983,865
G
Zmiz2
zinc finger, MIZ-type containing 2
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ZMIZ2 mRNA
CTD
PMID:30723492
NCBI chr14:81,251,391...81,267,936
Ensembl chr14:81,251,417...81,267,936
G
Zmym2
zinc finger MYM-type containing 2
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZMYM2 mRNA
CTD
PMID:12832660
NCBI chr15:31,035,835...31,108,945
Ensembl chr15:31,035,838...31,109,357
G
Zmynd15
zinc finger, MYND-type containing 15
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZMYND15 mRNA
CTD
PMID:30723492
NCBI chr10:55,171,198...55,177,812
Ensembl chr10:55,171,198...55,177,812
G
Znf750
zinc finger protein 750
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZNF750 mRNA
CTD
PMID:30723492
NCBI chr10:106,772,162...106,781,186
Ensembl chr10:106,772,669...106,781,200
G
Znrf3
zinc and ring finger 3
decreases expression
EXP
1-Naphthylisothiocyanate results in decreased expression of ZNRF3 mRNA
CTD
PMID:30723492
NCBI chr14:80,157,854...80,313,456
Ensembl chr14:80,160,278...80,313,485
G
Zscan10
zinc finger and SCAN domain containing 10
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZSCAN10 mRNA
CTD
PMID:30723492
NCBI chr10:12,636,302...12,646,275
Ensembl chr10:12,636,302...12,646,275
G
Zwilch
zwilch kinetochore protein
increases expression
EXP
1-Naphthylisothiocyanate results in increased expression of ZWILCH mRNA
CTD
PMID:30723492
NCBI chr 8:64,638,401...64,670,911
Ensembl chr 8:64,637,672...64,675,916
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all